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Abstract 
 
Mild cognitive impairment (MCI), a term used to describe the transitional state between 
normal aging and established dementia, has been identified as a potentially effective 
time point at which to target interventions to prevent or slow the decline into dementia.  
An efficient way of identifying people with MCI is required as a first step in conducting 
large scale studies to develop and evaluate interventions targeted at this high risk 
population. 
 
The aim of the thesis was to investigate the effectiveness of a range of brief cognitive 
tests to be used for the purpose of identifying people with MCI in an efficient and 
accurate manner. A systematic review of the literature found that over 40 brief cognitive 
tests have been developed and tested to identify amnestic MCI (aMCI). However, the 
majority of these previous studies were conducted in secondary care settings and were 
at high risk of unblinding the assessment process, which may have exaggerated the 
diagnostic accuracy of the assessed tests. 
 
The Memory Alteration Test (M@T) and Test Your Memory test (TYM) were selected 
as potentially useful brief cognitive tests for aMCI and their validity was assessed 
within a cohort of older people recruited from the community, without prior knowledge 
of their cognitive status. A total of 472 older people were assessed for MCI according to 
the Petersen criteria using a standardised battery of neuropsychological tests. A 
prevalence of MCI of 16.5% was found within the assessed cohort and the M@T was 
found to be more accurate than the TYM at detecting aMCI, performing with a 
sensitivity of 85% and specificity of 84%. 
 
vi 
The ability of reaction time task derived measures to identify cognitive impairment 
within the cohort was also assessed. These were not as accurate at predicting cognitive 
status as the M@T. However, they did demonstrate some promising discriminative 
abilities and should be further explored as potentially useful alternatives to the 
traditionally used memory tests, which may be influenced by administrator bias, 
education level and language ability. 
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Chapter 1: Introduction 
 
As the population ages, dementia is becoming a common and increasing problem for 
individuals, families and society. Dementia is a general term used to describe a clinical 
syndrome with multiple aetiology, in which there is a progressive decline in areas of 
function such as memory, reasoning, communication skills and the ability to carry out 
daily activities (Department of Health, 2009; Knapp & Prince 2007). Alzheimer’s 
disease (AD), the predominant symptom of which is memory loss, is the most common 
cause of dementia (Ferri et al., 2005). There is currently no cure for AD and only 
limited progress has been made with research into drug treatments (Schneider et al., 
2014). Researchers have recognised that it may be more effective to target interventions 
at people in a pre-dementia phase of AD, before the progressive disease is established 
(Petersen et al., 2014).  
 
Several terms, including age-associated memory impairment (AAMI) (Crook et al., 
1986), aging-associated cognitive decline (AACD) (Levy, 1994) or cognitively 
impaired, not demented (CIND) (Ebly, Hogan, & Parhad, 1995; Ebly, Parhad, Hogan, & 
Fung, 1994) have been proposed in order to define the mild impairments that can 
precede established dementia. However, a concept which has become increasingly 
popular in clinical research and practice is the term Mild Cognitive Impairment (MCI). 
MCI is defined as “cognitive decline greater than that expected for an individual’s age 
and education level but that does not interfere notably with activities of daily life” 
(Gauthier et al., 2006).  
 
 
 
2 
Concept of Mild Cognitive Impairment (MCI) 
 
Mild cognitive impairment (MCI) was first introduced as a term to describe the 
intermediate stage between healthy ageing and dementia over 25 years ago (Reisberg et 
al., 1989). Reisberg and colleagues used the term to describe people who scored a rating 
of 3 on the Global Deterioration Scale (GDS). This scale (1-7) was developed for the 
assessment of primary degenerative dementia, with stages 1-3 describing pre-dementia 
phases (where 1 = no cognitive impairment; 2 = subjective cognitive impairment; 3 = 
MCI) and stages 4-7 describing established dementia of increasing severity (Reisberg, 
Ferris, de Leon, & Crook, 1982). A Clinical Dementia Rating (CDR) scale score of 0.5 
has also been applied to identify individuals with MCI. This is a scale used to stage the 
severity of AD and is derived from a semi-structured interview with the patient and a 
reliable informant (e.g. spouse or other family member/caregiver). Impairment in each 
of six cognitive categories (Memory, Orientation, Judgement and Problem Solving, 
Community Affairs, Home and Hobbies, and Personal Care) is rated on a five-point 
scale (where 0 = none, 0.5 = questionable, 1 = mild, 2 = moderate and 3 = severe) 
(Morris, 1993). 
 
Whilst both the GDS and CDR are useful scales for staging the severity of dementia, 
they do not necessarily correspond to specific diagnoses (Petersen & Negash, 2008). In 
1999, Petersen and colleagues further developed the concept of MCI by proposing 
definitive criteria to characterise individuals at high risk of further cognitive decline 
(Petersen et al., 1999).  The original criteria (see Table 1.1) were specifically designed 
to characterize the early stages of an Alzheimer's like process, and were thus centred on 
memory impairment, consequently described as amnestic MCI (aMCI) (Petersen & 
Negash, 2008). 
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Table 1.1: Petersen’s criteria for amnestic mild cognitive impairment 
Criteria 
1. Memory complaint, preferably corroborated by an informant 
2. Objective memory impairment for age 
3. Essentially preserved general cognitive function 
4. Largely intact activities of daily living 
5. Not demented 
 
Subsequent work indicated that aMCI may not encompass all of the prodromal states of 
dementia and that a broader conceptualisation of MCI was necessary. In 2003, a 
conference of international experts on MCI was convened and more expansive criteria 
for MCI were proposed, which included the consideration of multiple types of cognitive 
impairment (Petersen, 2004; Winblad et al., 2004). A diagnostic flowchart was devised 
(see Figure 1.1) to differentiate between MCI with memory impairment (amnestic MCI, 
aMCI) and MCI with non-memory cognitive domain impairment (non-amnestic MCI, 
naMCI). These two subtypes were further divided into single and multiple domain types 
depending upon whether only one or more cognitive domains were impaired 
respectively. 
 
An outcome framework, detailing the presumed outcome for each MCI subtype 
according to its presumed aetiology was also developed by Petersen and colleagues 
(2004) (see Figure 1.2). As the figure depicts, amnestic MCI subtypes with presumed 
degenerative aetiology are likely to represent a prodromal form of Alzheimer’s disease. 
Whereas the non-amnestic subtypes that emphasize impairments in non-memory 
domains have a higher likelihood of progressing to non-Alzheimer’s dementias such as 
frontotemporal dementia and dementia with Lewy bodies (Petersen, 2003; Petersen & 
Negash, 2008). 
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Figure 1.1: Flow chart of decision process for making diagnosis of subtypes of mild cognitive 
impairment. Adapted from Petersen (2004); Winblad et al. (2004)  
 
 Etiology 
 
 
 
Amnestic  
MCI 
  
Degenerative 
 
Vascular 
 
Psychiatric 
Medical  
Conditions 
Single  
domain 
AD  Depr  
Multiple  
domain 
AD VaD Depr  
 
Non-amnestic 
MCI 
Single  
domain 
FTD    
Multiple  
domain 
DLB VaD   
 
Figure 1.2: Predicted outcome of MCI subtypes according to presumed etiology  
Adapted from Petersen and Negash (2008) 
(KEY: MCI = mild cognitive impairment; AD = Alzheimer’s disease; FTD = frontotemporal dementia; 
DLB = dementia with Lewy bodies; VaD = vascular dementia; Depr = depression) 
 
Cognitive complaint
Not normal for age
Not demented
Cognitive decline
Essentially normal functional activities
MCI
Memory impaired?
Amnestic MCI Non-amnestic MCI
Yes No
Memory impairment 
only?
Single nonmemory 
cognitive domain 
impaired?
Amnestic MCI
Single Domain
Amnestic MCI
Multiple Domain
Non-amnestic MCI
Single Domain
Non-amnestic MCI
Multiple Domain
Yes No Yes No
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Since the publication of these expanded Petersen, or Mayo Clinic, criteria in 2003, 
numerous studies have used the definition to study the construct of MCI and they have 
become the most widely used criteria in the field. However, this is a continually 
developing field of research and recent advances in neuroimaging and neuropathology 
have led to the development of proposed biomarkers that reflect the neuropathological 
changes that are deemed to be the hallmark of AD, such as markers of Aβ deposition 
and of neuronal injury (Molin & Rockwood, 2016). These advances have led to the 
development of further diagnostic criteria, such as those proposed by the International 
Working Group for New Research Criteria for the Diagnosis of AD (Dubois et al., 
2007) and the National Institute on Aging-Alzheimer’s Association (NIA-AA) (Albert 
et al., 2011), which incorporate the use of biomarkers. However, their core criteria 
largely overlap with the Petersen criteria (Petersen et al., 2014) and the proposed 
biomarkers are not yet validated for use in routine practice (Molin & Rockwood, 2016; 
Petersen et al., 2014). Thus the diagnostic criteria proposed by Petersen and colleagues 
(2003) remain the most widely and routinely applied criteria and hence were the focus 
of the following work. 
 
The prodromal state of MCI has been demonstrated with regard to neuropathological 
substrates (e.g. neuritic plaques, neurofibrillary tangles, hippocampal atrophy) in 
numerous studies (Luck, Luppa, Briel, & Riedel-Heller, 2010). For instance, a study by 
Petersen and colleagues (2006) compared autopsy tissue from 15 individuals who died 
whilst their clinical diagnosis was aMCI to that from age-matched groups of people who 
were either clinically healthy or had probable AD at the time of their death. Their study 
found that the aMCI individuals exhibited neuropathologic features which were 
intermediate between the neurofibrillary changes of aging and the pathologic features of 
early AD. In particular, all the patients with aMCI had pathologic findings involving 
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medial temporal lobe structures that likely accounted for their memory impairment, as 
well as many concomitant pathologic abnormalities, including argyrophilic grain 
disease, hippocampal sclerosis, and vascular lesions (Petersen et al., 2006). Another 
study by Grundman and colleagues (2004) found that people with aMCI had 
hippocampal volumes that were intermediate between those of controls and patients 
with AD (Grundman et al., 2004). Taken together this provides further evidence to 
suggest that MCI represents a transitional state between normal aging and dementia. 
 
Incidence, Prevalence & Progression of MCI 
 
A systematic review of population-based studies conducted by Luck and colleagues 
(2010) found that the reported incidence rates of MCI vary substantially, with rates 
ranging from 8.5 to 76.8 per 1000 person-years in persons aged ≥60 years (Luck et al., 
2010). With regards to different subtypes, reports of aMCI incidence ranged from 9.9 to 
40.6 per 1000 persons-years, and of naMCI incidence ranged from 28 to 36.3 per 1000 
person-years. Five of the nine included studies reviewed the possible risk factors for 
incident MCI and found that higher age, lower education and hypertension were 
particularly associated with a higher risk of developing MCI (Luck et al., 2010).  
A more recent systematic review by Ward and colleagues (2012) also found substantial 
variation in the reported prevalence rates of MCI, with rates of MCI ranging from 3 to 
42% and of the aMCI subtype ranging from 0.5 – 31.9% (Ward, Arrighi, Michels, & 
Cedarbaum, 2012). This variation in both incidence and prevalence rates could be 
explained by the fact that there is currently no consensus on how MCI criteria should be 
operationalised, which has led to great variety in the methods employed to assess for 
MCI (Petersen et al., 2014). For instance, a wide variety of different procedures and 
tests have been used to assess cognition, as well as different cut-off points on test scores 
to define impairment (Ward et al., 2012). Other reasons for the wide disparity in 
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incidence and prevalence rates have been suggested, such as differences in sample size, 
recruitment strategies, geographic region and length of follow-up (Luck et al., 2010; 
Ward et al., 2012). The Medical Research Council (MRC) Cognitive Function and 
Aging Study (CFAS), a large-scale multi-centre study that was set up to investigate 
dementia and cognitive decline in a UK-based representative sample of more than 
18,000 people aged over 65 years, conducted a direct comparison of different 
classifications of MCI in a subsample of their population to further investigate reported 
disparities in prevalence rates. Across the different classification systems, prevalence 
varied widely from 0.1% - 42%, reflecting differences in the focus and content of each 
system. For aMCI and multiple domain MCI specifically classified according to the 
Petersen criteria, they reported a prevalence of 2.5% (1.7 – 3.6%) and 2.6% (1.8 - 3.5%) 
respectively (Stephan, Matthews, McKeith, Bond, & Brayne, 2007).   
 
A number of studies have also investigated the rates of progression of people with MCI 
to dementia. In the paper in which they first proposed diagnostic criteria for aMCI, 
Petersen and colleagues (1999) reported conversion rates to AD of 12% per year in a 
cohort of 76 people with aMCI who were followed up for 4 years. This was in contrast 
with a 1-2% conversion rate observed in the control subjects (Petersen et al., 1999). 
Other studies have reported similar rates, for instance, a study by Lonie and colleagues 
(2010) reported an annual conversion rate of 11.4% (95% CI 4–23%) to dementia (most 
often AD) in participants with aMCI (Lonie et al., 2010). The MRC CFAS study 
(referred to above) reported a 7.4% conversion rate of MCI to dementia at 2 year 
follow-up in the same subsample used to investigate prevalence rates. Again conversion 
rates varied depending on the classification system used, from 0.3 – 29.0% (Matthews, 
Stephan, McKeith, Bond, & Brayne, 2008). Other studies have reported even higher 
conversion rates. For instance a study by Geslani and colleagues (2005) reported a 
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conversion rate to AD of 41% after one year, based on a longitudinal follow-up of 54 
aMCI participants (Geslani, Tierney, Herrmann, & Szalai, 2005). However, other 
studies with longer follow-up periods have reported lower conversion rates. A 
systematic review of 15 studies that had a follow-up period of 5 years or longer reported 
a pooled annual conversion rate to dementia of 4.2% (95% CI 3.9% to 4.6%) (Mitchell 
& Shiri-Feshki, 2008). It was observed by Mitchell and Shiri-Feshki (2008) that the 
highest rates of conversion were often seen in clinical samples recruited from specialist 
centres, such as memory clinics. The review also reported that the proportion converting 
to dementia tended to decline with longer observation periods, suggesting that the risk 
of progression diminishes with time. It was argued that this was likely to be due to the 
fact that in the first few years of follow-up many of those with the most adverse risk 
profile will tend to progress, dropout or die, leaving a cohort of less vulnerable 
sufferers. The authors pointed out, however, that an inverse temporal relationship was 
also evident in those who completed long term follow-up, suggesting other factors could 
be involved such as sampling issues or heterogeneity in the construct of MCI itself 
(Mitchell & Shiri-Feshki, 2008). 
 
The instability of MCI has been highlighted in some studies. For instance, in the study 
by Lonie and colleagues (2010), of the aMCI participants who did not convert to 
dementia, 31% in fact had reverted back to normal cognition within 4 years. Other 
population-based studies have estimated that up to 44% of patients who have MCI at 
baseline return to normal cognitive function a year later (Ganguli, Dodge, Shen, & 
DeKosky, 2004; Ritchie, 2004). These studies underline the fact that there are many 
factors affecting cognitive performance in elderly populations apart from 
neurodegenerative disorders, including education, depression, anxiety, medication, 
vascular disease, and other treatable conditions, which could account for why many 
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cases of MCI are reversible (Petersen et al., 2014). Petersen argues that instability of the 
construct is perhaps not surprising due to the subtle nature of early impairment and it 
has been demonstrated that stability of the diagnosis improves with longer follow-up 
periods (Petersen et al., 2014).  
 
Rationale for Detecting MCI 
 
Despite the controversy surrounding the concept and diagnosis of MCI, it is clear that 
these individuals have a higher risk for developing neurodegenerative dementia, and are 
therefore of research and clinical interest. Dementia is one of the major causes of 
disability and dependency among older people worldwide (Dementia: A Public Health 
Priority, 2012). The burden of dementia is enormous, affecting the individual, as well as 
their family and friends, on personal, emotional, financial and social levels. A report to 
the Alzheimer’s society in 2007 estimated that there were approximately 700,000 
people living with dementia in the UK and that this was set to rise to 1.7 million by 
2051 (Knapp & Prince, 2007). The same report estimated the financial cost of dementia 
to the UK to be £17.03 billion per annum, including formal care costs as well as the 
ﬁnancial value of unpaid informal care provided by family and friends (Knapp & 
Prince, 2007). 
 
Alzheimer’s disease (AD) is the most common cause of dementia, accounting for 60-
80% of cases (Barker et al., 2002). There is currently no cure for AD and clinical trials 
of interventions to meaningfully slow or prevent disease progression post-diagnosis 
have largely been unsuccessful (Schneider et al., 2014; Stephan & Brayne, 2014). 
Consequently, there have been calls to target intervention trials at individuals in a pre-
dementia phase, possibly before irreversible neuronal damage has occurred. As 
discussed earlier, the concept of MCI has been developed to try to identify people who 
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are potentially in a transitional state between normal and pathological ageing and at a 
high risk of progressing to dementia and are thus important to consider for future early 
intervention trials.   
 
In order to develop and test interventions, large cohorts of people with MCI need to be 
identified. However, the diagnosis of MCI, based on the Petersen criteria described 
earlier, involves in depth neuropsychological testing which is time consuming and 
burdensome. Shorter, less arduous cognitive measures would provide a more efficient 
and feasible method for researchers to identify people with probable MCI from large, 
community-based populations for participation in large scale, pragmatic intervention 
studies. Shorter procedures would also be of use to primary care clinicians who often 
lack the time, training and resources to perform in depth cognitive assessments (Artero 
& Ritchie, 2003). Quick tests, sensitive enough to detect MCI, could provide a practical 
approach to screening for people at high risk of developing dementia who may require 
referral to specialist services for further assessment and monitoring. 
 
Aims of Research & Outline of Thesis 
 
The overall aim of the current thesis was to investigate the effectiveness of a range of 
brief cognitive tests to be used for identifying people with MCI in an efficient and 
accurate manner. This aim was met by addressing four research questions which are 
addressed in the following Chapters. 
 
Research Question 1: What brief cognitive tests have been used previously to 
identify people with aMCI and what is the evidence for their accuracy? 
Research question 1 is addressed in Chapter 2, which covers the findings from a 
systematic review, providing a summary of the studies that have previously investigated 
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the validity of brief cognitive tests for identifying people with the amnestic form of 
MCI (aMCI). This Chapter details the reported validity and reliability results of 
previously investigated tests as well as provides a commentary on the methodological 
quality of these previous studies. 
 
Research questions 2-4 are covered in Chapters 3-5, which describe the experimental 
work that has been carried out to investigate the validity of two brief memory tests 
identified from the literature (the Memory Alteration Test (M@T) (Rami, Molinuevo, 
Sanchez-Valle, Bosch, & Villar, 2007) and the Test Your Memory (TYM) test (Brown, 
Pengas, Dawson, Brown, & Clatworthy, 2009)) as well as reaction time task derived 
measures for detecting MCI.  
 
Research Question 2: Can people with MCI be identified and recruited from the 
community in an efficient and timely manner? 
Research question 2 is addressed in Chapter 3, which describes the recruitment of the 
cohort of older people upon whom the tests under investigation were validated. This 
Chapter details the assessment methods that were employed to classify people as having 
MCI or not. As discussed previously, the Petersen criteria provide a framework by 
which to determine whether or not a person has MCI; however there is currently no 
consensus on how these criteria should be operationalised (Petersen et al., 2014). For 
this study, a standardised protocol of neuropsychological tests was developed in order to 
assess for objective cognitive impairment. The tests included in the battery are widely 
used in clinical settings and have established normal reference values and cut-offs. A 
classification consistent with MCI was determined according to the Petersen criteria 
(Petersen, 2004). 
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Research Question 3: Are candidate brief cognitive tests (namely the Memory 
Alteration Test (M@T) and the Test Your Memory (TYM) test) accurate, reliable 
and usable in identifying people with aMCI from the community? 
Research question 3 is addressed in Chapter 4, which reports on the findings from the 
validation work that was carried out to assess the effectiveness of the M@T and TYM 
for identifying people with aMCI from the recruited cohort. The aims of this work were 
threefold: to investigate (1) their sensitivity/specificity in detecting aMCI; (2) their test-
retest reliability performance; and, (3) their clinical utility, assessed in terms of 
administration time and completion rates.  
 
Research Question 4: Are reaction time (RT) derived measures accurate in 
identifying MCI? 
Research question 4 is addressed in Chapter 5, which reports on an investigation into 
the utility of simple reaction time task derived measures for identifying cognitive 
impairment, as an alternative to the more traditionally used neuropsychological memory 
tests. Previous research has suggested that mean level of, and in particular variability in, 
processing speed performance is a key predictor of MCI/dementia (Christensen et al., 
2005; Hultsch, MacDonald, Hunter, Levy-Bencheton, & Strauss, 2000). The work in 
this chapter directly compares the ability of the M@T and TYM with these more 
objective measures for predicting cognitive status.  
 
The thesis ends with a discussion of the main findings from each of the studies, placing 
them within the context of previous work and highlighting their implications. The 
limitations of the current work are discussed as well as proposals for future work. 
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Development Work: From Concept to Thesis 
 
It is important to place this thesis within the context of the broader contributing 
development and grant work. The experimental work covered in Chapters 3 and 4 was 
funded by a National Institute for Health Research (NIHR) Research for Patient Benefit 
(RfPB) grant which was awarded in December 2011. I was a named co-applicant on the 
grant and contributed to the writing of the application and co-ordinated it’s submission. 
In July 2012, I registered to complete a PhD using the NIHR funded work as its basis. 
As ideas for the PhD thesis developed, further complementary pieces of work including 
the systematic review of brief cognitive tests (Chapter 2) and investigation of reaction 
time task derived measures (Chapter 5) were conducted. 
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Chapter 2: A Systematic Review of the Diagnostic Test Accuracy of 
Brief Cognitive Tests to Detect Amnestic Mild Cognitive Impairment 
 
Introduction 
 
As discussed in Chapter 1, MCI is a term used to describe the transitional state between 
normal aging and established dementia (Petersen et al., 1999). Subtypes of MCI include 
amnestic (with memory impairment, aMCI) and non-amnestic (without memory 
impairment, naMCI). MCI of the amnestic-type is the commonest subtype, with a 2.6 
fold increased incidence rate compared to naMCI being reported in a large longitudinal 
study by Roberts and colleagues (Roberts et al., 2012). People with MCI are at an 
increased risk of developing dementia and aMCI in particular is associated with 
elevated rates of conversion to Alzheimer’s disease (Petersen et al., 2001), which is the 
most common form of dementia (Ferri et al., 2005). The reliable recognition of people 
with aMCI is therefore of particular interest to both researchers and clinicians. 
 
It has been suggested that targeting interventions on people with aMCI might prevent or 
slow their decline into dementia (Petersen, Roberts, Knopman, Boeve, Geda, Ivnik, 
Smith, & Jack, 2009).  However, the application of the Petersen criteria to diagnose 
aMCI is not straightforward and requires assessment by a trained specialist, along with 
considerable commitment from the patient to complete a complex battery of cognitive 
tests that are time consuming and can be fatiguing. Less demanding cognitive tests 
might have utility to provide a more efficient method to identify people with aMCI in 
research or clinical settings, but this would require test accuracy to have been 
confirmed. 
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This Chapter describes the findings from a systematic review that was conducted to 
identify the brief cognitive tests that have been used to identify people with aMCI and 
to evaluate the evidence for their accuracy. The work updates an earlier review (Lonie, 
Tierney, & Ebmeier, 2009) but is also more focussed, including only those tools that 
take less than 15 minutes to administer and incorporates a quality appraisal of the 
included studies, an aspect not covered in the previous review. In addition, new 
information on any predictive validity and reliability measures reported for the tools is 
included.  
 
Methods 
 
A systematic review was performed to describe the test accuracy of brief cognitive tests 
that have been used to identify people with aMCI. The methodology and reporting of 
this review followed standard guidance (Deeks, Bossuyt, & Gatsonis, 2010; Moher, 
Liberati, Tetzlaff, Altman, & Group, 2009). 
 
Criteria for considering studies for this review 
Prospective studies assessing the diagnostic test accuracy (DTA) of brief and simple 
cognitive tests used to identify people with aMCI (index tests) against a reference 
standard were considered for inclusion. Studies published in a language other than 
English were excluded. Only peer reviewed articles were included. 
 
Participants  
Participants were people with aMCI (single and multi-domain) diagnosed according to 
the Petersen criteria. 
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Index tests 
Index tests considered for inclusion were those that were considered to be brief and 
simple cognitive tests, where “brief” was defined as: (1) taking less than 15 minutes to 
administer and “simple” was defined as: (2) not computer-based or requiring specialist 
equipment; and (3) not requiring specialist staff for administration. Studies assessing 
telephone administered or wholly carer/informant rated screening tools were excluded.   
 
Reference standard 
As it is the most widely used procedure for diagnosing aMCI, only those studies which 
used the Petersen criteria as the reference standard for verification of diagnosis were 
included in the review. 
 
Search methods for identification of studies 
The following databases were searched to identify studies for inclusion: MEDLINE, 
EMBASE, BIOSIS Previews, Web of Science, PsychINFO, LILACS, CINAHL, 
AMED, Cochrane Library, ASSIA, IBSS, PsychARTICLES, Scopus, Sociological 
Abstracts and ProQuest dissertations and theses. Databases were searched from 1999 – 
July 2013 (see Appendix 2.1 for the strategy used to search CINAHL). 
 
Selection of studies 
The search results were imported into Endnote, de-duplicated, and all titles and abstracts 
of the remaining citations were examined for potential eligibility. Following this initial 
“sifting” stage, full text copies of all potentially relevant articles were obtained and 
assessed for inclusion according to the stated eligibility criteria. Each study selection 
phase was performed by two independent reviewers and any disagreements in the 
selection of abstracts and full texts were settled by consensus. 
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Data extraction and management 
Two independent reviewers extracted all data from included studies using a bespoke 
standardised data extraction form (see Appendix 2.2) and any disagreements within the 
extraction forms between reviewers were resolved by consensus. The extracted data 
included information on methods (e.g. study design, recruitment procedure) and 
participant characteristics. The operationalised reference criteria used and index tests, 
including cut-off points for diagnosis, were recorded. In addition, any validity and test-
retest reliability measures reported for the index tests were also extracted.  The 
measures for DTA included: sensitivity, specificity and AUC (area under the receiver 
operating characteristic (ROC) curve) for discriminating between aMCI and cognitively 
normal participants.  Where sensitivity and/or specificity were reported for more than 
one cut-off, only the values reported as optimal by the author were extracted. In cases 
where no optimal value was stated, the cut-off providing the highest sensitivity was 
extracted.  Where available, data concerning the ability of the test to predict future 
dementia were also extracted.  
 
Assessment of methodological quality 
Two independent reviewers assessed the methodological quality of the included studies 
using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool 
(Whiting et al., 2011), as recommended by The Cochrane Collaboration. QUADAS-2 
involves a structured assessment using signalling questions in four domains: patient 
selection, index test, reference standard, and flow and timing (see Appendix 2.2). For 
each domain, a judgement of high, low or unclear risk of bias was made. A judgement 
of high risk was made if the answer to any of the signalling questions within a domain 
was “No”, a judgement of low risk was made if the answer to all of the signalling 
questions within a domain was “Yes”, and a judgement of unclear risk was made in all 
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other circumstances. Similarly, for overall assessment of risk of bias, a study was 
considered to be at high risk of bias if any of the domains were judged to be high, at low 
risk of bias if all of the domains were judged to be low and at unclear risk of bias in all 
other circumstances. 
 
Statistical analysis and data synthesis 
RevMan 5.2 software (http://tech.cochrane.org/revman) was used to construct 2 x 2 
tables of index test performance (i.e. number of true positives (TP), false negatives 
(FN), false positives (FP) and true negatives (TN)) using reported sensitivity and 
specificity values, as well as total number of participants and proportion of aMCI 
participants.  These data were used to calculate the sensitivity and specificity with 95% 
confidence intervals (CI) and construct forest plots. Positive and negative predictive 
values (PPVs and NPVs) and positive and negative likelihood ratios (LR+ and LR-) 
were also calculated.  Meta-analysis was performed, where appropriate, using STATA 
version 13.0 (StatCorp, 2013) software. Where sufficient studies were found (n ≥ 4) that 
reported DTA data for the same test and cut-off, pooled estimates of sensitivity, 
specificity, LR+, LR- and summary diagnostic odds ratios were produced using a 
random effects bivariate model (Harbord, Deeks, Egger, Whiting, & Sterne, 2007; 
Reitsma et al., 2005) and heterogeneity was assessed using the I
2
 statistic.  Where four 
or more studies were assessing the same test at different cut-offs, summary ROC curves 
were produced using the STATA MIDAS module (Dwamena, Sylvester, & Carlos, 
2010).  
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Results 
 
Results of the search 
The search identified 6431 citations, of which, 158 were considered as potentially 
relevant and the full articles obtained. Subsequently, 119 reports were excluded and 39 
included (see Figure 2.1).  Of these, 37 were cross-sectional DTA studies and two were 
longitudinal DTA studies that investigated the predictive validity of several index tests. 
There were 5766 aMCI and cognitively normal participants included in these studies.  
The mean prevalence of aMCI reported in the cross-sectional DTA studies was 42.4% 
but varied considerably from 3.1% to 72%.  The majority of these studies (n = 32) 
recruited their aMCI population from secondary care settings, such as memory clinics 
and hospital departments, four studies recruited from the community and the remainder 
recruited from a mixture of secondary care and community based settings (n = 3). The 
characteristics of the included studies are summarised in Table 2.1. 
 
In total, 42 brief and simple cognitive tests were investigated in the 39 studies. These 
tests are listed and described in Table 2.2.  Thirty five of the index tests involve single 
tasks. The similar single task index tests have been grouped together, for example, four 
versions of clock drawing tests (CDTs), five verbal fluency tasks (VFTs) and three 
verbal learning tasks (VLTs), one of which has four scoring methods. The CDTs 
involve the participant drawing a clock and setting the time. The VFTs involve the 
participant naming as many words as they can within a certain time period (usually one 
minute), either from a certain category or beginning with a certain letter.  The VLTs 
involve the participant recalling a word list after it has been read out to them. Seven of 
the index tests involve multiple tasks. By their nature, they tend to involve the 
assessment of more cognitive domains and take slightly longer to administer.  
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Figure 2.1: Study Selection Process Diagram (using the PRISMA guidelines) 
Findings 
 
DTA assessment  
A summary of the DTA results reported for identifying people with aMCI is presented 
in Table 2.3 for single task index tests and Table 2.4 for multi-task index tests. Forest 
plots of sensitivity and specificity for each index test are presented in Appendices 2.3 
and 2.4. Across the studies, sensitivity ranged widely from 7 to 100%, and specificity 
from 35 to 100%. 
Citations identified by electronic 
database search (n=6431) 
Citations excluded (n = 6073) 
Potentially relevant citations identified 
after screening titles/abstracts (n=358) 
Studies retrieved for more detailed 
evaluation (n=158) 
Studies included in the systematic 
review (n=39) 
Studies excluded (n = 119) 
Reasons: did not specify aMCI 
criteria (n= 35); index tool not 
simple (n = 23); not exclusively 
aMCI pts (n=19); did not report 
DTA data (n=18); conference 
abstract (n=15); no aMCI pts 
(n=8); retrospective study (n=1) 
Citations excluded (n = 200) 
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Table 2.1: Characteristics of included studies 
Study Year Country Total Number 
of Participants* 
aMCI 
Prevalence (%) 
aMCI Sample Source aMCI Age 
(Mean (SD)) 
Index Test(s) Risk of 
Bias 
Cross-sectional DTA studies        
Ahmed et al 2012 2012 UK 35 42.9 Community (OPTIMA 
cohort) 
80.9 (7.2) MoCA Unclear 
Ahn et al 2010 2010 Korea 120 35.8 Memory clinic NR MMSE High 
Alegret et al 2009 2009 Spain 88 50.0 Diagnostic unit of Fundacio 
ACE 
76.5 (5.1) 15-Objects Test High 
Cacho et al 2010 2010 Spain 87 24.1 Memory clinic 73.8 (5.0) CDT-command; 
MMSE (alone & in 
combination) 
High 
Chandler et al 2005 2005 USA 155 38.7 University Clinic for 
Alzheimer’s and Related 
Diseases 
72.8 (7.5) VLT (CERAD-
WLDR); MMSE 
High 
Costa et al 2012 2012 Germany 130 23.1 Memory clinic 67.8 (8.1) MoCA High 
Dierckx et al 2007 2007 Belgium 92 43.5 Memory clinic & psychiatric 
hospital 
75.0 (6.0) MIS-plus & VAT High 
Diniz et al 2008 2008 Brazil 165 46.1 Memory clinic 72.3 (6.6)
SD 
70.2 (6.5)
MD 
MMSE High 
Freitas et al 2013 2013 Portugal 270 33.3 Dementia clinic 70.5 (8.0) MMSE; MoCA High 
Fujiwara et al 2010 2010 Japan 66 45.5 Memory clinic 77.3 (6.3) HDS-R; MoCA High 
Gonzalez-Palau et al 2013 2013 Spain 241 54.8 Memory clinic, residential 
facilities, community centres 
82.0 (9.2) VLT (HVLT LE); 
MMSE 
High 
Guo et al 2012 2012 China 508 61.2 Memory clinic 70.0 (9.1)
SD 
70.3 (8.8)
MD 
MES; MMSE High 
Hanyu et al 2009 2009 Japan 63 49.2 Memory clinic 75.6 (5.1) VFT-Animals High 
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Study Year Country Total Number 
of Participants* 
aMCI 
Prevalence (%) 
aMCI Sample Source aMCI Age 
(Mean (SD)) 
Index Test(s) Risk of 
Bias 
Hanyu et al 2011 2011 Japan 80 57.5 Memory clinic 76.0 (6.6) MMSE; TYM High 
Karrasch et al 2005  2005 Finland 30 50.0 Neurologist referral 67.5 (9.2) CDT-CERAD; 
Constructional Praxis-
Savings; Naming-
BNT-M; VFT-
Animals; VLTs 
(CERAD-WLDR, -
WLLE, -WLRE, 
WLSA); MMSE 
High 
Kato et al 2013 2013 Japan 109 55.0 Hospital 76.1 (9.2) CDT-command; 
MMSE 
High 
Ladeira et al 2009 2009 Brazil 166 50.0 Memory clinic 70.3 (6.1) CDT-Sunderland; 
VFT-Animals; MMSE 
(alone & in 
combination) 
Unclear 
Lee et al 2008 2008 Korea 152 24.3 Hospital & community 71.3 (5.9) MoCA Unclear 
Loewenstein et al 2009  2009 USA 103 22.3 Centre for AD and memory 
disorders 
79.7 (6.0) FBMS High 
Luis et al 2009 2009 USA 98 24.5 Memory clinic & 
community 
78.9 (5.3) MMSE; MoCA Unclear 
McLennan et al 2011 2011 Australia 98 3.1 Cardiac & diabetic/ 
endocrine outpatient clinics 
NR MoCA Low 
Muangpaisan et al 2010 2010 Thailand 107 72.0 Community (BLOSSOM 
cohort) 
66.3 (7.9) Digit Span (Forward & 
Backward); VFTs 
(Animals, Fruits, Letter 
Koh & Soh) 
Unclear 
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Study Year Country Total Number 
of Participants* 
aMCI 
Prevalence (%) 
aMCI Sample Source aMCI Age 
(Mean (SD)) 
Index Test(s) Risk of 
Bias 
Nasreddine et al 2005 2005 Canada 184 51.1 Memory clinic 75.2 (6.3) MMSE; MoCA High 
Rahman et al 2009 2009 Egypt 184 51.1 Community (geriatric clubs) NR MoCA Unclear 
Rami et al 2007 2007 Spain 450 11.1 Memory-Alzheimer’s Unit 
Hospital Clinic 
76.6 (6.6) M@T High 
Rami et al 2010 2010 Spain 87 57.5 Memory clinic 76.6 (6.6) M@T Unclear 
Ravaglia et al 2005 2005 Italy 93 40.1 University Centre for 
Physiopathology of Aging 
76.5 (7.1) CDT (Sunderland, 
Wolf-Klein); MMSE 
(alone & in 
combination) 
High 
Saka et al 2006 2006 Turkey 51 35.3 Dementia outpatient clinic 69.4 (8.3) ECR (3
rd
 free & total 
recall) 
High 
Scheurich et al 2005 2005 Germany 20 65.0 Memory clinic 66.4 (9.7) DemTect Unclear 
Schrijnemaekers et al 2006 2006 UK 73 26.0 Community (Foresight 
Challenge study) 
76.2 (9.4) MMSE; VLT (HVLT 
LE) 
High 
Smith et al 2007 2007 UK 35 65.7 Memory clinic 77.5 (7.8) MMSE; MoCA Unclear 
Takahashi et al 2012 2012 Japan 50 50.0 Medical centre for dementia 75.2 (5.4) AQT-CF Unclear 
Tsai et al 2012 2012 Taiwan 109 65.1 Memory clinic 79.2 (6.8) MoCA High 
Woodard et al 2005 2005 USA 179 10.1 General Internal Medicine & 
Geriatric clinics 
75.9 (5.7) VFT-Animals; VLTs 
(CERAD-WLDR, -
WLREDI, -WLSA) 
Unclear 
Yoshida et al 2012 2012 Japan 112 34.8 Memory clinic 71.4 (9.2) MMSE High 
Zhao et al 2011 2011 China 300 50.0 Hospital 70.7 (4.3) MoCA High 
Zhao et al 2012 2012 China 641^
 
50.7^ Memory clinic 74.1 (2.8)^ VLT (AVLT SR) High 
Longitudinal Studies         
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Study Year Country Total Number 
of Participants* 
aMCI 
Prevalence (%) 
aMCI Sample Source aMCI Age 
(Mean (SD)) 
Index Test(s) Risk of 
Bias 
Ahmed et al 2008 2008 UK 18
A 
38.9
P 
Memory clinic 71.7 (6.8)
P 
71.3 (7.7)
NP
 
Naming-GNT; TMT-
Part B; VFT-Animals  
High 
Sarazin et al 2007 2007 France 217
A 
27.2
P 
Memory clinic 74.8 (4.1)
P
 
70.9 (5.4)
NP
 
FCSRT (Total & Free 
Recall); Serial digit 
ordering; Stroop -
inhibition; TMT (A & 
B); VFTs (Fruits & 
“S”); WAIS 
(Similarities & Digit 
Symbol) 
High 
KEY: *aMCI and cognitively normal participants only; ^70-79yrs age group only; 
A
aMCI participants only; 
MD
multi-domain aMCI; 
NP
aMCI non-progressors; 
P
aMCI progressors; 
SDsingle domain aMCI; AD = Alzheimer’s disease; NR = not reported 
NB: for index test definitions see Abbreviations 
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Table 2.2: Description and cognitive domain coverage of the included index tests 
Index Test Brief Description Max 
Score 
TTA 
(min) 
Memory Semantic 
Knowledge/ 
Language 
Visuospatial/ 
Perceptual 
processing 
Attention / 
Orientation 
Executive 
function / 
Fluency 
Single Task Index Tests – MEMORY         
ECR 
-Free Recall 
-Total Recall 
Name 16 items (following semantic cues) and recall them over 3 trials 
Number of free recall items per trial 
Sum of free and cued recall items 
 
16 
48 
7 Yes - - - - 
FBMS Read and recall 15 presented words 15 3-4 Yes - - - - 
FCSRT 
-Free Recall 
-Total Recall 
Name 16 items (following semantic cues) and recall them over 3 trials 
Sum of free recall items 
Sum of free and cued recall items 
 
48 
48 
NR Yes - - - - 
MIS-plus Verbal cued recall task (6 words) 6 4 Yes - - - - 
VAT Name 6 pairs of objects/animals from line drawings, then recall 1 
object after being presented with 1 from the pair 
6 NR Yes - - - - 
VLT 
-AVLT SR 
-CERAD WLDR 
-CERAD WLLE 
-CERAD WLRE 
-CERAD WLSA 
-HVLT LE 
Recall as many words as possible 
3 x 12 words, short delay recall 
3 x 10 words, short delay recall 
Sum of words recalled over 3 trials 
Recognition of words from list 
Delayed recall adjusted for acquisition 
3 x 12 words, sum of words recalled  
 
12 
10 
30 
100% 
100% 
36 
NR 
 
Yes - - - - 
Construct. 
Praxis-Savings 
Copy 4 geometric forms. Savings score is the proportion of elements 
remembered on delayed recall 
100% ~5 Yes - Yes - - 
Digit Span 
-Forward 
-Backward 
Recall a series of numbers: 
in the original order 
in reverse order 
- NR Yes - - Yes - 
26 
Index Test Brief Description Max 
Score 
TTA 
(min) 
Memory Semantic 
Knowledge/ 
Language 
Visuospatial/ 
Perceptual 
processing 
Attention / 
Orientation 
Executive 
function / 
Fluency 
Serial Digit 
Ordering Test 
Repeat a series of 7 digits, reordering them in ascending order for 15 
trials 
105 NR Yes - - Yes - 
WAIS-Digit 
Symbol 
After being shown digit-symbol pairs, write down the corresponding 
symbol under each digit (time limited) 
NR 
 
1.5 Yes - 
 
Yes Yes - 
Single Task Index Tests – NON-MEMORY       
Naming 
-BNT-M 
-GNT 
Name objects from line drawings 
 
 
 
15 
30 
NR 
 
 
- Yes - - - 
VFT 
-Animals/Fruits 
-Koh/Soh/S 
Name as many items as possible:  
from a category  
beginning with a certain letter (Koh) 
- 1 - - - - Yes 
15-OT Name all objects shown in a line drawing of 15 overlapping objects. 15 NR - Yes Yes Yes Yes 
AQT-CF Timed test of naming colours & forms Timed 3-5 -  Yes Yes - 
CDT 
-CERAD 
-Command 
-Sunderland 
-Wolf Klein 
Clock drawing (various versions) 
No detail given 
Draw clock and set time (11.10) 
Draw clock and set time (2.45) 
Scored based on number placement 
 
NR 
10 
10 
10 
1-2 - Yes Yes - - 
Stroop Test-
inhibition 
Name colours when the colour word and ink are incongruent 100 NR - Yes - Yes - 
TMT 
-A 
-B 
Trace a line joining: 
numbers up in order 
numbers and letters up in order 
Timed - - - - Yes Yes 
WAIS-
Similarities 
Explain how two items might be similar 33 
 
NR - Yes - 
 
- 
 
Yes 
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Index Test Brief Description Max 
Score 
TTA 
(min) 
Memory Semantic 
Knowledge/ 
Language 
Visuospatial/ 
Perceptual 
processing 
Attention / 
Orientation 
Executive 
function / 
Fluency 
Multi-Task Index Tests        
DemTect 5 tasks: a 10-word list learning task & delayed recall, number 
transcoding, semantic fluency, digit span reverse 
18 8-10 Yes - - Yes Yes 
HDS-R 9 questions/tasks: age, orientation in time & place, repeat & recall of 
3 words, serial subtraction, digits backwards, recall of 5 objects, 
category fluency 
30 NR Yes - - Yes Yes 
M@T 5 sections: Encoding & Free & Cued Recall (5 words & 2 sentences); 
Temporal Orientation; Semantic Memory 
50 ~5 Yes Yes - Yes - 
MES 7 tasks: sentence repeat and short & long delay recall, category 
fluency, conflicting instructions, action imitation, inhibitory control 
test  
100 ~7 Yes - - - Yes 
MMSE 6 sections: Orientation (time & place); Registration & Recall (3 
words); Attention (serial subtraction/backward spelling);  Language 
(naming, repeating, command following, sentence writing); Copying 
(intersecting pentagons) 
30 ~10 Yes Yes  Yes Yes - 
MoCA 8 sections: Visuospatial/Executive (TMT B, copy cube, CDT); 
Naming (animals); Registration & Recall (5 words); Attention (digit 
span, target detection, serial subtraction); Language (sentence repeat, 
letter fluency); Abstraction (similarity); Orientation (time & place)  
30 10-15 Yes Yes Yes Yes Yes 
TYM Self-completed questionnaire with 10 tasks: Orientation; Sentence 
copying & Recall; Semantic Knowledge; Calculation; Category 
Fluency; Similarities; Naming; 2 x Visuospatial tasks (forming a letter 
& CDT) 
50 5-10 Yes Yes Yes Yes Yes 
KEY: NR = not reported; TTA = time to administer 
NB: for index test definitions see Abbreviations 
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Table 2.3: Summary of diagnostic test accuracy results for single task cognitive tests for identifying aMCI 
Index Test (units) Cut-
Off 
Sensitivity 
(%) 
Specificity 
(%) 
PPV 
(%) 
NPV 
(%) 
LR+ LR- AUC Study 
15-Objects Test 12 64 86 82 70 4.67 0.42 0.85 (Alegret et al., 2009) 
AQT-CF (seconds) 72/73 84 76 78 83 3.50 0.21 0.88 (Takahashi et al., 2012) 
Clock Drawing Test-
CERAD 
-Command 
 
-Sunderland 
 
-Wolf Klein 
 
5 
8/9 
 
ELD* 
≤5 
≤6 
 
7 
76 
50 
30 
26 
21 
 
87 
70 
88 
88 
85 
89 
 
33 
44 
83 
71 
56 
57 
 
48 
90 
59 
56 
63 
62 
 
0.50 
2.51 
4.08 
2.50 
1.81 
1.93 
 
1.08 
0.34 
0.57 
0.79 
0.86 
0.89 
 
NR 
0.78 
0.72 
0.59 
NR 
NR 
 
(Karrasch et al., 2005) 
(Cacho et al., 2010) 
(Kato et al., 2013) 
(Ladeira et al., 2009) 
(Ravaglia et al., 2005) 
(Ravaglia et al., 2005) 
Constructional  
Praxis-Savings (%) 
60 33 67 50 50 1.00 1.00 NR (Karrasch et al., 2005) 
Digit Span 
-Forward 
-Backward 
 
12 
4 
 
64 
77 
 
70 
57 
 
84 
82 
 
43 
49 
 
2.12 
1.77 
 
0.52 
0.41 
 
0.71 
0.73 
 
(Muangpaisan et al., 2010) 
(Muangpaisan et al., 2010) 
ECR 
-3
rd
 Free Recall 
-Total Recall 
 
9 
42 
 
56 
50 
 
79 
91 
 
59 
75 
 
76 
77 
 
2.62 
5.50 
 
0.56 
0.55 
 
0.69 
0.63 
 
(Saka et al., 2006) 
(Saka et al., 2006) 
FBMS 7
OR 
83 88 66 95 6.61 0.20 0.90 (Loewenstein et al., 2009) 
Naming-BNT-M 11 13 100 100 53 - 0.87 NR (Karrasch et al., 2005) 
Verbal Fluency Task 
-Animals 
 
 
ELD
$ 
14 
 
27 
81 
 
95 
69 
 
85 
71 
 
56 
79 
 
5.50 
2.58 
 
0.77 
0.28 
 
0.61 
NR 
 
(Ladeira et al., 2009) 
(Hanyu et al., 2009) 
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Index Test (units) Cut-
Off 
Sensitivity 
(%) 
Specificity 
(%) 
PPV 
(%) 
NPV 
(%) 
LR+ LR- AUC Study 
 
 
 
-Fruits 
-Letter Koh 
-Letter Soh 
 
15 
<20 
15 
9 
7 
83 
27 
72 
68 
50 
81 
43 
100 
55 
63 
73 
57 
79 
100 
15 
83 
83 
83 
50 
57 
95 
43 
36 
53 
1.47 
- 
1.62 
1.84 
1.88 
1.86 
0.39 
0.73 
0.50 
0.51 
0.68 
0.34 
0.63 
NR 
0.69 
0.69 
0.66 
0.71 
(Muangpaisan et al., 2010) 
(Karrasch et al., 2005) 
(Woodard et al., 2005) 
(Muangpaisan et al., 2010) 
(Muangpaisan et al., 2010) 
(Muangpaisan et al., 2010) 
Verbal Learning Task 
-AVLT SR 
-CERAD WLDR 
 
 
-CERAD WLLE 
-CERAD WLREDI 
-CERAD WLRE (%) 
-CERAD WLSA (%) 
 
-HVLT LE 
 
≤2^ 
6 
6.5 
<7 
20
OS
 
<10 
92
OS 
<80 
80 
≤15OR 
24.5 
 
97 
27 
82 
83 
73 
94 
47 
89 
33 
83 
84 
 
73 
100 
63 
60 
80 
35 
93 
55 
67 
65 
80 
 
79 
100 
58 
19 
79 
14 
88 
18 
50 
74 
59 
 
95 
57 
85 
97 
75 
98 
64 
98 
50 
76 
93 
 
3.55 
- 
2.22 
2.10 
3.67 
1.45 
7.00 
1.99 
1.00 
2.39 
4.13 
 
0.05 
0.73 
0.29 
0.28 
0.33 
0.16 
0.57 
0.20 
1.00 
0.26 
0.20 
 
0.94 
NR 
0.82 
0.76 
NR 
0.73 
NR 
0.77 
NR 
0.84 
NR 
 
(Zhao et al., 2012) 
(Karrasch et al., 2005) 
(Chandler et al., 2005) 
(Woodard et al., 2005) 
(Karrasch et al., 2005) 
(Woodard et al., 2005) 
(Karrasch et al., 2005) 
(Woodard et al., 2005) 
(Karrasch et al., 2005) 
(Gonzalez-Palau et al., 2013) 
(Schrijnemaekers et al., 2006) 
KEY: 
^
70-79 years age group; AUC = Area Under Receiver Operating Characteristic (ROC) curve; ELD* = education-level dependent (0-8 years of education <6; >8 years of 
education <8); ELD
$
 = education-level dependent (illiterate <10, 1+ year of education <14); LR+ = Positive Likelihood Ratio; LR- = Negative Likelihood Ratio; NPV = 
Negative Predictive Value; NR = Not Reported; PPV = Positive Predictive Value; 
OR
indicates >1 threshold was reported in the study but only author-reported optimal threshold 
was extracted; 
OS
indicates >1 threshold was reported in the study but only threshold with maximum sensitivity was extracted 
NB: for index test definitions see Abbreviations  
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Table 2.4: Summary of diagnostic test accuracy results for multi-task cognitive tests for identifying aMCI 
Index Test Cut-Off Sensitivity 
(%) 
Specificity 
(%) 
PPV 
(%) 
NPV 
(%) 
LR+ LR- AUC Study 
DemTect ≤13 85 86 92 75 5.92 0.18 0.92 (Scheurich et al., 2005) 
HDS-R 28/29 87 61 65 85 2.23 0.22 0.86 (Fujiwara et al., 2010) 
M@T 37
OR 
96 
96 
79 
70 
36 
81 
99 
93 
4.57 
3.23 
0.05 
0.06 
0.93 
0.88 
(Rami et al., 2007) 
(Rami et al., 2010) 
MES ≤72 
≤75 
88 
79 
91 
83 
91 
73 
88 
87 
10.2 
4.60 
0.13 
0.25 
0.96 
0.89 
(Guo et al., 2012)
MD 
(Guo et al., 2012)
SD 
MMSE <24 
24v25 
25 
<26 
≤26OR 
26 
26/27 
 
≤27 
 
 
27/28 
 
 
28.5 
 
 
<29 
ELD 
29 
52 
13 
18 
76 
17 
63 
41 
68 
68 
58 
72 
71 
70 
60 
67 
74 
67 
54 
87 
95 
93 
100 
69 
100 
96 
99 
61 
70 
84 
60 
61 
68 
70 
61 
69 
72 
71 
61 
79 
67 
100 
75 
100 
95 
96 
50 
69 
54 
33 
51 
74 
53 
52 
45 
71 
65 
64 
86 
52 
54 
71 
39 
68 
76 
77 
69 
86 
88 
78 
62 
76 
74 
88 
68 
61 
2.27 
11.5 
2.00 
- 
2.43 
- 
15.5 
41.0 
1.77 
2.26 
3.60 
1.78 
1.80 
2.15 
2.02 
1.71 
2.34 
2.40 
1.88 
0.81 
0.50 
0.93 
0.82 
0.34 
0.83 
0.38 
0.60 
0.52 
0.46 
0.50 
0.47 
0.48 
0.45 
0.56 
0.55 
0.38 
0.46 
0.64 
NR 
0.82 
NR 
NR 
0.76 
NR 
0.84 
NR 
0.67 
0.72 
0.76 
0.72 
0.73 
0.73 
0.72 
0.69 
NR 
0.75 
0.63 
(Ravaglia et al., 2005) 
(Cacho et al., 2010) 
(Karrasch et al., 2005) 
(Nasreddine et al., 2005) 
(Gonzalez-Palau et al., 2013)
 
(Smith et al., 2007) 
(Kato et al., 2013) 
(Yoshida et al., 2012) 
(Guo et al., 2012)
SD 
(Guo et al., 2012)
MD 
(Luis et al., 2009)
OR 
(Diniz et al., 2008)* 
(Diniz et al., 2008)
$
 
(Hanyu et al., 2011) 
(Ahn et al., 2010) 
(Chandler et al., 2005) 
(Schrijnemaekers et al., 2006) 
(Freitas et al., 2013) 
(Ladeira et al., 2009) 
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Index Test Cut-Off Sensitivity 
(%) 
Specificity 
(%) 
PPV 
(%) 
NPV 
(%) 
LR+ LR- AUC Study 
MoCA 
 
 
 
 
 
 
 
 
<22 
22/23
OR 
23
OR 
23.5 
23/24 
 
<24
OR 
25/26
OR 
<26 
 
≤26 
26 
81 
89 
96 
88 
86 
 
100 
93 
90 
93 
93 
83 
77 
84 
95 
65 
86 
 
50 
89 
87 
86 
62 
50 
78 
65 
85 
67 
- 
 
6 
88 
88 
87 
42 
76 
80 
96 
99 
87 
- 
 
100 
94 
90 
92 
97 
60 
3.48 
5.70 
17.7 
2.50 
5.93 
 
2.00 
8.40 
6.77 
6.41 
2.46 
1.65 
0.25 
0.13 
0.04 
0.19 
0.17 
 
0.00 
0.08 
0.11 
0.09 
0.11 
0.35 
0.86 
0.94 
0.97 
0.89 
- 
 
NR 
0.95 
NR 
NR 
0.85 
NR 
(Freitas et al., 2013) 
(Lee et al., 2008)
 
(Luis et al., 2009) 
(Ahmed et al., 2012) 
(Fujiwara et al., 2010; Lee et al., 2008; Tsai 
et al., 2012; Zhao et al., 2011)
& 
(McLennan et al., 2011) 
(Fujiwara et al., 2010)
 
(Nasreddine et al., 2005) 
(Rahman & El Gaafary, 2009) 
(Costa et al., 2012) 
(Smith et al., 2007) 
TYM 44/45 76 74 80 69 2.87 0.33 0.86 (Hanyu et al., 2011) 
KEY: 
&
 meta-analysis of 4 studies; 
MD
multi-domain aMCI; 
SD
single domain aMCI; AUC = Area Under Receiver Operating Characteristic (ROC) curve; ELD = education-level 
dependent (illiterate: <20, 1-4 years education: <25, 4-8 years education: <26, 9+ years education: <28); LR+ = Positive Likelihood Ratio; LR- = Negative Likelihood Ratio; NPV = 
Negative Predictive Value; NR = Not Reported; PPV = Positive Predictive Value; 
OR
indicates >1 threshold was reported in the study but only author-reported optimal threshold was 
extracted; 
OS
indicates >1 threshold was reported in the study but only threshold with maximum sensitivity was extracted 
NB: for index test definitions see Abbreviations 
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Of the single task index tests, the Auditory Verbal Learning Test- Short Delay Recall 
task (AVLT-SR) showed the highest sensitivity (97%) for detecting aMCI, with a high 
specificity also (73%). The high AUC value (0.94) confirms the high diagnostic 
accuracy of the test. The Consortium to Establish a Registry for Alzheimer’s Disease- 
Word List Memory Test Recognition Discrimination Index task (CERAD-WLREDI) 
also showed high sensitivity at 94% but very low specificity (35%).  The delayed recall 
task from the same Word List Memory Test (CERAD-WLDR) showed high sensitivity 
in two of the studies (82%-83%) but low in one study (27%) and the Hopkins Verbal 
Learning Test- Wordlist Learning task (HVLT-LE) showed high sensitivity across two 
studies (83-84%). The Florida Brief Memory Screen task (FBMS), which also involves 
word recall, also showed high sensitivity (83%) and specificity (88%). The evidence of 
accuracy for the VFTs was less certain, with sensitivities ranging from 27% to 83%. 
This wide discrepancy in results may be explained by the variation in formats and cut-
off scores used.  
 
There were five studies that investigated the CDT as another single task index test. 
Again, results were fairly inconsistent across the studies with sensitivities ranging 
between 7% and 76%. Again, this variation in results may be explained by the different 
cut-off scores, administration and scoring methods used.  
 
Of the multi-task index tests, the Mini Mental State Examination Scale (MMSE) was 
the most frequently investigated (17 studies). Sensitivity was reported for a number of 
cut-off values. The highest sensitivity reported was 76% for a cut-off value of ≤26. 
However, sensitivities were generally lower for other cut-offs, with most studies 
reporting sensitivities between 13% and 68%. The next most frequently investigated 
multi-task index test was the Montreal Cognitive Assessment (MoCA) with results 
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reported in 13 studies.  Again, sensitivity was reported for a number cut-offs and the 
highest sensitivity reported was 100% at a cut-off of <24 but specificity was low at 
50%.  Sensitivities ranged from 81% to 96% for other reported cut-off values.  Four 
studies reported sensitivity and specificity for the same cut-off of 23/24 and thus were 
combined in a meta-analysis (see Appendix 2.5).  A pooled sensitivity and specificity of 
86% was calculated at this cut-off value across the four studies (see Table 2.4). 
 
Summary ROC curves were produced to provide a visual summary of the DTA reported 
across all studies investigating the VFT-Animals, MMSE and MoCA (see Figure 2.2).  
These curves illustrate that MoCA generally performed with higher 
sensitivity/specificity across studies than the VFT-Animals and MMSE, with most 
points gathering towards the top left hand corner of the ROC space (see Figure 2.2C).  
The high AUC value for the MoCA sROC curve (0.92, 95%CI 0.89-0.94) also confirms 
the higher diagnostic accuracy of the test in comparison with the VFT-Animals and 
MMSE, which had AUC values of 0.75 (95%CI 0.71-0.79) and 0.73 (95%CI 0.69-0.77) 
respectively. 
 
Sensitivity was fairly high for all other multi-task index tests (ranging from 76% to 
96%).  Of these, the Memory Alteration Test (M@T) showed the highest sensitivity 
(96%) and fairly high specificity (70 – 79%) (see Table 2.4).  The high reported AUC 
values (0.88 - 0.93) confirm the high diagnostic accuracy of this test. 
 
Four studies reported DTA for combinations of index tests (see Table 2.5 and Appendix 
2.6). The combination of MMSE and CDT-command showed the highest sensitivity for 
aMCI (76%). 
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Figure 2.2: Summary receiver operating characteristic plots for studies using (A) VFT-Animals, (B) 
MMSE and (C) MoCA
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Table 2.5: Summary of diagnostic test accuracy results for combined cognitive tests for identifying aMCI 
Index Test (units) Cut-Off Sensitivity 
(%) 
Specificity 
(%) 
PPV 
(%) 
NPV 
(%) 
LR+ LR- AUC Study 
MMSE 
& CDT-Command 
& CDT-Sunderland 
& CDT-Sunderland & VFT-Animals 
& VFT-Animals 
OR CDT-Sunderland 
OR CDT-Wolf Klein 
OR CDT-Sunderland OR VFT-Animals 
 
35v36 
ELD 
ELD 
ELD 
<24 OR ≤5 
<24 OR ≤6 
ELD 
 
76 
19 
8 
17 
45 
37 
73 
 
77 
98 
100 
100 
69 
71 
45 
 
52 
89 
100 
100 
50 
47 
57 
 
91 
55 
52 
55 
64 
62 
63 
 
3.35 
8.00 
- 
- 
1.45 
1.27 
1.33 
 
0.31 
0.83 
0.92 
0.83 
0.80 
0.89 
0.59 
 
0.86 
0.58 
0.54 
0.58 
NR 
NR 
0.65 
 
(Cacho et al., 2010) 
(Ladeira et al., 2009) 
(Ladeira et al., 2009) 
(Ladeira et al., 2009) 
(Ravaglia et al., 2005) 
(Ravaglia et al., 2005) 
(Ladeira et al., 2009) 
CDT-Sunderland & VFT-Animals ELD 10 100 100 53 - 0.90 0.54 (Ladeira et al., 2009) 
MIS-Plus & VAT 8 58 96 92 75 15.0 0.44 NR (Dierckx et al., 2007) 
KEY: AUC = Area Under Receiver Operating Characteristic (ROC) curve; ELD = education level dependent (CDT-Sunderland: 0-8 years of education <6; >8 
years of education <8; VFT-Animals: illiterate <10, 1+ year of education <14; MMSE: illiterate <20, 1-4 years education <25, 4-8 years education <26, 9+ years 
education <28); LR+ = Positive Likelihood Ratio; LR- = Negative Likelihood Ratio; NPV = Negative Predictive Value; NR = Not Reported; PPV = Positive 
Predictive Value 
NB: for index test definitions see Abbreviations 
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Predictive Validity  
Two longitudinal studies reported on the validity of 12 index tests for predicting future 
dementia over periods of one (Ahmed, Mitchell, Arnold, Nestor, et al., 2008) or three 
(Sarazin et al., 2007) years (see Table 2.6 and Appendix 2.7). The Free and Cued 
Selective Recall Reminding Test- Total Recall task (FCSRT-Total Recall) was the most 
accurate prognostic test with a sensitivity of 80% for identifying progressors and a 
specificity of 90% for identifying non-progressors. All other tests showed relatively low 
sensitivities. 
 
Test-Retest Reliability  
Test-retest reliability data were available for seven of the index tests (see Table 2.7). 
The MoCA was the most frequently investigated (eight studies).  Most studies assessed 
reliability using the Intraclass Correlation Coefficient (ICC) with values ranging from 
0.75-0.92 indicating a fairly high to a high reliability over a range of time periods from 
four weeks to 18 months. Reported ICCs for the MMSE tended to be slightly lower 
ranging from 0.67-0.76. High test-retest reliability was reported in one study for the A 
Quick Test of Cognitive Speed- colour-form naming task (AQT-CF) (ICC = 0.88).  For 
other index tests, namely CDT, Florida Brief Memory Screen (FBMS) and MMSE & 
CDT, reliability data reporting was incomplete without a description of the method used 
to assess reliability (see Table 2.7). 
 
Methodological quality 
Of the 39 studies, 27 were assessed as high risk of bias; 11 were unclear risk of bias; 
and only one study (McLennan et al., 2011) scored a low risk of bias across all domains 
assessed (see Table 2.1 and Appendix 2.8). A summary of the quality assessment results 
across all four QUADAS-2 domains is provided in Figure 2.3.      
37 
Table 2.6: Summary of diagnostic test accuracy for single task cognitive tests for identifying aMCI-progressors (vs. non-progressors) 
 
Index Test (units) Cut-Off Sensitivity 
(%) 
Specificity 
(%) 
PPV 
(%) 
NPV 
(%) 
LR+ LR- AUC Study 
 
FCSRT 
-Total Recall 
-Free Recall 
 
40 
17 
 
80 
71 
 
90 
92 
 
75 
76 
 
92 
90 
 
7.87 
8.65 
 
0.23 
0.31 
 
0.94 
0.92 
 
(Sarazin et al., 2007) 
(Sarazin et al., 2007) 
Naming-GNT 14 43 91 75 71 4.71 0.63 NR (Ahmed, Mitchell, Arnold, Nestor, et al., 2008) 
Serial Digit Ordering Test 80 58 68 40 81 1.79 0.63 0.77 (Sarazin et al., 2007) 
Stroop Test-Inhibition 59 53 58 32 77 1.26 0.82 0.74 (Sarazin et al., 2007) 
Trail Making Task 
-Part A (seconds) 
-Part B (seconds) 
 
53 
128 
138 
 
63 
50 
63 
 
59 
55 
67 
 
36 
44 
42 
 
81 
60 
83 
 
1.52 
1.10 
1.91 
 
0.63 
0.92 
0.56 
 
0.73 
NR 
0.75 
 
(Sarazin et al., 2007) 
(Ahmed, Mitchell, Arnold, Nestor, et al., 2008) 
(Sarazin et al., 2007) 
Verbal Fluency Task 
-Animals 
-Fruits 
-Letter “S” 
 
11 
13 
17 
 
29 
56 
58 
 
100 
82 
56 
 
100 
54 
33 
 
69 
83 
78 
 
- 
3.16 
1.32 
 
0.71 
0.54 
0.75 
 
NR 
0.80 
0.74 
 
(Ahmed, Mitchell, Arnold, Nestor, et al., 2008) 
(Sarazin et al., 2007) 
(Sarazin et al., 2007) 
WAIS 
-Similarities 
-Digit Symbol Test 
 
11 
10 
 
49 
37 
 
72 
72 
 
40 
33 
 
79 
75 
 
1.77 
1.31 
 
0.70 
0.88 
 
0.78 
0.74 
 
(Sarazin et al., 2007) 
(Sarazin et al., 2007) 
KEY: PPV = Positive Predictive Value; NPV = Negative Predictive Value; LR+ = Positive Likelihood Ratio; LR- = Negative Likelihood Ratio; AUC = Area Under 
Receiver Operating Characteristic (ROC) curve; NR = Not Reported 
NB: for index test definitions see Abbreviations 
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Table 2.7: Test-retest reliability results 
 
Index Test Participants Time Period Measure Result Study 
AQT-CF Community, without dementia (n=22) 16 weeks ICC 0.88 (Takahashi et al., 2012) 
CDT Cognitively normal (n=30) &  Mild AD (n=30) 1-2 months NR 0.98 (Cacho et al., 2010) 
FBMS MCI & AD (n=29) 8.9 (6.2) weeks NR r = 0.65 (Loewenstein et al., 2009) 
MES Cognitively normal, MCI & AD (n=30) 29.1 (5.8) days Mean change 4.7 (5.8)  (Guo et al., 2012) 
MMSE Cognitively normal (n=30) & Mild AD (n=30) 
Cognitively normal (n=30) 
Cognitively normal (n=30) 
Cognitively normal (n=2), MCI (n=5) & AD (n=15) 
1-2 months 
3 months 
18 months 
4 weeks 
NR 
ICC 
ICC 
ICC 
0.99 
0.76 
0.67 
0.76 
(Cacho et al., 2010) 
(Freitas et al., 2013) 
(Freitas et al., 2013) 
(Yoshida et al., 2012) 
MMSE & CDT Cognitively normal (n=30) & Mild AD (n=30) 1-2 months NR 0.99 (Cacho et al., 2010) 
MoCA Cognitively normal (n=10) 
Cognitively normal (n=30) 
Cognitively normal (n=30) 
NR 
Status unknown (n=29) 
Cognitively normal, MCI & AD (n=26) 
Cognitively normal & MCI (n=26)  
Status unknown (n=20) 
Cognitively normal (n=80) & MCI (n=80) 
1 month 
3 months 
18 months 
8 weeks 
4 weeks 
35 (17.6) days 
35 (17.6) days 
4 weeks 
30 days 
Paired t test 
ICC 
ICC 
ICC 
ICC 
ICC 
Mean change 
ICC 
ICC 
p=0.537 
0.91 
0.88 
0.88 
0.75 
0.92 
0.9 (2.5) 
0.88 
0.80 
(Ahmed et al., 2012) 
(Freitas et al., 2013) 
(Freitas et al., 2013) 
(Fujiwara et al., 2010)
 
(Lee et al., 2008)
 
(Nasreddine et al., 2005) 
(Rahman & El Gaafary, 2009) 
(Tsai et al., 2012) 
(Zhao et al., 2011) 
KEY: ICC = Intraclass Correlation Coefficient; AD = Alzheimer’s Disease; NR = Not Reported; MCI = Mild Cognitive Impairment 
NB: for index test definitions see Abbreviations 
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Figure 2.3: Summary of risk of bias judgements across all studies 
 
Most studies (n=22) were judged to be at a high risk of bias in the patient selection 
domain due to unblinding of the participant assessment process resulting from the  
selection of people with known aMCI from memory clinics, and people with no 
cognitive impairment (“controls”) from the community or from relatives of patients 
attending memory clinics. Twenty six studies were judged to be at an unclear risk of 
bias for the index or reference test interpretation since it was unclear the extent to which 
the tests were interpreted blindly. Ten of the studies were judged to be at high risk of 
bias in the flow and timing domain since patients and controls were not assessed with 
the same reference standard.   Most studies (n=27) didn’t report the time period between 
the index test and the reference standard and were therefore judged as unclear on this 
aspect. 
 
Discussion 
 
There is increasing interest in detecting people with aMCI as a potentially more timely 
point for treatment before the neuropathology has become more fully established with 
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consequent dementia. The practical difficulty is that the diagnostic criteria for aMCI 
(the Petersen criteria (Petersen, 2004)) are resource intense to apply in routine care. 
Brief cognitive tests have therefore been investigated as a more practical first step in 
providing a quick indication of a person’s cognitive state. The idea is not that these brief 
tests would replace the standard diagnostic criteria but that they could be used to 
quickly identify people who may have aMCI and should be referred for further 
cognitive assessment. However, for them to be of use in identifying aMCI, a critical 
issue is to understand the diagnostic accuracy of the candidate tests. Therefore, a 
systematic search of the literature was conducted to find studies that had reported 
evidence on the DTA of brief cognitive tests for aMCI.  To ensure their applicability for 
clinical settings, and for potential community screening for case ascertainment in 
research studies, only those tools characterised as simple (not requiring specialist input 
or equipment), and quick (less than 15 minutes to administer) were included. Evidence 
for 42 cognitive screening tools that met these criteria was found.  
 
The AVLT-SR was the most accurate single task index test with a high sensitivity 
(97%), high specificity (73%) and high overall diagnostic accuracy (AUC = 0.94). 
Other verbal learning tasks (CERAD-WLDR and HVLT-LE), as well as FBMS, which 
involves word recall, also exhibited high sensitivity for aMCI (83-84%). The high 
accuracy of these word recall tests is perhaps unsurprising since they assess episodic 
memory, a feature known to be impaired in aMCI and early AD (Petersen et al., 1999) 
and thought to be the result of early pathological changes in the medial temporal lobe 
(Braak & Braak, 1998).  
 
Although episodic memory impairment is an important distinguishing feature of people 
with aMCI, studies have shown that non-memory cognitive impairments such as 
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attention, processing speed, semantic fluency, executive function and visuospatial 
processing are also frequently detected in patients with aMCI (Economou, 
Papageorgiou, Karageorgiou, & Vassilopoulos, 2007).  In this situation, the patient 
would be classified as multi-domain aMCI, that is, having cognitive impairment in 
memory and other non-memory domains. It has been reported that this form of aMCI 
may be more common than single-domain aMCI. For example, in a study by Alladi et al 
2006, it was found that only 25 out of 90 patients with MCI had single-domain aMCI, 
and that deficits in both semantic memory and attention were more common (Alladi, 
Arnold, Mitchell, Nestor, & Hodges, 2006).  Another study by Diniz et al 2008 reported 
a higher proportion of their patients had multi-domain aMCI compared with single 
domain (59% vs. 29% respectively) (Diniz et al., 2008) again supporting this idea. In 
addition, multi-domain aMCI may be more likely to progress to dementia than single 
domain aMCI (for review see (Hughes, Snitz, & Ganguli, 2011)).   
 
For these reasons assessment for impairment in multiple cognitive domains might be 
important in the identification of people with aMCI. Some single task cognitive but 
non-memory tests have shown promising results in the reviewed literature. For example, 
the AQT-CF which assesses perceptual speed and attention has a sensitivity of 84%. 
Nonetheless, multi-task tests that assess several cognitive domains provide the potential 
for a more comprehensive assessment. Of the multi-task tests identified in this 
systematic review, all provide an assessment of memory but in combination with 
various other cognitive domains. The MMSE was the most frequently reported multi-
task index test. However, the reported sensitivities were generally unsatisfactory in 
comparison to the other multi-task tests. The MoCA was the next most frequently 
reported multi-task test.  This test provides an assessment of five cognitive domains and 
takes 10-15 minutes to administer. Although a sensitivity to detect aMCI of 100% has 
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been reported in association with a test score cut-off value of less than 24, for the most 
widely reported score cut-off value of 23/24 (four studies), the combined sensitivity was 
86%.  The M@T, which assesses episodic memory, semantic memory and orientation, 
and takes just 5-10 minutes to administer, also exhibited a very high sensitivity for 
aMCI (96%).  
 
Another aim of this review was to identify evidence for the validity of brief cognitive 
tests for predicting future dementia in those with aMCI. Only two longitudinal studies 
were identified that investigated this issue. Of the 12 cognitive tests investigated, the 
FCSRT, which assesses free and cued item recall, had the highest sensitivity (80%) for 
identifying people with aMCI who progressed to dementia at three year follow-up. 
Clearly more longitudinal studies are needed to support these findings and to extend this 
aspect of validity to other cognitive tests. 
 
Test-retest reliability is another important property of cognitive testing.  Reliability data 
was reported for seven of the included brief cognitive tests. The reliability of the MoCA 
was reported in eight studies with fairly high to high reliability reported (ICC = 0.75-
0.92).  High test-retest reliability was also reported for the AQT-CF (ICC = 0.88), 
whereas the ICCs for the MMSE tended to be lower (0.67-0.76).   
 
The methodological quality of the included studies was also assessed in this review and 
only one study (McLennan et al., 2011) had a “low risk of bias” in all four assessed 
domains. This study assessed the validity of MoCA for detecting aMCI patients 
recruited from hospital cardiovascular outpatient clinics and, although the MoCA 
detected all three patients with aMCI, it exhibited a low specificity of 50%. All other 
studies were judged to be at a high or unclear risk of bias and this therefore limits the 
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confidence with which interpretations from the studies can be made. A large proportion 
of the studies were judged to be at a high risk of bias in the patient selection domain 
since they were at risk of unblinding the patient assessment process by recruiting 
patients with known aMCI from memory clinics and participants without cognitive 
impairment (“controls”) from the community or via relatives of the patients. It has been 
reported that studies such as these may exaggerate diagnostic accuracy (Lijmer et al., 
1999; Whiting et al., 2004). Another area that was assessed as high risk of bias for 
several studies was patient flow, where studies did not use the same reference standard 
for all participants. Improved study design should be a feature of future studies in this 
area.   
 
Strengths of the review 
This review used systematic methods and followed standard guidance to provide a 
comprehensive summary of the literature on the diagnostic test accuracy of brief 
cognitive tests for aMCI. Two independent reviewers screened all potential studies for 
inclusion and extracted data, reducing potential risk of bias in study selection or errors 
in data extraction.  All included studies were assessed for their methodological quality 
using a standardised tool (QUADAS-2). Finally, by ensuring that only those studies that 
used the Petersen criteria as the reference standard were included, the samples reported 
can be considered to be relatively homogeneous and comparable. 
 
Weaknesses of the review 
It is important to note that the mean prevalence of aMCI across the included studies was 
high at 42.4% (beyond the range of 0.5 – 31.9% reported in a systematic review of 
aMCI prevalence by Ward and colleagues (2012) and much greater than the rate of 14-
18% for individuals aged 70 years and older estimated by Petersen and colleagues 
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(2009)). Therefore calculated estimates of PPV/NPV from these included studies are 
possibly inflated and unlikely to be generalizable to older people in community settings.  
Also, some studies reported multiple thresholds and, in these cases, the optimal 
threshold reported by the author was chosen. This may have led to an overestimation of 
diagnostic accuracy (Leeflang, Moons, Reitsma, & Zwinderman, 2008), particularly in 
the summary ROC curves, where two included studies for MMSE and five included 
studies for MoCA reported multiple thresholds.  
 
Conclusion 
An ideal cognitive test for detecting people with aMCI would be one with high 
parameter values for DTA, predictive validity and test-retest reliability in the context of 
a well-designed experimental study. Of the 42 brief cognitive tests identified in this 
review, the MoCA was identified as the most comprehensively investigated test.  The 
MoCA has a high sensitivity and high test-retest reliability, but its predictive validity 
has yet to be investigated.  Other brief cognitive tests, such as those that assess word 
recall (AVLT-SR, CERAD-WLDR, HVLT-LE and FBMS), and multi-task tests that 
assess several cognitive domains (such as M@T), have also been found to exhibit high 
sensitivities and reasonable specificities. However, lack of evidence on the predictive 
validity of these tests, and concerns over the quality of the constituent studies, limit the 
confidence with which definitive recommendations can be made. Further validation 
studies of the most promising cognitive tests to detect aMCI are warranted.  
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Chapter 3: The Identification of a Cohort of Older People with Mild 
Cognitive Impairment from the Community 
 
Introduction 
 
The identification of people at risk of developing dementia is becoming increasingly 
important with the prospect that early intervention might delay their progression to 
dementia. As discussed in Chapter 1, mild cognitive impairment (MCI) has emerged as 
a term to capture the pre-dementia phase of cognitive dysfunction (Petersen, Roberts, 
Knopman, Boeve, Geda, Ivnik, Smith, Jack Jr, et al., 2009) and is associated with 
elevated rates of progression to dementia (Petersen et al., 2001). The accurate detection 
of individuals with MCI has important implications regarding the development of 
dementia preventative interventions and future clinical trial recruitment (Stephan & 
Brayne, 2014).  
 
Many brief cognitive tests have been developed for the detection of MCI, particularly 
the amnestic form of MCI, where memory impairment is the dominant symptom (see 
Chapter 2). However, these have largely been evaluated in the context of secondary care 
settings, such as memory clinics, with the performance of patients with known cognitive 
impairment being compared to unimpaired controls recruited from the community or via 
relatives of the patients. Studies which use such recruitment strategies are at high risk of 
unblinding the assessment process and may exaggerate diagnostic accuracy (Lijmer et 
al., 1999; Whiting et al., 2004). To address this limitation of previous validation studies, 
the current study investigated an alternative approach to recruitment which involved 
inviting volunteers from the community, without prior knowledge of their cognitive 
status, to form a cohort on which to validate some brief cognitive tests for identifying 
MCI. The following Chapters 4 and 5 report on the validity of the tests under 
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investigation. However, the focus of this Chapter is to report on the recruitment 
methods and assessment procedures that were employed to identify the cohort of older 
people. 
 
The recruitment strategy was designed to reflect one that might be applied in the future, 
within a research context, to identify people with MCI for participation in dementia 
prevention trials. One of the most difficult challenges in clinical trials is whether 
appropriate participants can be identified and recruited in a timely manner and many 
trials either fail to reach recruitment targets or have to be extended (McDonald et al., 
2006). This Chapter aims to provide valuable information on recruitment rates of people 
with MCI from a community-based cohort in order to provide an aid to planning future 
studies which seek to recruit older people with MCI. 
 
Methods 
 
Recruitment Process 
 
The procedures involved in recruiting participants for the study are listed in Table 3.1. 
There were three screening stages involved in identifying potential participants for the 
study, followed by two steps to inform volunteers about the study and gain their 
informed written consent. 
 
Screening Stage 1: GP Record Screening & Flyer Mail Out 
The first stage in identifying potential participants involved GP practice managers 
screening their electronic medical records to search for people who met the following 
criteria: (1) were aged 70 years and older; (2) were not resident in a care or nursing 
home; (3) did not have dementia; (4) did not have current depression; (5) did not have 
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history of stroke within the previous three months; and (6) were not receiving palliative 
care. Study information flyers were then posted to all individuals who were found to be 
eligible from the electronic record screening. Recipients of the flyers were invited to 
answer some questions on the flyer and return it to our research office if they were 
interested in taking part in the study. A stamped addressed envelope was provided with 
the flyer to encourage responses. The GP practices involved were all based in Bradford, 
UK and had “research ready” status, accredited by the National Institute for Health 
Research (NIHR). Research Ready ® is a quality assurance programme intended for use 
by all research-active UK GP practices and designed in accord with the UK Research 
Governance Framework’s legal, ethical, professional, and patient safety requirements 
("Royal College of General Practitioners: RCGP Research Ready," 2016). 
 
Screening Stage 2: Flyer Screening 
The returned study information flyers were checked for eligibility by the research team. 
Over the study recruitment period (which ran from October 2012 to April 2015), the 
study information flyer and eligibility criteria were revised (see “Flyer Development” 
section for further details). According to the final version eligibility criteria, respondents 
were considered eligible to participate if they: (1) self-reported difficulty with their 
memory; (2) spoke English; (3) had attended school for at least eight years; and (4) had 
an informant available to answer some of the study questions.  
 
The presence of a subjective memory complaint is included as a criterion within the 
Petersen framework for a MCI diagnosis (Petersen, 2004) and therefore only those self-
reporting difficulty with their memory were primarily included in the study. However, 
there is some debate within the literature as to whether or not this criterion is essential 
for diagnosis (Mitchell, 2008b), and so it was decided that a sample of 100 people who 
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did not self-report memory difficulties should also be invited to take part. This enabled 
rates of MCI to be compared between those who did and did not report memory 
complaints.  
 
The requirement to speak English was essential due to the application of cognitive tests 
which have not been validated in other languages and the requirement to have received 
at least 8 years of education was needed in order to fulfil the validity criteria of the IQ 
task used in the study.  
 
Screening Stage 3: Telephone Screening 
Those respondents who were eligible to take part (or required further clarification) were 
telephoned and invited to take part in the study. Further information on the study was 
provided at this stage and it was ascertained whether or not the person was medically 
stable and well enough to travel to our research offices. Appointments were 
subsequently made for a first home visit with those people who were eligible and still 
interested in taking part. 
 
Final Steps 4 & 5: Informed Consent to Participate 
Consent to participate in the study was obtained face-to-face during a visit to the 
participant’s home. Participants were posted detailed study information sheets in 
advance of the appointment so that they had time to fully consider the study procedures 
before agreeing to take part.  
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Table 3.1: Recruitment procedures 
Recruitment process Description Performed by 
1. GP record screening and 
flyer mail out 
GP electronic medical records 
screened to identify potentially 
eligible participants and 
subsequent flyers posted. 
Practice manager 
2. Flyer screening Returned flyers checked for 
eligibility. 
Research team 
3. Telephone screening Eligible respondents were 
telephoned to (i) outline the 
study, (ii) check further 
eligibility criteria and (iii) 
invite to participate. Session 1 
appointments were made with 
eligible volunteers. 
Research team 
4. Participant and informant 
information sheets mailed  
Information sheets mailed out 
prior to Session 1 visit. 
Research team 
5. Informed written consent 
sought 
Participant and informant (if 
available) provide informed 
consent at Session 1 (in the 
participant’s home) and 
participate in first assessments. 
Research team 
 
Flyer Development 
The study information flyer was designed to include brief information about the study 
and some questions relating to eligibility criteria that could not be checked via the GP 
electronic record screening procedure. Clear and concise wording was used and drafts 
were checked by members of the Older People’s Forum, which is a well-established 
group of consumer colleagues who meet regularly to discuss our Academic Unit’s 
research, to ensure it was easily understood. During the study recruitment period, the 
study information flyer and eligibility criteria were revised (see Table 3.2).
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Table 3.2: Flyer questions and eligibility criteria 
 Flyer Version 1 Flyer Version 2 
Memory Questions 
1. Do you have any difficulty with your memory? 
2. Do you forget where you left things more than you used to? 
3. Do you forget the names of close friends or relatives? 
4. Have you ever been in your own neighbour-hood and forgotten your way? 
All four memory questions included. Only memory question 1 included. 
Mood Questions 
During the past month have you often been bothered by: 
5. feeling down, depressed or hopeless? 
6. having little interest or pleasure in doing things? 
Both mood questions included. Not included. 
Eligibility Questions 
7. Do you speak English? 
8. Did you attend school for at least 8 years? 
9. Do you have a husband/wife/relative/friend who would be willing to 
answer some questions during the study? 
10. Are you well enough to travel to our research offices? 
Questions 7-10 included. Questions 7-9 included. 
Eligible if Version 1.1 
 Q1 or 2 or 3 or 4 = YES 
 Q5-6 = NO 
 Q7-10=YES 
Version 1.2 
 Q1 or 2 or 3 or 4 = YES, plus sample of Q1-4 = NO 
 Q7-9=YES 
 Q1 = YES, plus sample of Q1 = NO 
 Q7-9=YES 
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The original flyer (Version 1) included ten questions in total: four questions from the 
Cambridge Mental Disorders of the Elderly Examination (CAMDEX) which are 
designed to identify people with subjective memory impairment (Roth et al., 1986); the 
two Whooley questions which are recommended by the National Institute of Health and 
Care Excellence (NICE) to screen for possible mood disturbance (NICE, 2009; 
Whooley, Avins, Miranda, & Browner, 1997); and four questions checking further 
eligibility criteria. According to the original eligibility criteria (Version 1.1), 
respondents were considered eligible if they (i) reported a memory complaint (i.e. 
answered yes to any of the four CAMDEX questions); (ii) screened negative for 
possible depression (i.e. answered no to both Whooley questions); (iii) answered yes to 
all four eligibility questions.  Since depression has been shown to be associated with 
deficits in cognitive performance (Rock, Roiser, Riedel, & Blackwell, 2014), the aim 
was to exclude people with possible low mood from the outset to ensure that this factor 
did not confound our results. 
 
However, upon inspection of the batch of flyers returned within the first month, it was 
discovered that large numbers of respondents were being excluded based on not meeting 
criteria (i) and (ii). A decision was therefore made to relax the eligibility criteria (from 
Version 1.1 to 1.2). It was decided that a sample of 100 people who did not report a 
memory complaint (i.e. answered no to all four CAMDEX questions) should be invited 
to take part and that people should not be excluded based on their answers to the two 
Whooley questions. Instead, a more in depth assessment of mood was conducted using 
the Geriatric Depression Scale (GDS) (Sheikh & Yesavage, 1986), once the participant 
had been enrolled onto the study. Twelve months later the flyer was simplified to 
remove redundant questions in order encourage a higher return rate (from version 1 to 
version 2, see Appendix 3.1 for the final flyer Version 2 that was used). 
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Ethics 
The study was approved by the Yorkshire and The Humber National Research Ethics 
Service Committee (ref: 12/YH/0207). One of the major ethical issues for consideration 
in the design and set up of this study was whether or not to inform participants of the 
results of their cognitive assessments. Upon careful consideration, it was decided that, 
since the cognitive tests only provided indications of cognitive function and were not 
diagnostic or performed by clinicians, it would have been inappropriate to have 
informed participants of their results. This point was made clear to participants from the 
outset. In cases where the participant became particularly anxious or concerned during 
testing, they were given the option of discussing their worries with a clinician based at 
the Academic Unit where the research was taking place, or encouraged to discuss any 
further concerns with their GP. Participating GP practices were regularly sent a list of 
the names of their participating patients so that they were aware of who was taking part 
in the study. 
 
Assessment Process 
 
Participants were administered a standardised protocol of neuropsychological tests (see 
Table 3.3) at a second session which was scheduled to take place within two weeks of 
the participant consenting to take part in the study. The tests were administered by 
trained researchers and took place in a well lit room within the Clinical Research 
Facility based at the Bradford Royal Infirmary. 
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Table 3.3: Battery of cognitive and functional assessments used to classify mild cognitive impairment 
Cognitive/ Functional 
Domain 
Test(s) Domain Impairment Definition 
Memory  CVLT-II – Short Delay Free Recall 
 CVLT-II – Long Delay Free Recall 
Short Delay and Long Delay free recall >1.5sd below mean of published 
norms 
Executive Functions  Brixton Spatial Anticipation Test (BSAT) 
 Trail Making Test Part A (TMT A) 
 Trail Making Test Part B (TMT B) 
Number of errors on BSAT ≥5th percentile and time taken on TMT B ≥10th 
percentile of published norms 
Language  Graded Naming Test (GNT) 
 Pyramids & Palm Trees Test (PPT) 
GNT<12 and PPT≤48 
Visuo-spatial Function  Visual Object & Space Perception (Letter 
Identification, Object Decision, Dot 
Counting, Number Location) 
 Clock Drawing Test 
Impaired scores on any two or more tests: Letter Identification (<17); 
Object Decision (<15); Dot Counting (<9); Number Location (<8); CDT 
(<4)) 
ADLs  Bristol Activities of Daily Living Scale Score ≥10 
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As discussed in Chapter 1, there is currently no consensus on how the Petersen criteria 
for MCI should be operationalised. A standardised battery of tests was developed for 
this study to objectively assess for cognitive impairment and the included tests were 
chosen based on their regular use within clinical settings and the availability of 
established normal reference values and cut-offs. The tests assessed cognitive 
performance across a number of domains, including: 
1. Memory, which was assessed using the California Verbal Learning Test (CVLT), 
2nd Edition (Delis, Kramer, Kaplan, & Ober, 2000). The CVLT tests the ability to 
encode and recall words. It involves the administrator reading out a list of 16 words, 
each of which belongs to one of four categories (vegetables, transport, furniture and 
animals). The participant is asked to recall the words immediately and this is 
repeated for five trials. Following this encoding period, the participant is asked to 
recall the 16 words after a short delay (of a few minutes, during which a distractor 
list of words is read aloud) and also after a long delay (of approximately 20 
minutes). For each participant, the number of words correctly recalled was recorded 
and the CVLT-II Comprehensive Scoring System software was used to convert 
scores to the number of standard deviations below published norms (Delis et al., 
2000).  
2. Executive function and attention, which was assessed using the Brixton Spatial 
Anticipation Test (BSAT) (Burgess & Shallice, 1997) and Trail Making Test Parts 
A & B (TMT A & B) (Reitan & Wolfson, 1985). The BSAT primarily measures the 
ability to detect a rule, to follow it, and to switch to a new rule. During the BSAT, 
participants are presented with a booklet of pages, each of which contains an array 
of 10 circles, one of which is coloured blue. The position of the blue circle changes 
from one page to the next and the changes are governed by a series of simple rules 
that alter without warning. Participants are presented with one page of the booklet at 
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a time and asked to point to where they think the blue circle will be on the next 
page, based on the rule inferred from previous pages. For each participant, the total 
number of errors (i.e. incorrect position predictions) was recorded. The TMT is a 
test of visual attention and task switching. The task requires the participant to draw 
connecting lines between a sequence of consecutive circular targets on a sheet of 
paper. In Part A, the targets are all numbers (1-25) and the participant is instructed 
to connect them in sequential order. In Part B, the targets are numbers (1-12) and 
letters (A-L) and the participant is instructed to alternate between them. The 
participant is asked to complete the tasks as quickly and accurately as possible. The 
time taken to complete each part was timed using a standard stopwatch and recorded 
for each participant. Using published norms, these times were converted to 
percentiles (Tombaugh, 2004).  
3. Visuospatial function, which was assessed using the Visual Object and Space 
Perception (VOSP) battery (Warrington & James, 1991) and the Clock Drawing 
Test (CDT) (Reitan & Wolfson, 1985). In order to minimise testing time, only four 
of the eight VOSP subtests were applied in this study: two object perception subtests 
(Incomplete Letters and Object Decision) and two spatial perception subtests (Dot 
Counting and Number Location). In the Incomplete Letters subtest, the participant is 
shown 20 incomplete letters and asked to name or identify them. The Object 
Decision subtest involves the participant being shown pages on which silhouettes of 
four objects are presented. Only one of the silhouettes represents a real object and 
the participant is asked to point to the one that they think is real. In the Dot 
Counting task, participants are asked to count how many black dots there are on a 
page. For the Number Location task, participants are shown pages which present 
two squares arranged one above the other. The top square contains numbers 
arranged randomly and the bottom square contains one black dot. The participant is 
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asked to identify which number corresponds to the black dot. The number of correct 
answers on each subtest was recorded for each participant. The CDT is used as a 
measure of spatial dysfunction and neglect. The CDT can be performed in different 
ways and various scoring procedures have been proposed (Agrell & Dehlin, 1998). 
In this study the free-drawn method was used, where the participant was asked to 
draw a clock face, including all numbers, and set the time to “10 past 5”. The clock 
was scored on five features (clock face, number quantity, number distribution, hour 
hand position, minute hand position) with a point awarded for each correct feature. 
The total score out of 5 was recorded for each participant.  
4. Language, which was assessed using the Graded Naming Test (GNT) (Warrington, 
1997) and Pyramids and Palm Trees test (PPT) (Howard & Patterson, 1992). The 
GNT assesses object naming ability and requires the participant to name drawings 
of 30 objects ordered in ascending difficulty. The PPT assesses the capacity to 
access detailed semantic information about words, necessary for the identification of 
associations between two perceptually and functionally distinct entities. The PPT 
can be administered as a word and/or picture version; in this study, the word version 
only was applied. During the task, participants are presented with 52 triads of words 
(e.g. Pyramid, Palm Tree, Fir Tree). The target word (e.g. Pyramid) is always 
presented above the other two and, for each triad, the participant is asked to select 
which of the two bottom words (e.g. Palm Tree or Fir Tree) is semantically related 
to the top word. For both tasks, the total number of correct answers was recorded for 
each participant. 
 
In addition, the National Adult Reading Test (NART) (Nelson & Willison, 1991) was 
administered to provide an indication of pre-morbid verbal IQ. Mood was also assessed, 
initially via the two depression screening questions included in the study information 
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flyer. Following their removal from the flyer, a more detailed assessment of mood was 
completed using the Geriatric Depression Scale-short form (GDS) (Sheikh & Yesavage, 
1986), once the participant had been enrolled onto the study. The GDS was 
administered to the majority (93%) of participants (the remainder of the participants had 
been enrolled onto the study prior to the introduction of the GDS to the testing 
schedule). 
 
Activities of daily living (ADL) performance was assessed using the Bristol Activities 
of Daily Living Scale (BADLS) (Bucks, Ashworth, Wilcock, & Siegfried, 1996). This 
is an informant-rated questionnaire consisting of statements to rate 20 daily living 
activities, designed specifically to reveal the everyday abilities of people who have 
memory difficulties. Each activity is rated on a four-point scale to indicate the level of 
independence with which the person can perform the task, ranging from a score of 0 
which indicates that no help is required through to a score of 3 which indicates that the 
person is unable to complete the task even with supervision. This produces a total score 
range of 0–60. Participants were asked to attend the second session with a spouse, 
relative or friend who could answer these questions. The informant was asked to 
provide written informed consent prior to answering any questions. 
 
Classification Process 
 
A classification flowchart, based on the flowchart of the decision process for making 
diagnoses of MCI subtypes proposed by Petersen et al (Petersen, 2004), was devised to 
classify participants (see Figures 1.1 and 3.1). The cut off scores used to determine 
cognitive domain impairment are listed in Table 3.3. Memory impairment was defined 
using a cut-off score of 1.5 standard deviations (SD) below the mean of published 
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norms on short and long delay recall on the CVLT. Although no particular cut-off score 
is specified in the Petersen criteria, a cut-off score of 1.5 SD below norms is generally 
recommended based on the fact that in the original description of the MCI cohort 
followed by Petersen and colleagues (1999), the MCI group’s mean memory 
performance was 1.5SD below age- and education-matched control subjects (Petersen, 
2004; Petersen et al., 1999). For the remaining cognitive domain test scores, either cut-
off scores recommended in the test manuals were applied or 5
th
 – 10th percentile cut–off 
scores were applied since they approximately correspond with a cut-off score of 1.5SD 
below the normative mean on a normally distributed curve.  
 
The classification categories were as follows: 
1. Amnestic MCI (aMCI) – this included participants who demonstrated impairment 
in memory and no impairment in ADLs. This category included both single and 
multi-domain aMCI. 
2. Non-amnestic MCI (naMCI) – this included participants who demonstrated 
impairment in non-memory cognitive domain(s) and no impairment in ADLs. This 
category included both single and multi-domain naMCI. 
3. Cognitive difficulties beyond MCI (>MCI) – this included participants who 
demonstrated impairment in one or more cognitive domains and also impairment in 
ADLs. 
4. Low Mood – this included participants who scored ≥ 6 on the GDS. This cut-off 
score was selected as it has been cited as the optimal cut-off for identifying 
depression in numerous studies (Wancata, Alexandrowicz, Marquart, Weiss, & 
Friedrich, 2006). 
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5. Control - this included participants who did not demonstrate cognitive impairment 
in any one cognitive domain and did not meet the criteria for aMCI, or the other 
possible study classifications listed above. 
Classifications were initially determined by the trained researcher administering the 
tasks and were verified by the study neuropsychologist (Dr Krist Noonan). 
 
Sample Size Target 
Sample size estimates for diagnostic test accuracy studies are calculated based on the 
desired confidence interval for the adequate estimation of sensitivity/sensitivity (Hajian-
Tilaki, 2014). Wilson’s ‘score’ method (Wilson, 1927) was used to calculate 95% 
confidence intervals for an observed sensitivity/specificity of 90% or 95% for a range of 
sample sizes (see Table 3.4). It has been reported that this method is particularly well 
suited to calculating confidence intervals in situations where the proportion is large, as 
is optimally the case with measures of sensitivity and specificity and it has the added 
advantage of being relatively straight forward to calculate (Newcombe, 1998). 
Confidence intervals were calculated using an online calculator provided by PEDro, the 
Physiotherapy Evidence Database (Herbert, 2013).   
 
As can be seen from Table 3.4, as sample size increases, the width of the confidence 
intervals decreases. The aim at the outset of the study was to recruit 200 people with 
aMCI in order to achieve a lower bound confidence interval of 85% for an observed 
sensitivity of 90%. It was proposed that this could be achieved by approaching 4800 
people with the study information flyer, assuming a 14% eligible response rate (based 
on 70% of flyers being returned, with only 20% of returns reporting a subjective 
memory complaint (Jonker, Geerlings, & Schmand, 2000)) and a 30% rate of aMCI in 
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those reporting subjective memory impairment (Benito-Leon, Mitchell, Vega, & 
Bermejo-Pareja, 2010; Mitchell, 2008a). 
 
Table 3.4: 95% Confidence intervals for observed sensitivity/specificity of 90% or 95% for a range 
of sample sizes 
n Observed Sensitivity/Specificity 95% Confidence Interval 
60 90% 
95% 
(79.9%, 95.3%) 
(86.3%, 98.3%) 
100 90% 
95% 
(82.6%, 94.5%) 
(88.8%, 97.9%) 
200 90% 
95% 
(85.1%, 93.4%) 
(91.0%, 97.3%) 
 
Data Analysis 
Response, eligibility and recruitment rates were calculated as percentages of the total 
population that were contacted or responded. Rates of the subtypes of MCI were 
calculated as percentages of the total population that were assessed or contacted. 
Sensitivity and specificity of subjective memory complaint status in detecting aMCI and 
of the two Whooley questions in detecting low mood as measured by the GDS were also 
calculated.  Between-group differences based on cognitive classification in participant 
characteristics (including age, years of education, NART IQ, GDS score and the 
neuropsychological test battery scores) were explored using the Kruskal-Wallis H test 
(since the data were not normally distributed).  Subsequently, pairwise comparisons 
were performed using Dunn's (1964) procedure with a Bonferroni correction for 
multiple comparisons. Difference in gender proportion between the classification 
groups was analysed using the Chi-square test of homogeneity. These analyses were 
performed using SPSS Statistics v22 (IBM). 
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GDS    Low Mood
YES
Memory 
impairment?
NO
ADL impairment?
Impairment in 
cognitive domain 
(NOT memory)?
YES NO
Control
NO
aMCI
(SD)
>MCI
NO YES
Impairment in one 
or more OTHER 
cognitive 
domains?
ADL impairment?
aMCI
(MD)
>MCI
NO YES
NO
YES
ADL impairment?
naMCI
(SD)
>MCI
NO YES
Impairment in >1 
non-memory 
domain?
ADL impairment?
naMCI
(MD)
>MCI
NO YES
NO
YES
YES
 
Figure 3.1: Classification flowchart  
(adapted from (Petersen, 2004)). NB: GDS information not available for 34 participants (Whooley questions screen = negative) 
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Results 
 
Figure 3.2 details the recruitment flow of participants throughout the study. 
 
Screening Stage 1: GP Record Screening & Flyer Mail Out 
 
A total of 85,870 medical records were screened across nine participating GP practices 
(average list size: 9541) and 7618 patients (8.9%) were found to be eligible and were 
sent screening flyers. The first 2600 patients were sent the original flyer Version 1 and, 
following revisions, the remaining 5018 patients were sent flyer Version 2. 
 
Screening Stage 2: Flyer Screening 
 
A total of 1477 flyers were returned, giving an overall return rate of 19.4%. The return 
rates from both flyer versions were similar (19.2% and 19.5% for flyer Version 1 and 2 
respectively). The first batch of returned Version 1 flyers (n=126) were screened using 
the original eligibility criteria (Version 1.1, see Table 3.2) and only 19.8% (n=25) of 
this batch were deemed eligible. The most common reasons for being ineligible were 
having positive depression screening answers (54%) and no self-reported memory 
problems (40%). The remaining batch of returned Version 1 flyers (n=372) were 
screened using the revised eligibility criteria (Version 1.2, see Table 3.2) and the 
eligible rate increased to 73.4%.  This time, the most common reason for being 
ineligible was having no informant available (90.7%). For the participants recruited 
from this later batch of flyers, the Whooley question depression screening data 
(Whooley et al., 1997) as well as GDS scores were available. The diagnostic test 
accuracy of the screening questions could therefore be estimated for the sample (see 
Table 3.5). It can be seen that the depression screening questions were 100% sensitive at 
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detecting people with low mood as measured by the GDS; however, they performed 
with lower specificity (71.8%) and 33 people who would have been excluded based on 
the original criteria were deemed not to have low mood upon further testing with the 
GDS. 
 
Table 3.5: Diagnostic test accuracy of the Whooley depression screening questions 
 GDS Sensitivity 
(%) 
Specificity 
(%)  
Whooley screening 
questions 
 + - 
+ 5 33 100 71.8 
- 0 84   
 
The remaining returned flyers were the revised version 2 flyers (n=979). Of these, 559 
(57.1%) were deemed to be eligible and, again, the most common reason for being 
ineligible was having no informant available (n = 201, 49.5%). 174 (42.9%) people 
were excluded for having no self-reported memory problems (once the quota of 100 had 
been reached). 
 
Screening Stage 3: Telephone Screening 
 
In total, following the flyer screening stage, 857 people (58.0% of those people who 
returned flyers) were eligible for further follow-up by telephone. Of these, 557 (65.0%) 
were still interested in taking part and a home visit was arranged to consent them into 
the study. Those people who were excluded at this stage, included 157 (18.3%) who 
declined to take part, 30 (3.5%) who could not be contacted after numerous attempts 
and 113 (13.2%) who were ineligible. Again, the most common reason for being 
ineligible was having no informant available (n = 59, 52.2%). 
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7618 (8.9%) eligible
sent flyers
1477 (19.4%)
flyers returned
2600 v1 5018 v2
498 (19.2%) v1
126 v1.1; 372 v1.2
979 (19.5%) v2
857 (58.0%)
eligible
25 (19.8%)
v1.1
273 (73.4%)
v1.2
559 (57.1%)
v2
557 (65.0%)
eligible
507 (91.0%)
recruited
472 (93.1%)
assessed
603 ineligible
100 v1.1
54 possible depression
40 no memory problems
33 no informant
17 unable to travel to unit
4 <8 years schooling
2 non-English speaking
2 blank flyers
97 v1.2
88 no informant
14 <8 years schooling
2 visually impaired
1 non-English speaking
1 no contact details given
1 impaired memory due 
to cerebral aneurysm
406 v2
201 no informant
174 no memory problems 
(quota reached)
44 <8 years schooling
19 non-English speaking
17 declined to take part
113 ineligible
(59 no informant; 14 unwell; 11 hearing/visual impairment; 11 unable to attend 
unit; 10 dementia/possible dementia; 6 <70 years; 1 no memory problems; 1 
non-English speaking)
157 declined to take part
30 unable to contact
16 ineligible
(5 depression diagnosis; 4 unwell; 3 visual impairment; 2 no informant; 1 <70 
years; 1 lacked capacity to consent)
34 declined to take part
31 withdrew
4 excluded
(2 hearing/visual impairment; 2 abandoned assessment)
MCI 
(n=78)
aMCI 
(n=52)
naMCI 
(n=26)
85,870 patient records 
screened
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Figure 3.2: Recruitment flowchart 
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Recruitment & Assessment 
 
The majority of those people who were eligible at the telephone screening stage went on 
to be recruited during a visit to their home (n = 507, 91.0%), and the majority of these 
people remained in the study and were assessed with the standardised battery of 
neuropsychological tests at a second session which took place at the BIHR and were 
assigned a cognitive classification (n = 472, 93.1%). Of those people not classified, 31 
had withdrawn before the second session and four were excluded (two had 
visual/hearing impairment that affected their performance on the tasks and two could 
not complete the assessment due to distress or fatigue). 
 
Classification Results 
 
Figure 3.3 illustrates the proportions of the assessed participants that were grouped into 
each of the study classifications. Of the 472 people who were assessed, 78 people 
(16.5%) were classified as having some form of MCI. Of the people with MCI, 52 
people (66.7%) were classified as having amnestic MCI (aMCI) and 26 people (33.3%) 
were classified as having non-amnestic MCI (naMCI). For both subtypes of MCI, single 
domain MCI was more prevalent than multi domain (n = 31, 59.6% for aMCI and n = 
24, 92.3% for naMCI). Fourteen people were found to have cognitive difficulties 
beyond MCI (3.0% of the assessed population) and 20 people (4.2% of the assessed 
population) were classified as having low mood. The remaining 360 (76.3%) people did 
not demonstrate impairment in any one cognitive domain and were therefore classified 
as controls. 
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Figure 3.3: Cognitive classifications of assessed participants 
KEY: aMCI = amnestic mild cognitive impairment; naMCI = non-amnestic mild cognitive impairment; 
>MCI = cognitive difficulties beyond mild cognitive impairment 
 
Classifications by subjective memory complaint status 
Table 3.6 shows the number of participants in each classification group with and 
without a memory complaint.  Of those reporting a memory complaint, only 24% (n = 
90) showed some form of cognitive impairment on formal testing (including 9 out of 19 
people with low mood who demonstrated cognitive domain impairment), with 18.3% (n 
= 69) of people meeting the criteria for any form of MCI and 12.5% (n = 47) of people 
meeting the criteria for aMCI.  3.2% (n = 12) of those reporting a memory complaint 
had cognitive difficulties beyond MCI.   
 
Of those reporting no memory problems, the majority (n = 84, 88.4%) did not 
demonstrate cognitive domain impairment on formal testing (including all controls and 
one participant with low mood).  The remainder (n = 11, 11.6%) did show some 
impairment on cognitive testing, with 9.5% (n = 9) meeting the criteria for any form of 
MCI and 5.3% (n = 5) meeting the criteria for aMCI. 
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Table 3.7 reports how sensitive and specific subjective memory complaints were at 
identifying people with aMCI. As can be seen from the results, subjective memory 
complaints appear to be highly sensitive at picking up cases of aMCI (demonstrating 
sensitivity of 90%) but are not very specific (23%). 
   
Table 3.6: Number of participants in each classification group with and without a memory 
complaint 
Classification Memory Complaint No Memory Complaint 
Control 277, 73.5% 83, 87.4% 
aMCI 47, 12.5% 5, 5.3% 
naMCI 22, 5.8% 4, 4.2% 
>MCI 12, 3.2% 2, 2.1% 
Low Mood 19 (9), 5.0% (2.4%) 1, 1.1% 
Total 377 95 
NB: Memory complaint defined as: answering yes to Q1 or 2 or 3 or 4 on flyer 
Version 1 (n=157) or answer yes to Q1 on flyer Version 2 (n=315); 19(9) indicates 
that 9 out of 19 people with low mood demonstrated cognitive domain impairment 
 
Table 3.7: Ability of subjective memory complaint status to discriminate between aMCI and 
controls 
 Total 
Sample* 
aMCI 
participants 
Control 
participants 
Sensitivity 
(%) 
Specificity 
(%) 
Total, n 412 52 360 90 23 
With SMC 324 47 277   
No SMC 88 5 83   
*excluding naMCI, >MCI and low mood participants 
KEY: SMC = subjective memory complaint 
 
Participant demographics and neuropsychological test scores 
 
Demographic characteristics of the assessed participants are reported in Table 3.8.  
There were statistically significant differences between the groups in age (χ2(4) = 
68 
35.337, p<0.001), years of education (χ2(4) = 24.509, p<0.001) and NART IQ (χ2(4) = 
25.411, p<0.001). Post-hoc pairwise comparisons revealed that the aMCI, naMCI and 
>MCI groups were significantly older than the controls, the aMCI and low mood groups 
had significantly fewer years of education than the controls and the low mood group 
had a significantly lower NART IQ than the controls.  
 
Table 3.8 also reports the mean neuropsychological test scores of the assessed 
participants, categorised by their classifications (control, aMCI, naMCI, >MCI and low 
mood). Since the test scores formed the basis of the classifications, as expected, 
statistically significant differences were found between groups on all tests scores (at 
p<0.02). It is perhaps interesting to note that the low mood group performed 
significantly worse than controls on a number of cognitive tests, including CVLT short 
and long delay recall, Brixton errors, VOSP-Number Location and the Pyramids & 
Palm Trees test, indicating that their mood status may have had some impact on their 
cognitive performance. 
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Table 3.8: Participant characteristics and neuropsychological tests scores for the study cohort by classification 
 Control (n=360) aMCI (n=52) naMCI (n=26) >MCI (n=14) Low Mood (n = 20) p value 
 Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Age (years) 75.0 (7) 216.68 78 (10)*** 299.92 79.0 (6)* 299.19 80.0 (10)** 350.93 76.0 (9) 266.70 <0.001 
Gender (% female) 45.0 - 50.0 - 61.5 - 64.3 - 55 - 0.28 
Ethnicity (% White) 99.7 - 98.1 - 92.3 - 92.9 - 100 - - 
Education (years) 12.0 (4) 251.95 11.0 (2)** 187.11 11.5 (3) 229.00 11.0 (1) 155.61 10.0 (2)** 153.20 <0.001 
NART IQ
†
 116.0 (13) 252.36 112.0 (19) 203.16 111.5 (22) 186.31 106.0 (13) 172.54 106.0 (15)** 136.72 <0.001 
GDS
¶ 
1 (2) 196.70 1 (1)
$ 
232.16 2 (2)**
$ 
293.74 2 (3)
$
 285.19 7 (3)*** 428.50 <0.001 
CVLT SD Free Recall, z score 0.5 (2) 279.33 -2.0 (1)*** 37.81 -0.5 (1)** 180.00 -1.5 (1)*** 51.93 -0.75 (2)*
#
 184.75 <0.001 
CVLT LD Free Recall, z score 0.0 (2) 279.16 -2.0 (1)***
$ 
42.39 -1.0 (1)***
 
157.85 -2.0 (1)*** 71.57 -0.75 (3)*
 
190.98 <0.001 
Brixton Errors
‡^
 19 (9) 210.42 23 (12)** 276.95 31 (12)*** 345.00 22.5 (17) 279.50 23.0 (11)* 298.16 <0.001 
Trails A
¥
, percentile 50 (50) 259.92 30 (40)*** 169.44 20 (30)*** 127.21 20 (20)** 117.39 40 (58) 193.58 <0.001 
Trails B
§
, percentile 60 (40) 257.43 25 (40)*** 146.70 10 (10)*** 80.60 10 (30)** 99.83 30 (50) 173.50 <0.001 
VOSP-Incomplete Letters score
†
 20 (1) 245.35 19.5 (1) 229.39 19 (2) 190.60 19 (2) 178.14 19 (1) 184.82 0.017 
VOSP-Object Decision score
^ 
18 (2) 253.35 18 (4)* 181.86 17.5 (3) 191.63 16.5 (3)* 141.43 17 (3) 200.08 <0.001 
VOSP-Dot Counting score 10 (0) 250.19 10 (1)*** 188.79 10 (1)*** 168.31 10 (1) 203.14 10 (0) 226.08 <0.001 
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 Control (n=360) aMCI (n=52) naMCI (n=26) >MCI (n=14) Low Mood (n = 20) p value 
 Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
VOSP-Number Location score
^ 
10 (1) 253.86 9 (2) 219.53 8 (3)*** 136.27 8 (4) 158.82 8 (6)** 152.80 <0.001 
Clock Drawing Test score
†
 5 (0) 247.68 5 (0)
% 
219.60 5 (1.3)** 177.69 4 (2)*** 117.18 5 (0)
% 
227.90 <0.001 
Graded Naming Test score
€^ 
24 (4) 263.61 20.0 (9)*** 143.31 19.5 (7)*** 149.48 18.5 (12)*** 104.43 21.0 (8) 179.88 <0.001 
Pyramids & Palm Trees Test score
†^ 
51 (2) 257.65 50.5 (2)*** 179.28 50.5 (3)** 172.81 50 (2)** 132.29 50.0 (2)** 149.52 <0.001 
BADLS score
†
 0 (0) 214.23 0 (3)**
% 
278.62 0.5 (3)*
% 
285.25 13 (4)*** 463.18 1.5 (2)*
% 
292.85 <0.001 
KEY: BADLS = Bristol Activities of Daily Living Scale; CVLT LD = California Verbal Learning Test, long delay recall; CVLT SD = California Verbal Learning Test, short delay 
recall; IQR = interquartile range; VOSP = Visual Object and Space Perception 
*p < 0.05, **p ≤ 0.01, ***p < 0.001 for difference from controls; #p < 0.05 for difference from aMCI and >MCI; %p < 0.05 for difference from >MCI; $p < 0.05 for difference from 
Low Mood with Bonferroni correction for multiple comparisons 
†
n = 359 control; 
¶
n = 330 control, 50 aMCI, 25 naMCI, 13 >MCI; 
‡
n = 355 control, 49 aMCI, 24 naMCI, 12 >MCI, 19 low mood; 
¥
n = 358 control; 
§
n = 356 control, 50 aMCI, 24 
naMCI, 9 >MCI, 19 low mood; 
€
n = 51 aMCI 
NB: Distributions of characteristics/scores were not similar for all groups, therefore comparisons are based on the mean rank (unless indicated 
^
 where distributions were similar, 
therefore comparisons are based on the median) 
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Discussion 
 
The purpose of this chapter was to report our experience of recruiting older people from 
the community to take part in a study investigating the validity of brief cognitive tests 
for identifying people with MCI, as well as provide some indication of the rates of MCI 
within a UK community-based population. 
 
Although the current study was not designed from the outset as a prevalence study, it 
does provide some indication of the prevalence of MCI within a defined population and 
thus it is interesting to discuss the findings in relation to previous studies of MCI 
prevalence.  As discussed in Chapter 1 of the thesis, previous studies have shown 
enormous variation in MCI prevalence, ranging from 3 to 42%, with the variability 
largely being attributed to a lack of consensus in criteria choice and implementation 
(Ward et al., 2012). Many of the studies included in the review by Ward and colleagues 
(2012) were large population-based studies, with the median sample size across all 
studies exceeding 1000 subjects. Such large studies tend to use abbreviated testing 
schedules or retrospectively apply criteria to previously assessed patients, resulting in 
less precise classifications.  
 
The current study included a well characterised, prospectively assessed cohort of older 
people recruited from the community and a prevalence of 16.5% of MCI was found 
within the assessed cohort. This finding lies within the range of that reported by other 
European-based studies applying similar criteria. For instance, a study by Artero and 
colleagues (2006), conducted in France using a similar GP practice based recruitment 
strategy, found an almost identical prevalence rate of 16.6% of MCI in their sample 
(Artero, Petersen, Touchon, & Ritchie, 2006). They also applied the criteria and 
diagnostic flowchart proposed by Petersen et al (Petersen, 2004; Winblad et al., 2004) 
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and assessed similar cognitive domains including episodic memory, attention, 
visuospatial ability and language, albeit using a different, computerised 
neuropsychological battery of tests. Our finding also falls within the range estimated by 
Luck and colleagues of 14.1% – 16.6%, which they report in their German study of 
prevalence of MCI among primary care patients (Luck et al., 2007). Again, although 
this study used a different battery of neuropsychological tests to those used in the 
current study, similar cognitive domains were assessed and the same criteria were 
applied.   
 
In terms of subtypes of MCI, we found that aMCI was twice as prevalent at naMCI. 
Similar findings have been reported in previous studies, for example the large 
population-based Mayo Clinic Study of Aging reported a 2:1 ratio of aMCI to naMCI in 
their sample of almost 3000 participants (Petersen et al., 2010).  
 
It is important to note that, for their prevalence estimates, Artero et al (2006) and Luck 
et al (2007) only included people with subjective cognitive complaints in their MCI 
groups. For comparison, however, Luck et al reported additional estimates of MCI 
prevalence including people without memory complaints. In this case, their estimate of 
prevalence increased to 23.7 – 26.7%, which is somewhat higher than our estimate 
(which included those with and without memory complaints). This discrepancy could be 
explained by the fact that their cognitive domain impairment definition was set slightly 
lower than ours at 1SD below norm. 
 
The adherence to the criterion of subjective cognitive complaint for the classification of 
MCI is a matter under debate (Mitchell, 2008b). Although subjective memory 
complaints are believed to indicate a decline in objective memory performance 
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(Petersen, 2004), studies have demonstrated poor correlations between the two 
(Jungwirth et al., 2004; Lenehan, Klekociuk, & Summers, 2012). In the study by Luck 
and colleagues (2007), it was reported that almost 40% of the cognitively impaired 
participants did not fulfil the criterion of a subjective cognitive complaint. In the current 
study, 13% of people classified as having MCI did not report a subjective memory 
complaint. Conversely, amongst those people who did report a subjective memory 
complaint, the rate of people who did not display impairment on objective testing was 
high, indicating that there was a high proportion of the “worried well”, a term which has 
been used previously in the literature to describe people with subjective memory 
complaints but no objective memory impairment (Ahmed, Mitchell, Arnold, Dawson, et 
al., 2008), within our sample. The low specificity of memory complaint status for aMCI 
of 23% reflects this finding. Together these findings provide further evidence to suggest 
that subjective memory complaints may not be a very reliable indicator of objective 
cognitive status, and therefore perhaps should not be an essential criterion in the 
classification of MCI.   
 
Although the study provides an estimate of prevalence of MCI, it should be pointed out 
that these figures are based on only 6.2% (472/7618) of the contacted population. 
Without information on the characteristics of the “unassessed” population it is 
impossible to evaluate whether or not they were similar to the assessed population and 
would have resulted in similar prevalence estimates. Non-responders or participants 
who declined to take part may well have been more cognitively impaired than those 
people who responded and agreed to take part in the study. In fact, a study that 
compared the prevalence of MCI between people who responded at first contact (quick 
responders) to a community based survey and those who responded after a follow-up 
(delayed responders), found a 2.3 fold increase in MCI in delayed compared to quick 
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responders (Miyamoto et al., 2009). This suggests that any future studies employing 
similar postal based recruitment strategies should consider re-contacting initial non-
responders as the rate of MCI may in fact be higher within that delayed responder 
cohort. 
 
An important aim of this work was to provide future researchers with information on 
recruitment rates of MCI. Over a two and a half year recruitment period, during which 
7618 people were contacted, 78 people with MCI were recruited. Or, in other words, 
1.02% of the contacted population were classified as having MCI and it is this more 
conservative MCI recruitment rate estimate that should be considered when designing 
future studies applying similar recruitment techniques. The target at the outset of the 
study was to recruit 200 people with aMCI; only a quarter of this target was achieved 
(n=52). This was largely due to the fact that the prevalence of aMCI within people 
reporting subjective memory impairment was lower than expected (12.5% compared 
with a predicted 30%, based on studies by Benito-Leon et al (2010) and Mitchell et al 
(2008)). In addition, the response rate to the flyers was much lower than anticipated at 
approximately 19%. As discussed previously, it perhaps would have been useful in the 
current study to have followed up those people who didn’t respond initially as this may 
have resulted in an increased recruitment of individuals with MCI.  
 
Of those people that did respond, only 58.0% were eligible for further follow-up. 
During the initial phase of the study, one of the most common reasons for exclusion of 
responders was having a positive depression screening answer to the two Whooley 
questions (Whooley et al., 1997). Removing this eligibility criterion increased the 
eligibility rate and further analysis of the Whooley questions revealed that although they 
were 100% sensitive at picking up depression (as defined by the GDS) they performed 
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with relatively low specificity, with a false positive rate of 28%. This finding is in line 
with that from a recent meta-analysis which found a pooled sensitivity of 95% (95% CI 
88 to 97) and pooled specificity of 65% (95% CI 56 to 74) for the screening questions 
(Bosanquet et al., 2015).  
 
Following the removal of the depression screening questions, the main reason for 
exclusion of responders was having no informant available. This was a requirement for 
the study due to the use of an informant-rated ADL scale. There is no consensus 
regarding the assessment of ADLs to satisfy the criterion of preserved ADLs for the 
classification of MCI. Several options exist including performance-based tasks and 
questionnaires or interviews (Gold, 2012). Both self-report and informant-report 
questionnaires are available, however, the practice of using an informant’s perspective 
when rating ADLs is important because there is evidence for impaired insight in MCI 
(Vogel et al., 2004). Performance based measures could prevent the need for an 
informant and thereby increase the inclusion rate for future studies. However, they 
present disadvantages in the fact that they represent a single evaluation point with 
typical everyday cues removed and also can be time consuming and expensive to 
administer (Gold, 2012). Questionnaires appear to be the most convenient option for 
large scale community based MCI case finding, due to their ease of use. However, due 
to the impact that the requirement of having an informant available has on recruitment 
rates, self-report ADL questionnaires should be considered for future study designs. It 
would be particularly useful to conduct a head-to-head comparison of self- and 
informant-reported ADL questionnaires in MCI cohorts in the future so that the 
reliability of each method may be evaluated. 
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Conclusion 
The current study has provided a prevalence estimate for MCI of 16.5% within a UK-
community based sample of people aged 70 years and above recruited using flyers 
posted from their GP practice. This estimate is similar to other European-based studies 
which have used similar recruitment techniques and criteria. However, when taking into 
account all people initially approached, this rate drops to 1.02% and this more 
conservative estimate should be considered when designing future studies applying 
similar recruitment techniques. The main reason for exclusion of potential participants 
was having no informant available and this fact should be considered in future studies 
which use an informant-based assessment of ADL ability. 
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Chapter 4: Assessing the Validity of Two Brief Cognitive Tests for 
Detecting aMCI in a Community Cohort 
 
Introduction 
 
Amnestic MCI (aMCI), which is associated with elevated rates of conversion to 
dementia caused by Alzheimer’s disease (AD) (Petersen et al., 2001) is largely 
unrecognised in primary care since its diagnosis depends on complex 
neuropsychological assessment methods not usually available in this setting. There is a 
need for simple, quick and sensitive cognitive tests that will provide a more efficient 
way of identifying people with aMCI. These would provide a useful resource to busy 
primary healthcare staff who are encouraged, as stated in UK national guidance, to refer 
people who show signs of MCI for further assessment by memory assessment services 
to aid early identification of dementia (NICE, 2006). They could also be applied by 
researchers to find suitable participants for enrolment into studies of candidate 
interventions targeted at this early stage of cognitive decline. 
 
As reported in the systematic review described in Chapter 2 (recently accepted for 
publication, (Ozer, Young, Champ, & Burke, 2016)) over 40 brief cognitive tests have 
been developed and tested to identify people with aMCI. Several of these cognitive tests 
demonstrated promising diagnostic test accuracy results, though the majority of studies 
were found to be at a high risk of bias due to the method of participant selection 
employed. Most studies selected patients with known aMCI from memory clinics and 
compared their performance on the test under evaluation with an opportunistically 
recruited group of people assumed to have no cognitive impairment. This exposed the 
studies to risk of unblinding of the patient assessment process and potentially 
exaggerated diagnostic accuracy (Lijmer et al., 1999; Whiting et al., 2004). The current 
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study aimed to address this limitation by assessing the validity of two brief cognitive 
tests in a cohort of participants all recruited from the community, without prior 
knowledge of their cognitive status, thereby reducing the risk of bias in the assessment 
process.  
 
The Memory Alteration Test (M@T) and the Test Your Memory (TYM) test were 
selected for investigation in this study. The findings from the systematic review in 
Chapter 2 (conducted in 2013) suggested that other tests, such as the MoCA and AVLT, 
demonstrated better diagnostic test accuracy than the chosen tests for this study 
(particularly than the TYM). However, at the time of test selection, which took place in 
2011 as part of the NIHR grant application process, the M@T and TYM were deemed 
to be the most promising tests available for community-based identification of aMCI. 
The M@T, which is a brief, interviewer-administered memory task, had been 
highlighted in a review by Lonie and colleagues (2009) as being particularly well suited 
to use in general practice, with a relatively short administration time (<7 minutes) and 
simple scoring method and its developers reported it to have very high sensitivity (96%) 
and high specificity (70-79%) for discriminating between people with aMCI and healthy 
controls (Rami et al., 2010; Rami et al., 2007). The TYM was identified as another 
potentially suitable, simple cognitive test for identifying aMCI in primary care. The 
developers of TYM reported that it had very high sensitivity (93%) and high specificity 
(86%) for discriminating between people with and without mild Alzheimer’s disease 
(Brown et al., 2009).  A subsequent study using a Japanese version of the test 
highlighted its potential for use as a screening tool for aMCI, reporting high sensitivity 
(76%) and specificity (74%) (Hanyu et al., 2011). The TYM has the added advantage of 
being self-administered and requiring minimal supervision.    
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The aim of the current study was to evaluate the effectiveness of the M@T and TYM 
for identifying people with aMCI by investigating: (1) their sensitivity/specificity in 
detecting aMCI in a community-based population in comparison with the widely used 
standard for diagnosing aMCI based on the Petersen criteria (Petersen, 2004); (2) their 
test-retest reliability performance; and, (3) their clinical utility, assessed in terms of 
administration time and completion rates.  
 
Methods 
 
Recruitment 
Recruitment methods for the study are covered in detail in Chapter 3. In brief, older 
people (aged 70 years and above) were contacted via a study information flyer sent to 
them from their GP practice. Eligible respondents were then contacted by telephone to 
be invited to take part in the study. Those people who wanted to take part were 
subsequently enrolled onto the study and gave informed written consent to participate 
during a visit to their home. 
 
Assessment Procedures 
All participants were assessed using the two brief cognitive tests under investigation 
(M@T and TYM), as well as the standardised battery of neuropsychological tests used 
to classify their cognitive status (described in Chapter 3). Following the classification 
flowchart (see Figure 3.1), participants were classified as having (1) amnestic MCI 
(aMCI), (2) non-amnestic MCI (naMCI), (3) cognitive difficulties beyond MCI (>MCI) 
and (5) low mood. Those participants who did not meet the criteria for aMCI, or the 
other possible study classifications, were classified as “controls” and formed the 
reference group for the subsequent discriminatory analyses.  
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The M@T and TYM were administered in a randomised order to avoid “order effects”, 
which refers to the differences in participant responses that can result from the order in 
which tests are presented to them ("Psychology Research and Reference," 2016). The 
allocation of the first administered test was determined by blocked randomisation (1:1 
ratio) in order to limit any potential differences in sample size between groups. Block 
sizes were varied randomly between 10 and 20. A randomisation website was used to 
generate the block sizes as well as the allocation sequence for each block 
(http://www.random.org/lists/). 
 
The first allocated brief cognitive test was administered during Session 1 which took 
place in the participant’s home. The other brief cognitive test followed by the 
neuropsychological test battery (described in Chapter 3), were administered during 
Session 2 which took place in the Clinical Research Facility based at Bradford Royal 
Infirmary within two weeks of Session 1. The M@T, TYM and neuropsychological 
battery were all administered by research assistants who were blinded to each other’s 
assessments. Both the M@T and TYM were timed by stopwatch. Classifications of 
participants were agreed in consensus with the study neuropsychologist (Dr Krist 
Noonan), who was blinded to the results of the M@T and the TYM.  
 
To assess test-retest reliability, Session 3 was arranged for a sample of participants who 
were re-administered the brief cognitive test they had completed during Session 1. The 
first 25 consecutive aMCI and control participants that were allocated the M@T first 
and that were allocated the TYM first were invited to take part in Session 3. When 
participants refused or could not be contacted for follow-up, the next eligible participant 
was invited. In cases where participants were part of a couple, both participants were 
invited to take part in Session 3 so that the reason for their invitation did not have to be 
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revealed, since cognitive status classifications were not disclosed to participants. 
Session 3 was scheduled to take place at home within four weeks of Session 1.  
 
Memory Alteration Test (M@T) 
The Memory Alteration Test (M@T) (Rami et al., 2007) is an interviewer-administered 
test comprising a  minimum  of  33,  and  a  maximum  of  43, questions depending  on  
free  recall  success (see Appendix 4.1). It  assesses  five  cognitive  skills (encoding,  
orientation,  semantic  memory,  free  recall  and  cued  recall, with recall intervals of 
<10 minutes) with a maximum total score of 50. It was developed and validated in 
Spain but has been translated into English, although not validated in this form. The 
translated version from the development paper was applied (Rami et al., 2007) (with 
slight amendments made to the wording of some of the semantic memory questions; see 
Appendix 4.2). 
 
Test Your Memory Test (TYM) 
The Test Your Memory (TYM) test (Brown et al., 2009) is a supervised, self-completed  
questionnaire comprising ten cognitive tasks, providing assessment of a wider range of 
cognitive domains than is covered in the M@T (see Appendix 4.3). In addition to 
memory and orientation tasks, the TYM also includes calculation, fluency, similarities, 
naming, and visuospatial tasks. As with the M@T, the recall interval for the memory 
task is <10 minutes. A score out of five is also given for the amount of help that the 
participant required to complete the task, with higher scores indicating that less support 
was required. The maximum total score is 50. 
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 Statistical Analysis 
All analyses were performed using SPSS Statistics v22 (IBM). Between-group 
differences (aMCI vs. control) in age, years of education, IQ and the M@T and TYM 
scores were explored using the Mann-Whitney U test (since the data were non-normally 
distributed). Difference in gender proportion between the groups was analysed using the 
Χ2 test.  
 
Receiver operating characteristic (ROC) curve analysis was applied to assess the ability 
of the M@T and TYM global and subtest scores to discriminate between the aMCI 
group and the control group for a range of cut-off values. The area under the curve 
(AUC) was reported as a single measure of overall accuracy. Optimal cut-off points 
were defined as those providing the highest Youden index, which is a way of combining 
sensitivity and specificity into a single measure, calculated as “sensitivity + (specificity-
1)” (Youden, 1950). Positive and negative predictive values and likelihood ratios were 
calculated for each optimal cut-off point. Wilson’s ‘score’ method (Wilson, 1927) was 
used to estimate 95% confidence intervals and they were calculated using an online 
calculator provided by PEDro, the Physiotherapy Evidence Database (Herbert, 2013).   
 
Test-retest reliability of the M@T and TYM was investigated using the established 
techniques of Bland and Altman (Bland & Altman, 1986). The mean difference between 
original test and retest scores was calculated, as was the reliability coefficient, which is 
twice the standard deviation of the differences and provides a measure of random error. 
Paired sample t-tests were applied to explore for any significant differences between 
original test and retest scores (since the data were normally distributed). Agreement 
between original test and retest classifications (based on optimal cut-off scores) was 
also explored using the kappa statistic to measure agreement beyond that which would 
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be expected by chance alone (established categories for interpreting the kappa statistic 
were applied from poor (<0.00) to moderate (0.41 -0.60) to almost perfect (0.81 – 1.00) 
(Landis & Koch, 1977).     
 
Results 
 
The characteristics of the recruited participants are described in detail in Chapter 3. Of 
the 472 participants who were recruited and classified, 52 people had aMCI and 360 
people were designated controls and formed the reference group for subsequent 
analyses. Seventy two per cent of these participants completed Session 2 within two 
weeks of Session 1.  
 
The aMCI participants were significantly older, had fewer years of education and a 
lower NART IQ than the controls (see Table 3.6). Since these factors could have had an 
influence on the M@T and TYM scores, age-, education- and IQ-matched controls were 
randomly selected for the discriminatory analyses. The aim was to select three matched 
controls for each aMCI participant; however some aMCI participants had less than 3 
matches (and some none at all), which resulted in 40 aMCI cases matched with 112 
controls. The demographic characteristics of these matched participants are provided in 
Appendix 4.4.  
 
M@T Performance 
 
Validity 
Participants with aMCI scored significantly lower on the M@T than the control 
participants (35 (10) vs. 45 (5), U = 1459, z = -9.7, p<0.001, see Table 4.1).  The box 
plots demonstrate the distribution of the M@T scores for each group (see Figure 4.1a).  
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Figure 4.2a shows the ROC curve of the M@T for differentiating the aMCI participants 
from the matched controls.  The AUC was 0.91 and a score of 40 provided the optimal 
cut-off for discriminating between aMCI and controls (sensitivity 85% (95% CI 70 – 
93%), specificity 84% (95% CI 76 – 89%); see Table 4.2). To give context to these 
figures, the findings indicate that if 100 people with aMCI were administered the M@T, 
85 of those people would be correctly classified as having aMCI (i.e. true positives) and 
the remaining 15 people would be incorrectly classified as not having aMCI (i.e. false 
negatives). On the other hand, if 100 controls were administered the M@T, 84 of those 
people would be correctly classified as not having aMCI (i.e. true negatives) and the 
remaining 16 people would be incorrectly classified as having aMCI (i.e. false 
positives).   
 
At the developer-recommended cut-off of 37 (Rami et al., 2007), a lower sensitivity 
(64%) but higher specificity (96%) was achieved. In other words, if the same groups of 
people in the above example were administered the M@T with this revised cut-off, 
there would be fewer true positives identified (64 compared with 85), but more true 
negatives identified (96 compared with 84).  
 
The diagnostic utility parameters for the M@T subtests are also summarised in Table 
4.2.  The most sensitive subtests to discriminate between the aMCI and control groups 
were Free Recall and Cued Recall, which both demonstrated AUC >0.85.  Orientation 
was the least sensitive subtest, with the lowest AUC value (0.61). 
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Reliability 
Twenty-five aMCI cases and 31 controls were reassessed with the M@T. Three quarters 
(75%) of these participants were reassessed within 4 weeks of Session 1.  Participants 
tended to score higher in Session 3 than Session 1 (mean difference 2.8 points (95% CI 
2.0 to 3.7); see Table 4.3). This difference was significant (t (54) = -6.05, p<0.001). The 
kappa value was 0.54 (indicating “moderate” agreement between sessions).  
 
Utility 
The median time to complete the M@T in the control group was 6min 5sec (IQR: 1min 
40sec). Participants with aMCI took significantly longer than the control group, with a 
median time of 8min 15sec (± 1min 45sec) (U = 2798, z = -7.95, p<0.001). 
 
The majority (n=409, 99%) of aMCI and control participants completed all the M@T 
questions. One aMCI participant had one missing item from the Free Recall subset and 
two control participants each had one missing item from the Cued Recall subset. These 
participants were excluded from any analyses concerning these scores (i.e. M@T total 
score, Free Recall subset and Cued Recall subset discriminatory analyses). In addition, 
one aMCI participant had missing data from their re-test M@T (three missing items 
from the Cued Recall subset) and was therefore excluded from the test-retest reliability 
analyses. 
 
The M@T requires the participant to encode and recall five words: cherry, axe, 
elephant, piano and green. However, it was noted that the words “axe” and “green” 
were commonly misheard and had to be repeated.  
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TYM Performance 
 
Validity 
Participants with aMCI scored significantly lower on the TYM than the control 
participants (41 (8) vs. 47 (4), U = 2921.5, z = -8.1, p<0.001, see Table 4.1). The box 
plots demonstrate the distribution of the TYM scores for each group (see Figure 4.1b).  
 
Figure 4.3b shows the ROC curve of the TYM for differentiating the aMCI participants 
from the matched controls.  The AUC was 0.80 and a score of 43 provided the optimal 
cut-off for discriminating between aMCI and controls (sensitivity 63% (95% CI 47 – 
76%); specificity 87% (95% CI 79 – 93%); see Table 4.2). To give context to these 
figures, the findings indicate that if 100 people with aMCI were administered the TYM, 
63 of those people would be correctly classified as having aMCI (i.e. true positives) and 
the remaining 27 people would be incorrectly classified as not having aMCI (i.e. false 
negatives). On the other hand, if 100 controls were administered the TYM, 87 of those 
people would be correctly classified as not having aMCI (i.e. true negatives) and the 
remaining 13 people would be incorrectly classified as having aMCI (i.e. false 
positives).   
 
At the commonly used cut-off of 44 (Hanyu et al., 2011; Munoz-Neira, Henriquez 
Chaparro, Delgado, Brown, & Slachevsky, 2014; Szczesniak, Wojtynska, & 
Rymaszewska, 2013), a slightly higher sensitivity (65%) but lower specificity (80%) 
was achieved.   In other words, if the same groups of people in the above example were 
administered the TYM with this revised cut-off, there would be more true positives 
identified (65 compared with 64), but fewer true negatives identified (80 compared with 
87). 
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The diagnostic utility parameters for the TYM subtests are summarised in Table 4.2.  
All subtests (except for the Fluency subtest) performed with less sensitivity than the 
global TYM test, and all subtests demonstrated AUC values of less than 0.75. Fluency 
and Free Recall were the most accurate subtests, with AUCs of 0.72. 
 
Reliability 
Nineteen aMCI cases and 30 controls were reassessed with the TYM. The majority 
(88%) of these participants were reassessed within four weeks of Session 1.  
Participants tended to score higher in Session 3 than Session 1 (mean difference 1.9 
points (95% CI 1.0 to 2.8); see Table 4.3). This difference was significant (t(48) = -4.40, 
p<0.0005). The kappa value was 0.51 (indicating “moderate” agreement between 
sessions).  
 
Utility 
The median time to complete the TYM in the control group was 7min 19sec (± 2min 
30sec). Participants with aMCI took significantly longer (p<0.005) than the control 
group, with a median time of 9min 26sec (± 2min 32sec) (U = 4374.5, z = -5.59, 
p<0.001). 
 
Fully completed TYM questionnaires were obtained for all of the aMCI participants and 
almost all of the controls. Only one control participant had missing items with four 
missing items from the Orientation subtest and no score for the Help Given subtest. This 
participant was excluded from analyses concerning these scores (i.e. TYM total score, 
Orientation subset and Help Given subset discriminatory analyses). 
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Table 4.1: M@T & TYM test scores for aMCI and Control participants 
 aMCI  
(n=52) 
Control  
(n=360) 
p value 
M@T global score 35 (10)
‡ 
45 (5)
§
 <0.001 
TYM global score 41 (8) 47 (4)
† 
<0.001 
Data are presented as median (interquartile range) unless indicated otherwise; p value for Mann-
Whitney-U test 
‡
n = 51; 
§
n = 358; 
†
n = 359;  
 
 
Figure 4.1: (a) M@T and (b) TYM global scores for control and aMCI participants 
KEY: o = mild outliers (i.e. data points that lie >1.5 * IQR away from the lower/upper quartile);  
* = extreme outliers (i.e. data points that lie >3 * IQR away from the lower/upper quartile); IQR = 
interquartile range 
 
(a) 
(b) 
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Figure 4.2: Receiver operating characteristics of the (a) M@T and (b) TYM for differentiating 
aMCI participants from age, education and IQ-matched controls 
(a) 
(b) 
90 
Table 4.2: Diagnostic utility of M@T to discriminate between aMCI and age, education and IQ-matched controls 
 
 
Test (maximum scores) AUC 
(95%CI) 
p value Optimal 
Cut-off* 
Sensitivity 
(95%CI) 
Specificity 
(95%CI) 
PPV 
(95%CI) 
NPV 
(95%CI) 
LR+ 
(95%CI) 
LR- 
(95%CI) 
M@T Total Score (50) 
 
 
0.91 
(0.85 – 0.96) 
<0.001 
 
<40 
 
85 
(70 – 93) 
84 
(76 – 89) 
34 
(25 – 44) 
98 
(96 – 99) 
5.17 
(3.32 – 8.05) 
0.18 
(0.09 – 0.39) 
Encoding (10) 0.79 
(0.70 – 0.87) 
<0.001 <9 58 
(42 – 71) 
88 
(80 – 92) 
32 
(22 – 43) 
 
95 
(93 – 97) 
4.60 
(2.63 – 8.04) 
0.48 
(0.34 – 0.70) 
Orientation (5) 0.61 
(0.50 – 0.71) 
0.05 <5 38 
(24 – 53) 
83 
(75 – 89) 
18 
(11 – 28) 
92 
(90 – 95) 
2.21 
(1.25 – 3.92) 
0.75 
(0.58 – 0.97) 
Semantic (15) 0.74 
(0.65 – 0.83) 
<0.001 <14 85 
(71 – 93) 
54 
(44 – 63) 
15 
(11 – 21) 
97 
(94 – 99) 
 
1.83 
(1.44 – 2.32) 
0.28 
(0.13 – 0.60) 
Free Recall (10) 0.88 
(0.82 – 0.94) 
<0.001 <6 90 
(76 – 96) 
77 
(68 – 84) 
28 
(21 – 36) 
99 
(97 – 99) 
3.87 
(2.72 – 5.50) 
0.13 
(0.05 – 0.34) 
Cued Recall (10) 0.86 
(0.78 – 0.93) 
<0.001 <9 80 
(65 – 90) 
78 
(70 – 85) 
27 
(20 – 35) 
97 
(95 – 99) 
3.67 
(2.49 – 5.40) 
0.26 
(0.14 – 0.48) 
*cut-off providing highest Youden index; PPV = positive predictive value; NPV = negative predictive values; PPV and NPV calculated for 10% prevalence 
of MCI  (calculated as PPV = TP/(TP+FP); NPV = TN/(TN+FN), where TP = true positive, FP = false positive, TN = true negative, FN = false negative); 
LR+ = positive likelihood ratio; LR- = negative likelihood ratio 
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Table 4.3: Diagnostic utility of TYM to discriminate between aMCI and age, education and IQ-matched controls 
Test (maximum scores) AUC 
(95%CI) 
p value Optimal 
Cut-off* 
Sensitivity Specificity PPV NPV LR+ LR- 
TYM Total Score (50) 0.80 
(0.72 – 0.88) 
<0.001 <43 63 
(47 – 76) 
87 
(79 – 93) 
32 
(22 – 43) 
95 
(93 – 97) 
4.67 
(2.75 – 7.92) 
0.43 
(0.29 – 0.65) 
Orientation (10) 0.57 
(0.46 – 0.67) 
0.22 <10 30 
(18 – 45) 
83 
(75 – 89) 
15 
(9 – 24) 
91 
(89 – 94) 
1.77 
(0.95 – 3.31) 
0.84 
(0.68 – 10.5) 
Copying (2) 0.52 
(0.41 – 0.62) 
0.77 <1 5 
(1 – 16) 
99 
(95 – 100) 
33 
(1 – 70) 
91 
(88 – 94) 
5.60 
(0.52 – 60.1) 
0.96 
(0.89 – 1.03) 
Semantic (3) 0.67 
(0.56 – 0.77) 
0.002 <2 40 
(26 – 55) 
91 
(84 – 95) 
31 
(20 – 44) 
93 
(91 – 96) 
4.48 
(2.22 – 9.05) 
0.66 
(0.51 – 0.85) 
Calculation (4) 0.58 
(0.47 – 0.69) 
0.14 <4 40 
(26 – 55) 
73 
(64 – 80) 
13 
(8 – 20) 
92 
(89 – 95) 
1.49 
(0.92 – 2.43) 
0.82 
(0.62 – 1.08) 
Fluency (4) 0.72 
(0.63 – 0.82) 
<0.001 <4 73 
(57 – 84) 
66 
(57 – 74) 
18 
(13 – 24) 
96 
(93 – 98) 
2.14 
(1.55 – 2.95) 
 
0.41 
(0.25 – 0.70) 
Similarities (4) 0.61 
(0.51 – 0.72) 
0.04 <4 53 
(38 – 67) 
68 
(59 – 76) 
14 
(9 – 20) 
 
93 
(90 – 96) 
1.63 
(1.10 – 2.43) 
0.69 
(0.49 – 0.99) 
Naming (5) 0.54 
(0.43 – 0.65) 
0.46 <5 13 
(5 – 26) 
 
96 
(90 – 98) 
 
24 
(11 – 45) 
91 
(88 – 94) 
2.8 
(0.86 – 9.2) 
0.91 
(0.80 – 1.04) 
Visuospatial 1 (3) 0.50 
(0.40 – 0.61) 
0.99 <1 13 
(5 – 26) 
94 
(88 – 97) 
17 
(8 – 34) 
91 
(88 – 94) 
2.00 
(0.67 – 5.95) 
0.93 
(0.82 – 1.06) 
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Table 4.4: Test-retest reliability of the M@T and TYM 
 Bland and Altman Results Cohen’s 
Kappa  Mean  
difference 
95% CI for mean 
difference 
SDdiff Reliability  
coefficient 
M@T -2.8 -2.0 to -3.7 3.5 6.9 (out of 50) 0.54* 
TYM -1.9 -1.0 to -2.8 3.0 6.0 (out of 50) 0.51* 
*p<0.001     
 
 
Visuospatial 2 (4) 0.53 
(0.42 – 0.63) 
0.65 <4 15 
(7 – 29) 
90 
(83 – 94) 
13 
(6 – 26) 
91 
(88 – 94) 
1.53 
(0.60 – 3.86) 
0.94 
(0.82 – 1.09) 
Free Recall (6) 0.72 
(0.62 – 0.82) 
<0.001 <3 50 
(35 – 65) 
93 
(87 – 96) 
42 
(29 – 56) 
94 
(92 – 97) 
7.00 
(3.35 – 14.6) 
0.54 
(0.39 – 0.74) 
Help (5) 0.53 
(0.43 – 0.64) 
0.55 <4 13 
(5 – 26) 
93 
(86 – 96) 
15 
(7 – 31) 
91 
(88 – 94) 
1.75 
(0.61 – 5.04) 
0.94 
(0.83 – 1.07) 
*cut-off providing highest Youden index; PPV = positive predictive value; NPV = negative predictive values; PPV and NPV calculated for 10% prevalence 
of MCI (calculated as PPV = TP/(TP+FP); NPV = TN/(TN+FN), where TP = true positive, FP = false positive, TN = true negative, FN = false negative); 
LR+ = positive likelihood ratio; LR- = negative likelihood ratio 
93 
Discussion 
 
The current study aimed to assess the accuracy of two brief cognitive tests (M@T and 
TYM) for identifying people with aMCI in the community. The M@T performed with 
higher diagnostic test accuracy than the TYM, with higher sensitivity (85% vs 63%), 
similar specificity (84% vs. 87%) and higher overall accuracy as demonstrated by the 
AUC values (0.91 vs. 0.80). Both tests were associated with a learning effect such that a 
second assessment repeated within one month of the first showed higher test scores. 
Both tests were acceptable to participants with completion times of less than ten 
minutes and very few missing items.  
  
Although the M@T demonstrated reasonably high levels of sensitivity and specificity 
for aMCI, the study did not reproduce the very high diagnostic test accuracy (DTA) 
results reported in previous studies. For example, a recent study by Custodio et al 
reported that a cut-off score of 37 had a sensitivity and specificity of 98% (AUC = 
0.999) to differentiate aMCI from controls (Custodio et al., 2014). The developers of the 
M@T recommend a cut-off score of 37 and they report sensitivity of 96% and 
specificity of 70-79% at this cut-off (Rami et al., 2010; Rami et al., 2007). However, a 
higher optimal cut-off value was found for the current sample (<40) and a lower 
sensitivity (63%) but higher specificity (96%) was demonstrated at the recommended 
cut-off.  
 
The DTA results for TYM also differed from those reported in previous studies. A cut-
off score of 44 has been recommended in three previous studies of TYM (Hanyu et al., 
2011; Munoz-Neira et al., 2014; Szczesniak et al., 2013). These studies report 
sensitivities of 74 – 86% and specificities of 60 – 74% at this cut-off. A slightly lower 
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optimal cut-off value was found in the current sample (<43) and lower sensitivity (65%) 
but higher specificity (80%) at the previously recommended cut-off.     
 
These DTA discrepancies might be explained by the community-based recruitment 
method that was used in the current study.  The previous studies were all conducted in 
secondary/specialist care settings such as memory clinics (Hanyu et al., 2011; Rami et 
al., 2010; Rami et al., 2007), neurology departments (Custodio et al., 2014; Munoz-
Neira et al., 2014) or psychiatry units (Szczesniak et al., 2013) and most recruited their 
aMCI sample from patients attending clinics and their “control” sample from a separate 
source, such as other hospital departments or the wider community (Custodio et al., 
2014; Hanyu et al., 2011; Rami et al., 2007; Szczesniak et al., 2013). Studies which use 
a “case-control” design such as this are known to exaggerate diagnostic accuracy 
(Lijmer et al., 1999; Whiting et al., 2004). The current study used a sampling method 
that was designed to reflect how the brief cognitive tests might be applied in routine 
care in the future, that is, community based aMCI case finding. This approach has 
resulted in more conservative estimates of DTA which are likely to be more 
generalizable to unselected populations. Assessing all participants with the same 
reference standard also meant that verification bias was avoided, which occurs when 
only a proportion of the study population receive confirmation of the diagnosis (usually 
those with positive test results) and can also result in overestimation of DTA values 
(Lijmer et al., 1999; Whiting et al., 2004). The fact that both tests were found to 
perform at lower sensitivity at the recommended cut-offs than previously demonstrated 
indicates that the current aMCI population were less impaired than those included in 
previous studies, likely to be a result of the community-based, rather than secondary 
care-based, approach to recruitment.   
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As reported by the developers of M@T, the current study also demonstrated that Free 
Recall and Cued Recall were the most accurate sub-tests for discriminating between the 
aMCI and control groups. It is perhaps unsurprising that these recall scores are the most 
useful for identifying aMCI since it is well known that episodic memory is impaired in 
aMCI and early AD (Petersen et al., 1999). This is thought to be the result of early 
pathological changes that occur in the hippocampus and medial temporal lobe (Jack, 
Shiung, Weigand, & al, 2005). Similarly, the Free Recall subtest was found to be the 
most accurate TYM subtest for identifying people with aMCI. Some TYM subtests 
were found to be of less value in discriminating between aMCI and controls (e.g. the 
naming subtest and two visuospatial subtests, all with AUC values ~0.5). The success of 
the recall subtests at detecting aMCI reflect the findings from the systematic review in 
Chapter 2, which found that the highest performing tests were those that involved some 
element of word recall (such as the AVLT-SR, HVLT-LE and FBMS). Together, these 
findings indicate that the Recall subtest scores are particularly useful for identifying 
aMCI and that particular emphasis should be placed on these subtests when interpreting 
scores.  
 
It is important to note here that an algorithmic, rather than clinical, categorisation of 
aMCI was applied in this study. Although this differs from usual clinical practice, which 
would involve the incorporation of clinical and neurological examination to make a 
final diagnosis, it enabled the criteria to be applied in a standardised and objective 
manner, thereby ensuring reliability of the classifications (Petersen et al., 2014). The 
M@T and TYM have both demonstrated that they are valid in identifying people with 
aMCI as classified using this algorithmic method. Of course, in practice, further clinical 
assessment would be required to make a differential diagnosis and it is the intention that 
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these instruments would be used as a first screening stage in clinical practice and not as 
diagnostic tools. 
 
Both the M@T and TYM performed with moderate test-retest reliability. Participants 
tended to score higher in the second session than the first on both tests indicating that 
there may have been a learning/practice effect. This is commonly seen with repeated 
cognitive testing (Heilbronner et al., 2010). The reliability coefficient (which reflects 
random error) was fairly high for both tests at 6.9 and 6.0 points for M@T and TYM 
respectively. These values give an indication of the maximum change in score on retest 
that might be expected by chance in the absence of change in an individual’s cognitive 
status. In other words, only a change of score that is more than 7 points for M@T and 6 
points for TYM would represent real change for an individual patient. To the authors’ 
knowledge, this is the first study to provide these data. This is relevant if these tests are 
to be used in applications such as measuring the effectiveness of interventions or 
monitoring change in cognition over time (although testing intervals may be longer than 
four weeks in these instances, which may lessen any practice effects).  
 
Both tests were quick to administer, taking less than 10 minutes, with the M@T being 
slightly quicker than the TYM (by approximately one minute, on average). 
Furthermore, there was very little missing data for both tests indicating that there were 
no issues with administering them. Both tests were designed to be administered by non-
specialist staff (with the TYM requiring minimal supervision). A particular issue with 
the M@T arose concerning the words used to assess episodic memory. The words “axe” 
and “green” were often misheard by the participants and had to be repeated and so these 
may need to be replaced by more easily distinguishable words for use in English 
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speaking populations (e.g. “hammer”, “yellow”). Any adaptations of the M@T would 
ideally need to be re-validated in further DTA studies.  
 
A limitation of the current study is that there was no long term follow-up of the 
participants and so the prognostic abilities of the tests cannot be commented on here. 
Future studies are required to see how accurate the tests are at discriminating between 
those people who go on to develop dementia and those who remain stable or improve. It 
would also be interesting to evaluate how the M@T and TYM might perform relative to 
other commonly used brief cognitive tests, such as the Memory Impairment Screen 
(MIS) (Buschke et al., 1999) and the Montreal Cognitive Assessment (MoCA) 
(Nasreddine et al., 2005) in a similar setting and head-to-head comparative studies are 
warranted in the future. 
 
Additionally, it is important to note here that, at the outset of the study, the aim had 
been to recruit 200 aMCI participants from the community on which to assess the 
validity of the tests (see Chapter 3). The fact that this sample size was not achieved has 
limited the precision with which the sensitivity of the tests can be reported here, with 
the tests demonstrating a lower bound value of sensitivity for aMCI of 70% and 47% for 
M@T and TYM respectively. Nevertheless, the point estimates of sensitivity provide 
useful indicators of the expected performance of the tests, but future studies with larger 
sample sizes would be required to provide more precise estimates. 
 
Conclusion 
In summary, the current study has provided evaluation of the performance of M@T and 
TYM within a community-based UK setting, providing results that are generalizable to 
the wider population. Amnestic MCI is largely unrecognised in primary care due to the 
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lack of simple, quick and sensitive cognitive tests. Both M@T and TYM were simple 
and quick to use and demonstrated moderate test-rest reliability. However, M@T was 
found to perform with higher DTA than TYM and could provide an efficient and 
accurate method for identifying aMCI in clinical or research settings. 
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Chapter 5: Exploring the Use of Reaction Time Measures in 
Identifying Cognitive Impairment 
 
Introduction 
 
Much research on the early detection of cognitive impairment and dementia has 
concentrated on the assessment of memory and other cognitive domain performance. 
However, there is growing interest in the use of other indicators of cognitive function, 
such as processing speed measures. A meta-analysis conducted to determine the 
characteristics of cognitive domain impairment in preclinical Alzheimer’s disease 
demonstrated that, in addition to the well-known deficits in episodic memory, losses in 
processing speed also occur early in the disease process (Backman, Jones, Berger, 
Laukka, & Small, 2005). A simple way of assessing processing speed is to measure the 
time it takes to react to a stimulus and this Chapter presents work which was conducted 
to evaluate the effectiveness of reaction time task derived measures in identifying MCI. 
These measures were selected as further potentially useful, simple tests that could 
provide an alternative to the traditionally used memory tests described previously. 
Measures based on reaction time tasks have an added benefit in that they are unlikely to 
be influenced by administrator bias, education level and language ability like many of 
the aforementioned tests.  
 
Previous research has demonstrated that mean reaction times tend to increase in normal 
ageing (Simon, 1968) and in pathological ageing, with studies showing increased 
reaction times in patients with cognitive impairment compared to unimpaired controls 
(Anstey et al., 2007; Dixon et al., 2007). Processing speed is thought to reflect 
underlying neural integrity and it has been theorised that cognitive performance is 
degraded when processing speed is slow due to a limited availability of neural resources 
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to support higher level cognitive behaviour such as episodic memory (Salthouse, 1996). 
In their study, Anstey et al (2007) provided evidence to suggest that processing speed 
performance is related to brain structure, with their results demonstrating that faster 
reactions times were associated with larger corpus callosum size in both healthy 
controls and those with mild cognitive disorders. 
 
As well as mean level of processing speed, the consistency with which an individual 
performs across trials within a task has also been suggested as being an important 
indicator of cognitive functioning (Hultsch & MacDonald, 2004; Jensen, 1992). The 
term most commonly used to describe a person’s level of consistency on a task is intra-
individual variability (IIV) and it has been proposed that this measure may provide 
another behavioural marker of neurobiological disturbance (Hultsch, Strauss, Hunter, & 
MacDonald, 2008; MacDonald, Nyberg, & Backman, 2006). Previous research has 
demonstrated that IIV increases in normal ageing (for review see (Dykiert, Der, Starr, & 
Deary, 2012), traumatic brain injury (Hetherington, Stuss, & Finlayson, 1996; Stuss, 
Pogue, Buckle, & Bondar, 1994), mild cognitive impairment (Christensen et al., 2005; 
Dixon et al., 2007; Gorus, De Raedt, Lambert, Lemper, & Mets, 2008) and mild 
dementia (Burton, Strauss, Hultsch, Moll, & Hunter, 2006; Hultsch et al., 2000). In their 
study, Hultsch et al (2000) demonstrated that IIV was greater in patients with mild 
dementia than in cognitively healthy elderly people, regardless of whether or not they 
had arthritis, indicating that increased IIV is probably primarily due to central 
neurological rather than somatic disturbances. In addition, Burton et al (2006) 
demonstrated that IIV is most likely associated with specific, rather than general 
nervous system disturbances, with their finding that patients with AD were more 
inconsistent than those with Parkinson’s disease. Studies have also shown that IIV in 
reaction time predicts longitudinal cognitive decline in ageing populations (Bielak, 
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Hultsch, Strauss, Macdonald, & Hunter, 2010; Lovden, Li, Shing, & Lindenberger, 
2007; MacDonald, Hultsch, & Dixon, 2003). 
 
Increases in IIV in reaction time performance have been proposed to reflect the 
increased neural noise and reduction in cortical representation that could result from the 
white matter decline that occurs in the brain during normal and pathological aging 
(MacDonald, Li, & Backman, 2009). Evidence to support this theory has been 
demonstrated in MRI studies; for instance, Bunce et al. (2007) found that white matter 
lesioning, particularly in the frontal lobe, was associated with elevated IIV on simple 
reaction time tasks. In addition, Jackson et al (2012) found strong associations between 
IIV measures and total cerebral white matter volume, as well as frontal and parietal 
region volumes, in healthy older adults and participants with early stage Alzheimer’s 
disease. Increased IIV has been linked to frontal cortex mediated processes such as 
attentional lapses (Bunce, Warr, & Cochrane, 1993) and fluctuations in executive 
control (West, Murphy, Armilio, Craik, & Stuss, 2002). 
 
Previous evidence suggests a link between cognition and performance on simple 
reaction time (RT) tasks, leading to the proposal that measures derived from RT tasks 
have the potential to aid the identification of a range of neurobiological disorders, 
including mild cognitive impairment (Bunce et al., 2013). This chapter reports the 
findings from a study that was conducted to investigate the use of RT task derived 
measures in identifying cognitive impairment.   
 
Studies to date of RT performance in cognitive impairment and dementia have tended to 
use clinical samples in which the disease is likely to be relatively far progressed (Burton 
et al., 2006; Hultsch et al., 2000). Alternatively, studies investigating pre-dementia 
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phases have tended to use a rather broad definition of mild cognitive impairment that 
includes individuals with “age-associated memory impairment”, “aging-associated 
cognitive decline” and “mild neurocognitive disorder” (Anstey et al., 2007; Christensen 
et al., 2005) or have focussed on only the amnestic form of MCI (Gorus et al., 2008). 
This study aimed to evaluate the use of RT task derived measures within a well-
characterised sample of community-dwelling participants including healthy controls, 
people with amnestic and non-amnestic MCI and people with cognitive difficulties 
beyond MCI (i.e. possible early dementia). People with low mood were also included 
since it has been proposed that depression may affect cognitive performance and has 
been associated with increased IIV in RT performance (Bunce, Handley, & Gaines, 
2008).  
 
Participants were administered two RT tasks: (i) a simple, two choice RT task (2CRT), 
with button box response and (ii) a more complex five choice RT task (5CRT), with 
touchscreen response. The inclusion of RT tasks with varying complexity enables the 
influence of task complexity to be investigated. There is evidence to suggest that 
increasing task complexity is associated with poorer performance in cognitively 
impaired groups (Dixon et al., 2007; Gorus et al., 2008; Hultsch et al., 2000); however, 
questions still remain as to the optimal level of complexity of RT task that should be 
used to assess RT performance in the identification of cognitive impairment (Bielak et 
al., 2010). Also, the use of touchscreen technology enabled spatial accuracy, as well as 
speed, of response to be measured, and thus provided an additional novel measure, 
currently unexplored (to the author’s knowledge) within this field of research. In 
summary, the current study aimed to investigate the effectiveness of a range of 
measures derived from RT tasks for identifying people with cognitive impairment, by 
addressing the following questions: (1) Are there differences in (a) mean RT and RT 
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variability and (b) accuracy measures between people depending on their cognitive 
classification?; (2) Does the complexity of the RT task (2CRT vs. 5CRT) have a 
differential effect on RT performance that is dependent on cognitive classification?; and 
(3) Are RT task derived measures able to predict cognitive classification?   
 
Methods 
Participants 
Older people (aged 70 years and above) were invited to participate via flyers sent to 
them from their GP practice. They were part of a larger study cohort recruited to assess 
the validity of two brief cognitive tests (described previously in Chapter 4). All 
participants were evaluated using the battery of cognitive assessments described in 
Chapter 3 and were categorised into the following groups: (1) Control; (2) Amnestic 
MCI (aMCI); (3) Non-amnestic MCI (naMCI); (4) Cognitive difficulties beyond MCI 
(>MCI) and (5) Low mood. A total of 225 people were included in this study. However, 
one person could not be categorised due to a hearing impairment that impacted on their 
performance in the cognitive assessments, and was therefore excluded, leaving a total of 
224 people in the study.  
 
Participants with cognitive impairment 
Thirty-nine people met the Petersen criteria for MCI (Petersen, 2004). Of these, 28 
demonstrated impairment in memory (defined as CVLT Short Delay and Long Delay 
free recall ≥ 1.5 standard deviations below mean of published norms (Delis et al., 
2000)) and were classified as having aMCI (amnestic MCI). The remaining 11 people 
demonstrated impairment in other non-memory domain(s) and were classified as having 
naMCI (non-amnestic MCI). Both single domain and multi-domain MCI participants 
were included.   
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Nine people demonstrated cognitive impairment that had detrimental effects on 
activities of daily living (as measured by the informant-administered Bristol Activities 
of Daily Living Scale (Bucks et al., 1996)) and were therefore classified as having 
cognitive impairment beyond MCI (>MCI).  
 
Participants with low mood 
Twelve people scored ≥6 on the Geriatric Depression Scale (Sheikh & Yesavage, 1986) 
and were classified as having a low mood. 
 
Control participants 
The remaining 164 people did not meet any of the previously described classifications 
and were therefore classified as controls and formed the reference group for the 
subsequent analyses. 
 
The study was approved by the Yorkshire and The Humber National Research Ethics 
Service Committee (ref: 12/YH/0207) and all participants gave informed written 
consent. Ethical approval was also granted from the University of Leeds for the 
administration of the RT tasks, which were developed and administered using 
University-owned equipment (ref: 13.0256).   
 
Reaction Time Tests 
Participants performed two reaction time (RT) tasks. One was a simple two choice RT 
task and the other was a more complex five choice RT task. Both tasks were designed in 
ePrime ® version 2.0.8.90 (Psychology Software Tools Inc., USA) and run on a 
Toshiba Portege M750-116 Touchscreen laptop. Participants were sat positioned an 
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arm’s length (30-50cm) away from the screen when performing the tasks. The order in 
which the tasks were administered was alternated between participants. 
 
Two Choice Reaction Time Task (2CRT) 
This task involved participants responding to a black circular target randomly presented 
on either the left or right hand side of a white screen (see Figure 5.1a) by pressing the 
corresponding button on a button box. A CEDRUS ® RB-540 button box attached via 
USB port to the laptop was used in this task. The circular targets were 25mm in 
diameter and were presented with an inter-stimulus interval of 500ms, during which a 
black fixation cross appeared in the centre of the screen. The circular target was 
positioned 4cm from the fixation cross and stayed on screen until the participant pressed 
a button. Participants were instructed to respond as quickly and as accurately as 
possible. Participants completed 12 practice trials, followed by 48 experimental trials. 
Based on an imposed maximum time limit per trial of 10 seconds, the task did not take 
longer than 10 minutes to administer, with the majority of participants able to complete 
the task in under 5 minutes.  
 
Five Choice Reaction Time Task (5CRT) 
This task utilised the touchscreen function of the laptop. In this task, participants 
responded to black circular targets appearing on a white screen by touching the target. 
The circular targets were 20mm in diameter and were randomly presented around the 
screen in one of five possible positions, equidistant from the centre at 9cm (see Figure 
5.1b). The inter-stimulus interval was 500 or 1000ms (determined randomly) and during 
this time a box containing the words “touch here” appeared at the bottom of the screen. 
Participants were instructed to begin each trial by pressing and holding the “touch here” 
box, ensuring that they began each trial from the same starting point. The circular target 
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stayed on screen until the participant touched the screen. Again, participants were 
instructed to respond as quickly and as accurately as possible. Participants completed 5 
practice trials, followed by 50 experimental trials. Based on an imposed maximum time 
limit per trial of 10 seconds, the task did not take longer than 9 minutes and 10 seconds 
to administer, with the majority of participants able to complete the task in under 5 
minutes. 
 
  
Figure 5.1: Possible target positions on the (A) 2CRT task and (B) 5CRT task 
 
Data Processing 
Two Choice Reaction Time Task (2CRT) 
The RT in milliseconds (ms) was registered for each trial, and was measured as the time 
from target onset until a button response was identified. The button that was pressed for 
each trial was also recorded so that correct and incorrect responses could be identified. 
The data was filtered so that all RTs <150ms (deemed to be anticipatory rather than 
genuine responses) and all incorrect responses (i.e. where the participant pressed the 
wrong button) were excluded. Excessively slow trials (i.e. RTs > individual mean RT + 
3SDs) were also removed and replaced with the mean RT over the remaining trials for 
each participant. These lower and upper bounds have been suggested by previous 
research (Hultsch, MacDonald, & Dixon, 2002; Hultsch et al., 2000) and removing such 
outliers and replacing missing values represents a conservative approach to computing 
IIV (Bunce et al., 2008). As a result of the filtering process, a total of 320 (3.1%) trials 
were excluded and 173 (1.7%) excessively slow trials were replaced.  
(A) (B) 
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Following the filtering of the data, the mean RT and RT IIV were calculated for each 
participant. Different measures have been proposed in the reporting of IIV (Hultsch et 
al., 2000). The raw standard deviation (SD) of responses has been used, but it has the 
disadvantage of being related to mean level of performance. A way of adjusting for this 
potentially confounding effect is to compute the coefficient of variation (CV), which 
involves dividing the raw SD by the mean RT (Hultsch & MacDonald, 2004) and it is 
this measure which has emerged as the standard measure of RT consistency recently 
due to its relatively easy calculation and high association with other measures of 
inconsistency (Bunce et al., 2013; Jackson et al., 2012; Lovden et al., 2007). Given this 
rationale, the CV was therefore calculated for each participant as a measure of IIV in 
this study. Finally, the number of incorrect responses for each participant was also 
calculated. 
 
Five Choice Reaction Time Task (5CRT) 
The RT in milliseconds (ms) was measured as the time from target onset until a 
touchscreen response was identified. The RT data was filtered in the same way as for 
the 2CRT task (see previous section). For this task, incorrect responses/task failures 
were defined as those trials where the participant touched the screen at a distance of 
>200 pixels from the target centre (these trials were outside the range of that deemed to 
be a “genuine” response). Trials were defined as “misses” when the participant touched 
the screen at a distance of >50 pixels but <200 pixels from the target centre (“misses” 
were classed as genuine attempts to touch the target and therefore included in the 
analysis). As a result of the filtering process, a total of 947 (9.1%) trials were excluded 
and 169 (1.6%) excessively slow trials were replaced. 
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In addition to mean RT, RT IIV and number of misses, spatial accuracy variables were 
also calculated for this task. Spatial accuracy was defined as the distance (measured in 
pixels) of the participant’s touch response from the centre of the target. Mean spatial 
accuracy and spatial accuracy IIV (calculated as the coefficient of variation: spatial 
accuracy SD/mean spatial accuracy) were calculated for each participant. 
 
Statistical Analyses   
All analyses were performed using SPSS Statistics v22 (IBM). Between-group 
differences in baseline characteristics (including age, years of education, NART IQ, 
GDS score and the neuropsychological test battery scores) were explored using the 
Kruskal-Wallis H test (since the data were not normally distributed).  Subsequently, 
pairwise comparisons were performed using Dunn's (1964) procedure with a Bonferroni 
correction for multiple comparisons. Difference in gender proportion between the 
classification groups was analysed using the Chi-square test of homogeneity. 
 
Mean RT and RT IIV for both tasks were also not normally distributed and an inverse 
transformation was applied to the data to achieve approximately normal distributions 
prior to subsequent analyses being run. One-way and mixed measures ANOVAs, with 
classification (cognitive status) as the between-group variable and task complexity 
(2CRT vs. 5CRT) as the within-group variable were used to explore for differences in 
mean RT and RT IIV between groups.  Bonferroni corrected post hoc group-by-group 
comparisons were subsequently performed.  
 
All accuracy variables (number of incorrect responses on the 2CRT task, number of 
misses, mean spatial accuracy and spatial accuracy IIV on the 5CRT task) were also not 
normally distributed. An inverse transformation was applied to mean spatial accuracy 
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and spatial accuracy IIV data to achieve approximately normal distributions prior to 
subsequent analyses being run. One way ANOVAs (with Bonferroni corrected post-hoc 
pair-wise comparisons) were applied to explore any between group-differences. Due to 
the nature of the data, the number of incorrect responses on the 2CRT task and the 
number of misses on the 5CRT could not be transformed and so between group 
differences were explored using the Kruskal-Wallis H test (with Bonferroni corrected 
post-hoc pairwise comparisons). 
 
Cohen’s d effect sizes for any significant pairwise comparisons were calculated and 
were interpreted as follows: 0.2 < Cohen’s d < 0.5 = small, 0.5 < Cohen’s d < 0.8 = 
medium and 0.8 < Cohen’s d = large effect size (Cohen, 1988; Lakens, 2013). 
 
Multinomial regressions were applied to assess whether the RT measures could predict 
classification. Age and NART IQ were included as covariates and the models were 
checked to ensure there was no multi-collinearity between the included variables. It is 
important to note that years of education was not included since it significantly 
correlated with both age and NART IQ.  
 
Results 
 
Baseline Characteristics 
The baseline characteristics and neuropsychological battery test scores of the 
participants by classification are shown in Table 5.1. Results from the Kruskal-Wallis H 
tests suggested that there were statistically significant differences between the groups in 
age (χ2(4) = 13.942, p=0.007), years of education (χ2(4) = 12.479, p=0.014) and NART 
IQ (χ2(4) = 10.755, p=0.029). However, post-hoc pair-wise comparisons revealed only a 
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significant difference in age between the controls and >MCI group (p=0.023), with the 
>MCI group being significantly older than the control group. 
 
As the neuropsychological test scores formed the basis of the classifications, as 
expected, statistically significant differences were found between groups in GDS, 
CVLT short and long delay recall, Brixton Errors, Trail making tests A and B, VOSP-
dot counting and -number location scores, CDT, GNT, BADLS (all at p<0.001) and 
VOSP-object decision score and PPT (at p<0.05) (see Table 5.1).  
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Table 5.1: Baseline characteristics and neuropsychological tests scores for the RT study cohort by classification 
 Control (n=164) aMCI (n=28) naMCI (n=11) >MCI (n=9) Low Mood (n = 12) p value 
 Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Age (years) 75.0 (8) 104.67 77.5 (11) 125.79 81.0 (6) 144.32 80.0 (13)* 172.22 75.5 (12) 114.54 0.007 
Gender (% female) 45 - 43 - 55 - 56 - 33 - 0.823 
Education (years) 11 (3) 118.92 10 (2) 84.59 12 (2) 138.09 11 (1) 85.83 10 (2) 86.42 0.014 
NART IQ
†
 116.0 (14) 119.74 112.5 (19) 99.27 115.0 (28) 100.27 105.0 (13) 78.56 106.5 (19) 72.42 0.029 
GDS 1 (2) 99.94 2 (3)
$ 
119.34 2 (2)
$ 
131.05 2 (2) 156.06 7.5 (3)*** 218.50 <0.001 
CVLT SD Free Recall, z score 0.5 (2) 134.98 -2.0 (1)*** 19.80 -0.5 (1) 82.18 -1.5 (1)*** 24.56 0.25 (3)
#
 115.25 <0.001 
CVLT LD Free Recall, z score 0.5 (2) 135.10 -2.0 (1)*** 24.91 -1.0 (1)** 54.09 -2.0 (2)*** 35.83 0.50 (5)
# 
119.04 <0.001 
Brixton Errors
‡^
 18 (8) 97.70 22.5 (11) 131.88 32.5 (17)** 176.75 22.5 (18) 134.56 22.0 (12) 130.23 <0.001 
Trails A
†
, percentile 60 (50) 127.38 30 (20)*** 71.61 10 (20)*** 45.41 10 (30)* 57.06 40 (45) 99.62 <0.001 
Trails B
§
, percentile 60 (50) 123.93 25 (45)*** 67.92 10 (15)*** 29.90 15 (35)* 47.08 30 (35)* 69.04 <0.001 
VOSP-Incomplete Letters score 20 (1) 115.71 20 (1) 117.88 19 (3) 76.27 19 (2) 102.22 19 (1) 97.00 0.204 
VOSP-Object Decision score
^ 
19 (3) 120.35 18 (3) 99.48 17 (2) 77.36 17 (3) 68.00 18 (5) 101.12 0.018 
VOSP-Dot Counting score 10 (0) 121.06 10 (1)** 87.48 10 (2)** 76.82 10 (2)* 79.22 10 (0) 111.58 <0.001 
VOSP-Number Location score
^ 
9.5 (1) 122.14 9 (3) 102.89 7 (3)** 48.68 8 (4) 88.83 8 (5) 79.42 <0.001 
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 Control (n=164) aMCI (n=28) naMCI (n=11) >MCI (n=9) Low Mood (n = 12) p value 
 Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Median 
(IQR) 
Mean 
Rank 
Clock Drawing Test score
†
 5 (0) 116.72 5 (0)
% 
109.55 5 (2) 95.59 4 (1.5)*** 54.89 5 (0)
% 
111.42 <0.001 
Graded Naming Test score
^ 
24 (4) 126.85 19.5 (8)*** 71.95 17 (12) 76.82 19 (12)** 54.00 20 (8) 87.62 <0.001 
Pyramids & Palm Trees Test score
^ 
51 (2) 122.69 50.5 (2) 88.73 49 (3) 71.45 51 (2) 86.28 50.5 (3) 86.04 0.002 
BADLS score
†
 0 (0) 99.68 1 (3)**
% 
137.54 0 (2)
% 
119.23 14 (3)*** 219.00 0.5 (2)
% 
132.83 <0.001 
KEY: BADLS = Bristol Activities of Daily Living Scale; CVLT LD = California Verbal Learning Test, long delay recall; CVLT SD = California Verbal Learning Test, short delay 
recall; IQR = interquartile range; VOSP = Visual Object and Space Perception 
*p < 0.05, **p ≤ 0.01, ***p < 0.001 for difference from controls; #p < 0.05 for difference from aMCI and >MCI; %p < 0.05 for difference from >MCI; $p < 0.05 for difference from 
Low Mood with Bonferroni correction for multiple comparisons 
†
n = 163 control; 
‡
n = 161 control, 26 aMCI, 10 naMCI, 8 >MCI, 11 low mood; 
§
n = 160 control, 26 aMCI, 10 naMCI, 6 >MCI 
NB: Distributions of characteristics/scores were not similar for all groups, therefore comparisons are based on the mean rank (unless indicated 
^
 where distributions were similar, 
therefore comparisons are based on the median) 
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Exclusions 
In the following analyses, for the 2CRT task, data could not be collected from 8 control 
participants and 2 aMCI participants due to software issues occurring during 
administration of the task. For the 5CRT task, data could not be collected from 3 control 
participants, 1 naMCI participant, 1 >MCI participant and 1 low mood participant due 
to software issues occurring during administration of the task. In addition, the 5CRT 
task could not be administered with 1 >MCI participant due to comprehension 
difficulties and had to be abandoned for 1 control participant due to visual difficulties. 
Finally, 5CRT data was excluded for 9 participants due to them having <50% of trials 
remaining after the filtering process (6 controls, 1 naMCI, 1 >MCI, 1 low mood). The 
large failure rate for these participants indicated that they had failed to comply with the 
task objectives and therefore their data was deemed to be invalid. 
 
Mean Reaction Time 
Table 5.2 and Figure 5.2 present the mean reaction times of the participants by 
classification for each task. Results from the one way ANOVAs suggested that there 
were statistically significant differences between groups for mean RT on the 2CRT task 
(F(4, 209) = 6.731, p<0.001, partial η2 = 0.114) and on the 5CRT task (F(4, 202) = 
7.453, p<0.001, partial η2 = 0.129). Post hoc analyses revealed that persons with aMCI 
and naMCI were significantly slower than the controls on both the 2CRT task and the 
5CRT task (p≤0.01). Effect sizes for these comparisons were large for both aMCI and 
naMCI on the 5CRT task (Cohen’s d = 1.07 and 1.09 respectively) and medium for 
aMCI and large for naMCI (Cohen’s d = 0.73 and 1.30 respectively) on the 2CRT task. 
 
All groups were faster on the simple task (2CRT) compared to the more complex task 
(5CRT). This difference was statistically significant for all groups: the control group 
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(F(1, 145) = 1196.29, p<0.001, partial η2 = 0.892), the aMCI group (F(1, 25) = 126.14, 
p<0.001, partial η2 = 0.835), the naMCI group (F(1, 8) = 57.08, p<0.001, partial η2 = 
0.877), the >MCI group (F(1, 5) = 15.73, p = 0.01, partial η2 = 0.759) and the low mood 
group (F(1, 9) = 46.64, p<0.001, partial η2 = 0.838).  
 
There was a statistically significant interaction between classification and task 
complexity on mean reaction time (F(4, 192) = 3.436, p = 0.01, partial η2 = .067), 
indicating that performance disproportionately slowed with increasing task complexity 
for some groups compared to others (see Figure 5.3). Looking at the difference between 
tasks in group mean RTs, compared to the controls, persons with low mood 
demonstrated the largest slowing from the simple to the complex task, followed by 
persons with naMCI and >MCI. Conversely, persons with aMCI demonstrated less 
slowing from the simple to the complex task (see Table 5.2).  
 
 
Figure 5.2: Mean RT for 2CRT and 5CRT task for each classification group  
Mean reaction time (in ms) is presented for the 2CRT (left hand side) and 5CRT (right hand side) tasks. 
The RT is presented per classification group. The height of the bars indicates median group performance 
and the error bars indicate IQR; * indicates a difference from controls at p ≤ 0.01 (analyses performed on 
transformed data for 146 controls, 26 aMCI, 9 naMCI, 6 >MCI, 10 low mood where data were available 
for both tasks). 
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Table 5.2: 2CRT task and TST task mean reaction times and reaction time variability by classification 
  Control (n=164) aMCI (n=28) naMCI (n=11) >MCI (n=9) Low Mood (n = 12) 
2CRT Task 
Mean RT (ms)
† 373.31 (87.56) 461.03 (128.94)*
b 
470.24 (221.43)*
c 
469.47 (496.38) 372.86 (175.57) 
RT IIV
†
 0.22 (0.09) 0.25 (0.14) 0.20 (0.10) 0.33 (0.10)*
c
 0.27 (0.07) 
TST Task 
Mean RT
‡
 822.79 (137.65) 881.66 (246.82)*
c 
984.71 (417.25)*
c 
956.67 (359.23) 887.61 (354.85) 
RT IIV
‡
 0.13 (0.06) 0.15 (0.11) 0.18 (0.22) 0.18 (0.19) 0.18 (0.13) 
TST – 2CRT RT difference 449.5 420.6 514.5 487.2 514.8 
Values reported are median (IQR) 
†
n = 156 control, 26 aMCI; 
‡
n = 154 control, 9 naMCI, 6 >MCI, 10 low mood 
* p ≤ 0.01 for difference from controls (analyses performed on transformed data for 146 controls, 26 aMCI, 9 naMCI, 6 >MCI, 10 low mood where 
data were available for both tasks). 
bCohen’s d = 0.5 – 0.8 (medium effect size); cCohen’s d > 0.8 (large effect size) 
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Figure 5.3: Mean RT x Task Complexity interaction 
Mean reaction time (in ms) vs. task complexity (where 1 = 2CRT and 2 = 5CRT) plotted for each 
classification group (values plotted are medians) 
 
Intraindividual Variability in Reaction Time 
Table 5.2 and Figure 5.4 present the RT IIV of the participants by classification for each 
task. Results from the one way ANOVAs suggested that there were statistically 
significant differences between groups for RT IIV on the 2CRT task (F(4, 209) = 4.277, 
p = 0.002, partial η2 = 0.076) and on the 5CRT task (F(4, 202) = 4.224, p = 0.003, 
partial η2 = 0.077). Post hoc analysis revealed that participants with cognitive 
difficulties beyond MCI (>MCI) were significantly more variable than controls on the 
2CRT task (p = 0.02) and the effect size for this comparison was large (Cohen’s d = 
1.02). However, for the 5CRT task, post-hoc analysis did not reveal any significant 
pairwise comparisons.  
 
All groups were more variable on the simple task (2CRT) compared to the more 
complex task (5CRT). This difference was only statistically significant for: the control 
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group (F(1, 145) = 133.54, p<0.001, partial η2 = 0.479), the aMCI group (F(1, 25) = 
15.61, p = 0.001, partial η2 = 0.384) and the low mood group (F(1, 9) = 5.90, p = 0.038, 
partial η2 = 0.396).  
 
There was no statistically significant interaction between classification and task 
complexity on RT IIV. 
 
 
Figure 5.4: RT variability (CV) for 2CRT and 5CRT task for each classification group  
Reaction time variability (measured as the coefficient of variation, CV) is presented for the 2CRT (left 
hand side) and 5CRT (right hand side) tasks. The RT variability is presented per classification group. The 
height of the bars indicates median group performance and the error bars indicate IQR; * indicates a 
difference from controls at p ≤ 0.01 (analyses performed on transformed data for 146 controls, 26 aMCI, 
9 naMCI, 6 >MCI, 10 low mood where data were available for both tasks). 
 
Accuracy 
2CRT Incorrect Responses 
The numbers of incorrect responses made on the 2CRT task by participants by 
classification are shown in Table 5.3. The numbers of incorrect responses were 
generally low across all participants. There were no statistically significant differences 
118 
in the number of 2CRT incorrect responses between the different classifications, χ2(4) = 
5.421, p=0.247. 
 
5CRT Misses 
The numbers of misses made on the 5CRT task by participants by classification are 
shown in Table 5.3. Again, the numbers of misses were generally low across all 
participants. There were no statistically significant differences in the number of 5CRT 
misses between the different classifications, χ2(4) = 9.453, p=0.051. 
 
5CRT Spatial Accuracy 
Table 5.3 presents the mean spatial accuracy and spatial accuracy IIV on the 5CRT task 
of the participants by classification. There were no statistically significant differences in 
5CRT mean spatial accuracy between the different classifications, F(4, 202) = 1.393, p 
= 0.238. Spatial accuracy IIV on the 5CRT task revealed a marginally statistically 
significant difference between the classifications, F(4, 202) = 2.544, p = 0.04, partial η2 
= 0.048. Post-hoc analyses, however, didn’t reveal any significant pairwise 
comparisons. 
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Table 5.3: 2CRT task and TST task accuracy scores by classification 
  Control (n=164) aMCI (n=28) naMCI (n=11) >MCI (n=9) Low Mood (n = 12) 
2CRT Task Number of errors
 0 (2) 1 (3) 0 (1) 2 (4) 0 (3) 
TST Task 
Number of misses 1 (3) 1 (2) 1 (2) 3 (5) 2.5 (3) 
Mean Spatial Accuracy (pixels) 23.23 (7.38) 21.28 (8.30) 20.34 (4.25) 25.77 (13.40) 23.83 (8.98) 
Spatial Accuracy IIV 0.55 (0.12) 0.57 (0.13) 0.58 (0.21) 0.63 (0.25) 0.65 (0.19) 
Values reported are median (IQR) 
†
n = 156 control, 26 aMCI; 
‡
n = 154 control, 9 naMCI, 6 >MCI, 10 low mood 
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Predictive Ability of Scores 
Multinomial regressions were performed to investigate the predictive abilities of the RT 
task derived measures. Regressions were performed for those measures that had 
demonstrated statistically significant differences between classifications: (1) Mean RT 
on the 2CRT task, (2) Mean RT on the 5CRT task, (3) RT IIV on the 2CRT task, (4) RT 
IIV on the 5CRT task and (5) spatial accuracy IIV on the 5CRT task. Regressions were 
also performed for the two brief cognitive tests that were investigated in Chapter 4 ((6) 
M@T and (7) TYM), in order that direct comparisons could be made. In order to avoid 
any confounding influence of age and NART IQ, both of which have been shown to be 
associated with increased risk of cognitive decline and dementia (Chen, Lin, & Chen, 
2009; Pavlik, Doody, Massman, & Chan, 2006), they were included as covariates in 
each regression. 
 
Table 5.4 summarises the results of the multinomial regression analyses. The overall hit 
ratio (% of cases with classifications correctly predicted) of the obtained models ranged 
from 72.3% to 78.3%. Of the RT measures, the best model was obtained using 5CRT 
mean RT (overall hit ratio = 76.7%); however, out of all measures, the best model was 
obtained using M@T (overall hit ratio = 78.3%). The groups for which a measure was 
found to be significantly predictive (in comparison with controls) have been highlighted 
in Table 5.4. For both the 2CRT and 5CRT tasks, the mean RT measure was found to 
significantly predict both aMCI and naMCI groups. However, the RT IIV measure was 
only significantly predictive of the aMCI group and only for the 2CRT task.  
 
Interestingly, the 5CRT spatial accuracy IIV measure was found to significantly predict 
low mood and the M@T and TYM significantly predicted all classifications. Notably, in 
eleven out of the twenty tested group comparisons for the RT task derived measures 
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only, age and/or NART IQ were significant predictors of group classification. All 
models were deemed to be a good fit according to a comparison of the final vs. intercept 
only models and almost all (except the M@T model) according to the Pearson statistic.  
 
Table 5.4: Multinomial regression analyses discriminating classifications (vs. control) for (1) 2CRT 
mean RT, (2) 2CRT RT IIV, (3) 5CRT mean RT, (4) 5CRT RT IIV, (5) 5CRT spatial accuracy IIV; 
(6) M@T, (7) TYM 
(1) 2CRT mean RT: Χ2(4) = 10.915, p = 0.03 (OHR = 73.7%) 
Goodness of Fit: Pearson, Χ2(836) = 773.499, p = 0.940; Final vs. Intercept only, Χ2(12)=36.1, p<0.001 
vs. Control B OR 95% CI 
aMCI 0.004** 1.004 1.001 – 1.007 
naMCI 0.004* 1.004 1.000 – 1.008 
>MCI
a 
0.004 1.004 1.000 – 1.007 
Low Mood
b 
0.001 1.001 0.996 – 1.006 
(2) 2CRT RT IIV$: Χ2(4) = 7.204, p = 0.126 (OHR = 72.3%) 
Goodness of Fit: Pearson, Χ2(836) = 762.83, p = 0.97; Final vs. Intercept only, Χ2(12)=32.39, p=0.001 
vs. Control B OR 95% CI 
aMCI 0.460* 1.584 1.028 – 2.441 
naMCI -0.207 0.813 0.366 – 1.808 
>MCI
a 
0.513 1.670 0.944 – 2.957 
Low Mood
b 
0.351 1.420 0.785- 2.569 
(3) 5CRT mean RT: Χ2(4) = 22.355, p < 0.001 (OHR = 76.7%) 
Goodness of Fit: Pearson, Χ2(808) = 689.74, p = 0.999; Final vs. Intercept only, Χ2(12)=51.71, p<0.001 
vs. Control B OR 95% CI 
aMCI 0.005** 1.005 1.003 – 1.008 
naMCI 0.006** 1.006 1.002 – 1.009 
>MCI
a 
0.003 1.003 0.999 – 1.008 
Low Mood
 
0.003 1.003 0.999 – 1.007 
(4) 5CRT RT IIV$: Χ2(4) = 5.988, p = 0.200 (OHR = 74.8%) 
Goodness of Fit: Pearson, Χ2(808) = 677.58, p = 1.000; Final vs. Intercept only, Χ2(12)=35.35, p<0.001 
vs. Control B OR 95% CI 
aMCI
a,b 
0.267 1.306 0.917 – 1.861 
naMCI
b 
0.413 1.511 0.908 – 2.514 
>MCI
a 
0.537 1.712 0.826 – 3.548 
Low Mood
 
0.386 1.471 0.924 – 2.343 
(5) 5CRT Spatial Accuracy IIV$: Χ2(4) = 5.512, p = 0.239 (OHR = 74.3%) 
Goodness of Fit (Pearson): Χ2(808) = 770.09, p = 0.83; Final vs. Intercept only, Χ2(12)=34.87, p<0.001 
vs. Control B OR 95% CI 
aMCI
a,b 
0.019 1.019 0.745 – 1.394 
naMCI
b 
0.315 1.370 0.934 – 2.010 
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>MCI
a 
0.188 1.206 0.739 – 1.969 
Low Mood
 
0.356* 1.428 1.017 – 2.004 
(6) M@T: Χ2(4) = 80.745, p < 0.001 (OHR = 78.3%) 
Goodness of Fit: Pearson, Χ2(856) =1206.7 , p <0.001; Final vs. Intercept only, Χ2(12)=105.7, p<0.001 
vs. Control B OR 95% CI 
aMCI
 
-0.347** 0.707 0.634 – 0.788 
naMCI
 
-0.203** 0.816 0.721 – 0.924 
>MCI
 
-0.389** 0.677 0.586 – 0.782 
Low Mood
 
-0.152* 0.859 0.757 – 0.974 
(7) TYM: Χ2(4) = 60.369, p < 0.001 (OHR = 78.0%) 
Goodness of Fit (Pearson): Χ2(848) = 815.77, p = 0.78; Final vs. Intercept only, Χ2(12)=88.78, p<0.001 
vs. Control B OR 95% CI 
aMCI
 
-0.365** 0.694 0.609 – 0.792 
naMCI
 
-0.176* 0.839 0.708 – 0.994 
>MCI
 
-0.519** 0.595 0.487 – 0.727 
Low Mood
 
-0.239** 0.787 0.672 – 0.922 
Notes: Age and NART IQ were included as covariates throughout all analyses and were non-significant 
predictors except where indicated (
a 
Age significant predictor at p<0.05;
b
 NART IQ significant predictor 
at p<0.05)  
$
Variability measures were multiplied by a factor of 10 prior to running multinomial regressions 
 
Discussion 
 
This study aimed to investigate the effectiveness of measures derived from RT tasks for 
identifying people with cognitive impairment. Participants with aMCI, naMCI, 
cognitive difficulties beyond MCI (>MCI) and low mood, as well as control 
participants, were administered a simple (2CRT) and a more complex (5CRT) task. 
Mean RT, RT IIV and the number of errors/misses made were measured for both tasks. 
In addition, mean spatial accuracy and spatial accuracy IIV were measured for the more 
complex (5CRT) task. The discriminative ability of these variables was evaluated. 
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Mean RT & RT Variability 
 
The results indicate that people with MCI (amnestic and non-amnestic) are significantly 
slower than healthy controls on simple and more complex RT tasks. These results 
reflect previous studies which have shown increased RTs in people with “mild cognitive 
disorders” (Anstey et al., 2007), aMCI (Gorus et al., 2008) and MCI (Christensen et al., 
2005; Dixon et al., 2007) compared with normal controls. The results are similar to 
those reported by Gorus and colleagues (Gorus et al., 2008), which demonstrated 
increasing RT with increasing cognitive impairment severity, with the >MCI group 
being slower on average than the aMCI group, who were in turn slower than the control 
group on both tasks. This finding supports the proposition that age-related cognitive 
decline is associated with a decline in basic processing speed (Salthouse, 1996). Perhaps 
due to the small sample size and heterogeneity of the group, the difference between the 
>MCI group and the controls did not reach statistical significance. The heterogeneity of 
the group is reflected in the large variation in their mean RT scores (as measured by the 
inter-quartile range). It is also interesting to point out that this group in fact did not 
score significantly lower than the MCI groups on any of the neuropsychological tests, 
apart from on the BADLS (which measures activities of daily living performance). 
Therefore, it is likely that the >MCI group were not as severely impaired as the mild-
moderate Alzheimer’s disease group included in the study by Gorus et al (2008).  
 
In terms of RT variability, only the >MCI group demonstrated a significantly greater 
RT IIV score than the control group, and this was found in the simple RT task only. 
This reflects previous research which has demonstrated increased IIV in mild dementia 
populations (Burton et al., 2006; Hultsch et al., 2000) and supports the idea that IIV 
may be a behavioural indicator of compromised neurological mechanisms (Hultsch et 
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al., 2008; MacDonald et al., 2006). The results again approximately mirrored those by 
Gorus et al (Gorus et al., 2008), which demonstrated increasing RT IIV with increasing 
cognitive impairment severity, with the >MCI group being more variable than the aMCI 
group, who were in turn more variable on average than the control group on both tasks. 
However, perhaps due to the small sample sizes, the differences in IIV between the 
aMCI group and controls were not statistically significant. 
 
To the author’s knowledge, this is the first study to present these RT task derived 
measures for people with non-amnestic MCI. These are people who have impairment in 
cognitive domains other than memory. As mentioned previously, these participants 
were significantly slower than controls on both tasks. Interestingly, they were also 
slower than the aMCI group on both tasks, and performed with a similar RT to the 
>MCI group on the 2CRT task and were even slower on the 5CRT task. In terms of RT 
IIV, compared to the control and aMCI groups, the naMCI group were slightly less 
variable on the 2CRT task but more variable on the 5CRT task. The differences were 
not statistically significant, however their poorer performance on the more complex task 
is interesting to point out and may be reflective of their impairments in executive 
function and attention which may have impacted on their ability to perform this more 
cognitively demanding task. 
 
The low mood group performed with a similar RT to controls on the simple task but 
were slower on the more complex task. The low mood group were also more variable 
than controls on both tasks, although, perhaps due to the small sample size, none of 
these differences reached statistical significance. In their study, Bunce et al (2008) 
found an association between depression scores and variability in performance on more 
cognitively demanding tasks. A task that demonstrated particularly strong associations 
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with both older age and higher depression was one that involved measuring the RTs of 
participants searching for targets on the basis of colour and shape (a conjunctive visual 
search task). It was proposed that this finding was in line with the suggestion that 
attentional resources tend to be reduced in people with depression and that those 
resources available tend to be deployed towards depression-related thoughts resulting in 
cognitive deficits, particularly in more effortful processing (Bunce et al., 2008; 
Hartlage, Alloy, Vazquez, & Dykman, 1993). 
 
Accuracy 
 
The number of errors made on the 2CRT task and the number of misses made on the 
5CRT task were generally low across all groups; however, for both tasks, the 
participants with cognitive difficulties beyond MCI (>MCI) made the most errors and 
misses (although not statistically significantly different from any other group). In their 
study, Gorus et al (2008) also found no significant differences in number of errors 
between cognitively healthy people and those with aMCI; however, they did find that 
those with mild-moderate AD made significantly more errors. Again, a statistically 
significant result may not have been found here due to the small sample size and 
heterogeneity of the >MCI group. 
 
To the author’s knowledge, there has been no previous research addressing spatial 
accuracy in relation to cognitive impairment. In terms of mean spatial accuracy 
performance, the MCI groups appeared to perform with slightly better spatial accuracy 
than the control group; whereas the >MCI and low mood groups performed slightly 
worse. This does not indicate a clear pattern between mean spatial accuracy and 
cognitive impairment and makes the result difficult to interpret. Overall there appeared 
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to be a significant effect of group classification on spatial accuracy IIV, however, upon 
further consideration of pairwise differences, no significant differences were found. 
However, there did appear to be a tendency towards an increase in variability in spatial 
accuracy with cognitive impairment severity (with the >MCI group showing increased 
variability compared to the MCI groups, which in turn showed increased variability 
compared to the control group). It is worth noting that the low mood group performed 
on average with the greatest variability in spatial accuracy. 
 
Effect of Task Complexity 
 
There was an interaction between task complexity and classification for mean RT but 
not for RT variability; this same effect was demonstrated in a study by Christensen et al 
(Christensen et al., 2005). All groups performed more slowly on the more complex 
compared with the simple RT task; however, some groups slowed disproportionately 
between tasks compared with the control group. In particular, the naMCI and low mood 
groups demonstrated the greatest slowing when switching from the simple to the more 
complex task. Participants with cognitive difficulties beyond MCI also demonstrated 
more slowing than the control group (but to a lesser extent than the naMCI and low 
mood groups). This finding is in agreement with previous research which has shown 
that increasing task complexity is usually associated with poorer performance in non-
healthy groups (Hultsch et al., 2000) and perhaps not surprising since more demanding 
tasks require more effortful processing. Conversely, however, the aMCI group 
demonstrated less slowing than controls when switching to the more complex task. 
 
As stated above, there was no interaction between task complexity and classification on 
the RT IIV measure. However, it is interesting to note that all groups performed with 
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reduced variability on the more complex task compared to the simple task. Previous 
research has shown that IIV tends to increase on more complex tasks, particularly in 
more impaired samples, such as those with Alzheimer’s disease (Burton et al., 2006). 
Whereas in less impaired samples, studies have demonstrated a reduction in IIV on 
more complex tasks, for example, studies by Anstey et al (2007) and Christensen et al 
(2005) report lower IIV values on a 2CRT task compared with a simple RT task for 
both normative and mild cognitive disorder samples. The findings from this study 
replicate these latter studies, which used similar community-based recruitment strategies 
and included samples with milder cognitive disorders, rather than established dementia 
cases. 
 
Predictive Ability 
 
Of the RT task derived measures assessed, mean RT on the more complex task (5CRT) 
produced the highest overall hit ratio (76.7%) to correctly identify all classifications. In 
particular, this variable was found to be a statistically significant predictor of aMCI and 
naMCI vs. control. This finding reflects previous studies which have demonstrated that 
more complex RT tasks tend to enhance discrimination between cognitive groups 
(Bielak et al., 2010; Gorus et al., 2008; Hultsch et al., 2000). For example, in their 
study, Bielak et al (2010) demonstrated that mean RT on a more complex 2CRT task 
provided better discrimination between cognitive groups than mean RT on a simple 
finger tapping task. This study has replicated these findings by demonstrating that an 
increase in choice level (2 vs. 5) provides enhanced prediction of cognitive groups. 
Bielak et al (2010) also demonstrated that further increasing task complexity, by 
including task switching (i.e. switching between responding to the shape or colour of a 
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figure), further enhanced discrimination between cognitive groups. This level of 
complexity was not investigated in this study.  
 
The variability measures were slightly less successful at discriminating between all 
classification groups; however, the 2CRT RT IIV measure was found to be a 
statistically significant predictor of aMCI vs. control and in fact demonstrated a larger 
odds ratio than those found for the mean RT measures. This finding indicates that IIV 
may in fact be better at identifying people with aMCI in particular than mean RT, a 
finding which has been suggested in previous studies (Dixon et al., 2007; Gorus et al., 
2008). However, it is unexpected to find that these measures were not statistically 
significantly predictive of more severe cognitive impairment (i.e. the >MCI group) but 
again this may be due to the heterogeneity of this sample, as well as it’s small sample 
size in comparison with the other groups. 
 
Spatial accuracy variability was not found to be statistically significantly predictive of 
the MCI or >MCI groups, however, interestingly, was found to be predictive of low 
mood status. This again could tie in with the idea that attentional resources tend to be 
reduced in those with depression resulting in cognitive deficits, particularly in more 
demanding tasks (Bunce et al., 2008; Hartlage et al., 1993).  
 
Additionally, it is important to note that, although the RT derived measures were 
moderately useful at predicting cognitive classification, they were less accurate than the 
two brief cognitive tests evaluated in the previous chapter, the M@T and TYM. These 
brief cognitive tests (M@T and TYM) demonstrated overall hit ratios of ~78% and were 
statistically significantly predictive of all classifications. This indicates that tests of 
episodic memory and other cognitive domains are perhaps more useful in identifying 
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cognitive impairment than measures such as processing speed. However, the 
preliminary nature of this work must be noted. The sample sizes of the cognitively 
impaired groups were small, which may have accounted for the lack of statistically 
significant results. In fact, a post-hoc power calculation revealed that 62 aMCI and 372 
control participants would have been required to detect a difference of 0.04 in 2CRT 
IIV (as was observed in the study by Anstey and colleagues (2007)) with a power of 
90%. RT task derived measures do still present a useful, simple alternative to the 
traditionally used memory tests due to the fact that they are not influenced by 
administrator bias, education level or language ability and future studies with larger 
sample sizes should be considered to further investigate the potential role of RT derived 
measures in identifying cognitive impairment. 
 
Conclusion 
In summary, the results indicate that people with cognitive impairment have deficits in 
processing speed compared with healthy controls. Task complexity appears to have an 
effect on performance, particularly causing increased slowing in people with non-
amnestic MCI, low mood and more severe cognitive impairment. Of the RT task 
derived measures, mean RT on the more complex task was the best overall predictor of 
cognitive status and RT variability on the simple task was shown to be particularly 
predictive of aMCI. However, none of the RT task derived measures were as accurate at 
predicting cognitive status as the two brief cognitive tests previously evaluated, the 
M@T and TYM. 
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Chapter 6: Discussion 
 
This thesis aimed to investigate the effectiveness of a range of brief cognitive tests to be 
used for identifying people with MCI in an efficient and accurate manner. There has 
been increasing interest in identifying people with MCI since they are at an increased 
risk of developing dementia and could be ideal candidates on which to trial new 
dementia prevention interventions. However, MCI is largely unrecognised in primary 
care since its diagnosis depends on complex neuropsychological assessment methods 
not usually available in this setting. There is a need for a brief, sensitive and well-
validated cognitive test to be used at initial patient contact to identify those most at risk 
of developing dementia. The previous chapters have presented a body of work that 
included: (a) the identification of candidate brief cognitive tests, (b) the recruitment of a 
cohort of older people on which to validate the chosen tests and (c) the investigation of 
the performance of these tests within the identified cohort. This final Chapter will 
collate the main findings of the work contained within the thesis and discuss the 
strengths and limitations of the work, as well as make suggestions for future directions.   
 
Chapter 2 reported the findings from a systematic review that was conducted to identify 
the brief cognitive tests that have been used to detect people with the amnestic form of 
MCI (aMCI) and to evaluate the evidence for their validity. The focus of the review was 
aMCI since it is the commonest subtype (Roberts et al., 2012) and is associated with 
elevated rates of conversion to Alzheimer’s disease (AD) (Petersen et al., 2001), which 
is the most common form of dementia (Ferri et al., 2005). Tests chosen for inclusion 
were those that were deemed to be quick (taking less than 15 minutes) and simple (not 
requiring equipment or specialist staff) to administer to ensure their suitability for use in 
busy primary care and research settings.  
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It was discovered that over 40 brief cognitive tests have been developed and tested for 
the identification of aMCI. Verbal learning tests that assess word recall were found to 
be particularly sensitive at detecting aMCI (for example, short delay recall on the AVLT 
(Zhao et al., 2012) and on the CERAD (Chandler et al., 2005; Karrasch et al., 2005; 
Woodard et al., 2005), as well as wordlist learning on the HVLT (Gonzalez-Palau et al., 
2013; Schrijnemaekers et al., 2006)). Tasks such as these assess episodic memory, a 
feature known to be impaired in aMCI and early AD (Petersen et al., 1999) and thought 
to be the result of early pathological changes in the medial temporal lobe (Braak & 
Braak, 1998). It was argued, however, that tests that assess multiple cognitive domains 
provide the potential for a more comprehensive assessment, with the ability to detect 
non-memory cognitive impairment that is also frequently found in patients with aMCI, 
defined as multi-domain aMCI (Economou et al., 2007). The MoCA (Nasreddine et al., 
2005), which involves the assessment of memory, semantic knowledge, language, 
visuospatial processing, attention, orientation and executive function, was identified as 
the most comprehensively investigated test, displaying high sensitivity for aMCI and 
high test-retest reliability. However, the MoCA can take up to 15 minutes to administer 
and another, quicker multi-task test named the M@T (Ravaglia et al., 2005), which 
takes just 5-10 minutes to administer and also exhibited very high sensitivity for aMCI, 
was highlighted as a potentially useful test.  
 
A strength of this review over a similar previous review conducted by Lonie and 
colleagues (Lonie et al., 2009), is that an in depth quality appraisal of the included 
studies using a well-established tool (QUADAS-2, (Whiting et al., 2011)) was 
conducted. This appraisal revealed that a large proportion of included studies were 
judged to be at a high risk of unblinding the patient assessment process by comparing 
the performance of people with known aMCI from secondary care settings with that of 
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opportunistically recruited “controls” from the community. It has been reported that 
studies such as these may exaggerate diagnostic accuracy (Lijmer et al., 1999; Whiting 
et al., 2004). In addition, studies often did not use the same reference standard for all 
participants, with aMCI patients often undergoing more extensive assessments of 
cognition than the “controls” who were assumed to have no cognitive impairment, 
which was usually verified by a briefer set of tests. It was therefore argued that further 
validation studies, with improved design, were warranted.  
 
The experimental work covered within the thesis was designed to address these 
limitations of previous studies. Chapter 3 described the work involved in identifying a 
cohort of older people from the community on which to investigate the validity of the 
chosen candidate tests. By inviting volunteers from the community to take part, without 
prior knowledge of their cognitive status, there was reduced risk of unblinding the 
assessment process. In addition to reducing the risk of bias in the validation process, the 
community based approach also provided useful information on recruitment rates of 
people with MCI to inform future studies applying similar recruitment techniques. 
 
A prevalence of 16.5% of MCI within the assessed population was found, with aMCI 
being twice as prevalent as naMCI. A review by Ward and colleagues (2012) reported 
large variation in MCI prevalence across international studies, ranging from 3 to 42%, 
with the variability largely being attributed to a lack of consensus in MCI criteria and 
implementation (Ward et al., 2012). However, the current estimate is similar to that 
reported by other studies using similar recruitment techniques and criteria (Artero et al., 
2006; Luck et al., 2007). As discussed in the Chapter, however, the current estimate was 
based only on those people who were assessed, which equated to 6.2% of the contacted 
population, and when taking into account all people who were approached, the rate of 
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MCI in fact dropped to 1.02%. It was argued that this more conservative estimate 
should be considered when designing future studies applying similar recruitment 
techniques.  
 
At the outset of the study, the aim had been to recruit 200 people with aMCI, in order to 
maximise the precision with which the sensitivity of the tests under investigation could 
be reported. Only a quarter of this sample size target was actually achieved (n=52). This 
was largely due to the fact that the prevalence of aMCI within people reporting 
subjective memory impairment was lower than expected (12.5% compared with a 
predicted 30%, based on studies by Benito-Leon et al (2010) and Mitchell et al (2008)). 
In addition, the response rate to the flyers was much lower than anticipated. A 
recommendation was made that any future studies employing similar postal based 
recruitment strategies should consider re-contacting any initial non-responders as the 
rate of MCI may have in fact been higher within the delayed responder cohort, as 
demonstrated in a study by Miyamoto and colleagues (Miyamoto et al., 2009). Of those 
people who did respond at initial contact, a large proportion had to be excluded due to 
having no informant available to answer the informant-reported ADL scale. The use of 
alternative, performance-based ADL measures that do not require input from an 
informant for future studies was discussed; however, these can be unrepresentative of 
everyday functioning and are unsuited to large scale population-based aMCI case 
finding due to being time consuming and expensive to administer (Gold, 2012).     
 
Chapter 4 covered the findings from the validation study of the M@T (Rami et al., 
2007) and the TYM (Brown et al., 2009), which were identified from the literature as 
being potentially useful brief cognitive tests for identifying people with aMCI.  Both 
tests were simple and quick to administer, confirming their suitability for use in busy 
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clinical and research settings. However, the M@T was found to perform with higher 
diagnostic test accuracy (DTA) than the TYM, with higher sensitivity (85% vs. 63%) 
and similar specificity (84% vs. 87%) and higher overall accuracy as demonstrated by 
the AUC values (0.91 vs. 0.80). The study found that, for both tests, the diagnostic test 
accuracy was not as high as had been previously reported (Custodio et al., 2014; Hanyu 
et al., 2011; Munoz-Neira et al., 2014; Rami et al., 2010; Rami et al., 2007; Szczesniak 
et al., 2013). The discrepancies were attributed to the fact that a community-based 
recruitment strategy was applied here, with the aMCI population assessed likely to be 
less impaired than those included in previous studies, which have mostly recruited from 
secondary care-based settings, such as memory clinics and neurology departments. The 
study therefore provided more conservative estimates of DTA, more likely to be 
generalizable to unselected populations.  
 
In Chapter 5, the use of reaction time task derived measures in identifying cognitive 
impairment was explored. Reaction time (RT) tasks provide a simple way of assessing 
processing speed, which has been reported to demonstrate deficits early in the 
Alzheimer’s disease process (Backman et al., 2005). As well as mean level of 
performance, which has been shown to increase with cognitive impairment (Anstey et 
al., 2007; Dixon et al., 2007), the consistency with which an individual performs across 
trials within a task has also been suggested as being an important indicator of cognitive 
functioning (Hultsch & MacDonald, 2004; Jensen, 1992). RT task measures present an 
attractive alternative to the more traditionally used memory tests such as M@T and 
TYM since they are not influenced by administrator bias, education level or language 
ability. 
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As expected, people with cognitive impairment were found to be slower than healthy 
controls on a simple two choice reaction time task (2CRT) and a more complex five 
choice reaction time task (5CRT). People with cognitive impairment were also found to 
be more variable than healthy controls on the simple 2CRT task; however, the 
difference only reached significance in participants with cognitive difficulties beyond 
MCI. Mean RT on the more complex 5CRT task was found to be the most accurate RT 
task derived measure at predicting cognitive status overall, reflecting previous studies 
which have demonstrated that more complex RT tasks tend to enhance discrimination 
between cognitive groups (Bielak et al., 2010; Gorus et al., 2008; Hultsch et al., 2000). 
For aMCI in particular, RT variability on the 2CRT task demonstrated slightly better 
discriminative abilities than mean performance. However, although these RT derived 
measures were moderately useful at predicting cognitive classification, they were less 
accurate than either the M@T or TYM, indicating that tests of episodic memory and 
other cognitive domains are perhaps more useful in identifying cognitive impairment 
than measures such as processing speed. However, the preliminary nature of the work 
was stressed and it was suggested that future studies using larger samples of cognitively 
impaired people should be conducted to further investigate the potential of RT task 
derived measures in identifying cognitive impairment. 
 
Limitations & Future Work 
 
It could be argued that a limitation with the experimental work is that the classifications 
of cognitive impairment were not clinically verified. Rather, an algorithmic approach to 
cognitive classification was applied. Although this differs from usual clinical practice, 
which would involve the incorporation of clinical and neurological examination, it did 
enable the criteria to be applied in a standardised and objective manner, thereby 
ensuring reliability of the classifications (Petersen et al., 2014). It would have been 
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useful to have completed longitudinal follow-up of the cohort to ascertain which 
individuals went onto develop dementia and were therefore exhibiting a true prodromal 
state of dementia, however, due to time limitations this could not be completed within 
the scope of this study. Cards were sent out to participants at completion of the study, 
with an invitation for those interested in taking part in future studies to return the card 
and so there is perhaps potential to perform a longer term follow-up of those who 
responded as part of a future study. It would be particularly useful to investigate how 
accurate the brief cognitive tests were at detecting future dementia converters. 
 
Another limitation of the study, as discussed previously, is that the target sample size of 
200 aMCI participants was not reached, which limited the precision with which the 
sensitivity of the memory tests could be reported. Future studies with larger cohorts of 
people with aMCI are required to provide more precise estimates of sensitivity for the 
M@T and TYM. 
 
The M@T performed with high diagnostic test accuracy, albeit at a reduced level 
compared to that reported previously in the literature, largely as a result of the 
community-based recruitment strategy. It would be interesting to evaluate how it might 
perform relative to other well-validated tests such as the MoCA (Nasreddine et al., 
2005) in a similar setting and head-to-head comparative studies are warranted in the 
future. The M@T also requires some adaptation to the wordlist for use in English-
speaking populations so that more easily distinguishable words are included to reduce 
the risk of words being misheard. Therefore, it would be useful to use an adapted M@T 
in any future validation studies.  
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The current study only included English speaking people as the cognitive tests used to 
fulfil the Petersen criteria assessment have only been validated in English. However, 
this requirement to speak English will have led to the exclusion of a large number of 
people, particularly in the diverse area of Bradford where the research took place, which 
includes a large South Asian community, with many of its older generation unable to 
speak English to an adequate standard (Fuller, 2013). Therefore, it could be argued that 
the included cohort was not very representative of the local area. Further studies using 
translated versions of the cognitive tests are warranted so that future research in this 
area may be more inclusive. 
 
Reaction time derived measures were investigated as a potential alternative to the 
traditionally used memory tests for identifying cognitive impairment. Measures such as 
these are not influenced by administrator bias and do not have particular education level 
or language requirements, which means they are more inclusive by nature. 
Unfortunately these measures were not as accurate at predicting cognitive status as the 
M@T or TYM. However, they did provide some promising results, which could be 
explored further. For instance, the effect of task complexity on the performance of 
people with naMCI in particular could be investigated further by including increased 
levels of task complexity that require even more effortful processing, to see if the 
discriminative abilities improve with increased task complexity.  
 
Conclusion 
 
This thesis has provided novel information on the validity of brief cognitive tests 
assessed within a cohort of volunteers recruited from the community, without prior 
knowledge of their cognitive status. This has resulted in more conservative estimates of 
the validity of the tests and provided useful estimates of the recruitment rates of people 
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with MCI, which should be considered when designing future studies applying similar 
recruitment techniques. 
 
The current study has provided a prevalence estimate for MCI of 16.5%, based on an 
assessed sample of 472 people aged 70 years and above. However, future studies using 
a similar recruitment strategy should take account of the fact that this rate is 
dramatically reduced to 1.02% when taking account of all people approached.  
 
Of the brief tests investigated, the M@T was found to be the most effective at 
identifying aMCI. It was quick and simple to administer and was found to perform with 
high sensitivity and specificity for identifying aMCI within the assessed cohort. RT task 
derived measures were not as accurate at predicting cognitive status as the M@T. 
However, they did demonstrate some promising discriminative abilities and should be 
further explored as potentially useful alternatives to the traditionally used memory tests, 
which may be influenced by administrator bias, education level and language ability. 
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Appendix 2.1 – CINAHL Search Strategy 
 
1 CINAHL “mild cognit* impair*”.ti,ab 1439  
Apply 
Limits  
 
2 CINAHL MCI.ti,ab 959  
Apply 
Limits  
 
3 CINAHL “early dementia”.ti,ab 125  
Apply 
Limits  
 
4 CINAHL “early AD”.ti,ab 85  
Apply 
Limits  
 
5 CINAHL “early Alzheimer*”.ti,ab 153  
Apply 
Limits  
 
6 CINAHL “preclinical dementia”.ti,ab 18  
Apply 
Limits  
 
7 CINAHL “pre-clinical dementia”.ti,ab 1  
Apply 
Limits  
 
8 CINAHL “incipient dementia”.ti,ab 19  
Apply 
Limits  
 
9 CINAHL “isolated memory impairment”.ti,ab 1  
Apply 
Limits  
 
10 CINAHL (Amci OR Nmci OR Mmc).ti,ab 254  
Apply 
Limits  
 
11 CINAHL (“N-MCI” OR “A-MCI” OR “M-MCI”).ti,ab 34  
Apply 
Limits  
 
12 CINAHL “pre-clinical AD”.ti,ab 0  
Apply 
Limits  
 
13 CINAHL “preclinical AD”.ti,ab 32  
Apply 
Limits  
 
14 CINAHL “pre-clinical AAD”.ti,ab 0  
Apply 
Limits  
 
15 CINAHL “pre-clinical Alzheimer*”.ti,ab 2  
Apply 
Limits  
 
16 CINAHL AAMI.ti,ab 196  
Apply 
Limits  
 
17 CINAHL ARCD.ti,ab 2  
Apply 
Limits  
 
18 CINAHL CIND.ti,ab 57  
Apply 
Limits  
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19 CINAHL AACD.ti,ab 16  
Apply 
Limits  
 
20 CINAHL SMC.ti,ab 119  
Apply 
Limits  
 
21 CINAHL “questionable AD”.ti,ab 1  
Apply 
Limits  
 
22 CINAHL “questionable dementia”.ti,ab 22  
Apply 
Limits  
 
24 CINAHL “preclinical AD”.ti,ab 32  
Apply 
Limits  
 
24 CINAHL “mild neurocognitive disorder*”.ti,ab 3  
Apply 
Limits  
 
25 CINAHL “pre-clinical Alzheimer*”.ti,ab 2  
Apply 
Limits  
 
26 CINAHL (“benign AND senescent AND forgetfulness).ti,ab 0  
Apply 
Limits  
 
27 CINAHL BSF.ti,ab 12  
Apply 
Limits  
 
28 CINAHL (“Limited cognitive disturbance” OR LCD).ti,ab 105  
Apply 
Limits  
 
29 CINAHL (prodrom* adj2 dement*).ti,ab 24  
Apply 
Limits  
 
30 CINAHL (“global deterioration scale” AND “stage 3”).ti,ab 1  
Apply 
Limits  
 
31 CINAHL (“GDS 3” OR “stage 3 GDS”).ti,ab 3  
Apply 
Limits  
 
32 CINAHL “Age associated memory impair*”.ti,ab 19  
Apply 
Limits  
 
33 CINAHL “preclinical AAD”.ti,ab 0  
Apply 
Limits  
 
34 CINAHL “preclinical Alzheimer*”.ti,ab 29  
Apply 
Limits  
 
35 CINAHL “age related cognitive decline”.ti,ab 63  
Apply 
Limits  
 
36 CINAHL ACMI.ti,ab 33  
Apply 
Limits  
 
37 CINAHL “age associated cognitive decline”.ti,ab 9  Apply 
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Limits 
 
38 CINAHL “subjective memory complaint*”.ti,ab 80  
Apply 
Limits  
 
39 CINAHL “cognitive impairment-no* dement*”.ti,ab 44  
Apply 
Limits  
 
40 CINAHL (“minimal dementia” OR “MD”).ti,ab 5085  
Apply 
Limits  
 
41 CINAHL 
1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 
OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 
OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 
OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 
OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 
OR 38 OR 39 OR 40 
7958  
Apply 
Limits  
 
41 CINAHL 
(screen* adj3 (ora ge* OR method* OR scale* OR 
test* OR tool*)).ti,ab 
9573  
Apply 
Limits  
 
42 CINAHL 
(screen* adj1 (examination* OR 
questionnaire*)).ti,ab 
1039  
Apply 
Limits  
 
43 CINAHL 
((“clinical assessment tool*” OR “functional 
assessment*” OR “geriatric assessment*” OR 
“geriatric functional assessment*”)).ti,ab 
2248  
Apply 
Limits  
 
44 CINAHL exp GERIATRIC ASSESSMENT/ 9227  
Apply 
Limits  
 
45 CINAHL NEUROPSYCHOLOGICAL TESTS/ 15173  
Apply 
Limits  
 
46 CINAHL PSYCHOMETRICS/ 7161  
Apply 
Limits  
 
47 CINAHL 
(((cognit* OR memory OR mental) adj2 (assess* 
OR evaluat* OR screen* OR examin* OR diagnos* 
OR instrument* OR measure* OR questionnaire* 
OR scale* OR test*))).ti,ab 
14019  
Apply 
Limits  
 
48 CINAHL 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 50446  
Apply 
Limits  
 
49 CINAHL REPRODUCIBILITY OF RESULTS/ 13319  
Apply 
Limits  
 
50 CINAHL VALIDATION STUDIES/ 15038  
Apply 
Limits  
 
51 CINAHL ROC CURVE/ 6330  Apply 
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Limits 
 
52 CINAHL SENSITIVITY AND SPECIFICITY/ 25795  
Apply 
Limits  
 
53 CINAHL specific*.ti,ab 119750  
Apply 
Limits  
 
54 CINAHL ora ge*.ti,ab 41732  
Apply 
Limits  
 
55 CINAHL reliabil*.ti,ab 21576  
Apply 
Limits  
 
56 CINAHL accura*.ti,ab 36453  
Apply 
Limits  
 
57 CINAHL exp DIAGNOSTIC ERRORS/ 8607  
Apply 
Limits  
 
58 CINAHL Roc.ti,ab 1480  
Apply 
Limits  
 
58 CINAHL 
49 OR 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 
56 OR 57 OR 58 
225045  
Apply 
Limits  
 
145 CINAHL 41 AND 48 AND 58 474  
Apply 
Limits  
 
146 CINAHL 145 [Limit to: Publication Year 1999-2013] 457  A 
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Appendix 2.2 – SRR Data Extraction Form 
 
Reviewer:  Author(s):  Publication Year:  
 
Study detail 
Brief statement of aims  
Authors’ key conclusions  
Any design details/notes  
Duration of follow-up  
 
Participants 
Setting  
Country  
Characterisation  
Method of recruitment  
Inclusion criteria  
Exclusion criteria  
 
Clinical/neuropsychological assessment 
 
 
Group 1 
Name  
Definition  
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Group 2 
Name  
Definition  
 
Group 3 
Name  
Definition  
 
Participant Characteristics 
 Total Group 1 Group 2 Group 3 P value 
Number      
Age      
% Female      
Education, years      
MMSE      
Notes:  
 
Results – Diagnostic Test Accuracy 
Test Name     
Comparison groups     
AUC 
Standard error 
P 
95% CI 
    
Cut off     
159 
Sensitivity %     
Specificity %     
PPV %     
NPV %     
Number of true positives     
Number of false negatives     
Number of false positives     
Number of true negatives     
 
Results – Test-Retest Reliability 
Test-retest reliability reported?  YES NO  
Test Name     
Participants     
Time period     
Measure Used     
Result     
160 
QUADAS-2 tool 
 
Domain Signalling Questions Notes YES NO UNCLEAR 
1. Selection of 
patients 
a. Was a case-control design avoided?     
b. Was a consecutive or random sample of 
patients enrolled? 
    
2. Index test c. Were the index test results interpreted 
without knowledge of the results of the 
reference standard? 
    
3. Reference 
standard 
d. Were the reference standard results 
interpreted without knowledge of the results 
of the index test? 
    
4. Patient flow e. Was there an appropriate interval between 
the index test and reference standard?   
    
f. Did all patients receive the same reference 
standard?   
    
g. Were all patients included in the analysis?     
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Appendix 2.3: Forest plots summarising sensitivity and specificity for single 
task screens for identifying aMCI, with associated 95% confidence intervals  
 
162 
 
 
163 
 
NB: cut-off score in brackets; for index test definitions, see Abbreviations 
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Appendix 2.4: Forest plots summarising sensitivity and specificity for multi-
task screens for identifying aMCI, with associated 95% confidence intervals
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166 
 
NB: cut-off score in brackets; for index test definitions, see Abbreviations 
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Appendix 2.5: Forest plot of diagnostic odds ratios of studies looking at the 
diagnostic accuracy of MoCA (cut off score 23/24) 
 
  
Overall  (I-squared = 0.0%, p = 0.880)
Tsai 2012
Lee 2008
Zhao 2011
Fujiwara 2010
Study
36.88 (22.19, 61.27)
40.63 (12.95, 127.47)
54.38 (12.29, 240.60)
30.71 (15.93, 59.19)
46.75 (9.07, 240.92)
OR (95% CI)
100.00
16.01
%
13.39
61.79
8.81
Weight
  
1.00415 241
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Appendix 2.6: Forest plots summarising sensitivity and specificity for 
combined screens for identifying aMCI, with associated 95% confidence 
intervals 
 
NB: cut-off score in brackets; for index test definitions, see Abbreviations 
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Appendix 2.7: Forest plots summarising sensitivity and specificity for single 
task screens for identifying aMCI-progressors, with associated 95% 
confidence intervals  
 
NB: cut-off score in brackets; for index test definitions, see Abbreviations
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Appendix 2.8: Risk of Bias 
Study Selection of Patients Index Test Ref Standard Patient Flow Overall  
RoB 1 2 3 4 5 6 7 
(Ahmed et al., 2012) YES U/C U/C YES U/C U/C YES U/C 
(Ahn et al., 2010) NO U/C NO NO U/C NO YES HIGH 
(Alegret et al., 2009) NO U/C U/C YES U/C YES YES HIGH 
(Cacho et al., 2010) NO YES YES YES U/C YES YES HIGH 
(Chandler et al., 2005) NO U/C U/C YES U/C NO YES HIGH 
(Costa et al., 2012) NO U/C U/C U/C U/C NO YES HIGH 
(Dierckx et al., 2007) U/C U/C U/C U/C U/C NO YES HIGH 
(Diniz et al., 2008) NO U/C U/C U/C YES YES YES HIGH 
(Freitas et al., 2013) NO U/C NO NO YES NO YES HIGH 
(Fujiwara et al., 2010) NO U/C YES YES YES NO YES HIGH 
(Gonzalez-Palau et al., 2013) NO U/C YES YES U/C U/C YES HIGH 
(Guo et al., 2012) NO U/C U/C U/C U/C U/C YES HIGH 
(Hanyu et al., 2009) U/C U/C U/C U/C U/C NO YES HIGH 
(Hanyu et al., 2011) NO U/C U/C U/C U/C YES YES HIGH 
(Karrasch et al., 2005) NO U/C U/C U/C U/C YES NO HIGH 
(Kato et al., 2013) NO U/C U/C U/C U/C NO YES HIGH 
(Ladeira et al., 2009) YES U/C U/C YES U/C YES YES U/C 
(Lee et al., 2008) YES U/C YES YES U/C U/C YES U/C 
(Loewenstein et al., 2009) NO U/C U/C U/C U/C U/C YES HIGH 
(Luis et al., 2009) YES U/C YES YES U/C U/C YES U/C 
(McLennan et al., 2011) YES YES YES YES YES YES YES LOW 
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Study Selection of Patients Index Test Ref Standard Patient Flow Overall  
RoB 1 2 3 4 5 6 7 
(Muangpaisan et al., 2010) U/C U/C U/C U/C U/C U/C YES U/C 
(Nasreddine et al., 2005) NO U/C YES YES U/C YES YES HIGH 
(Rahman & El Gaafary, 2009) YES U/C YES YES U/C YES YES U/C 
(Rami et al., 2007) NO U/C U/C U/C U/C NO YES HIGH 
(Rami et al., 2010) YES U/C U/C U/C U/C U/C YES U/C 
(Ravaglia et al., 2005) YES U/C NO NO YES YES YES HIGH 
(Saka et al., 2006) NO U/C U/C YES YES NO YES HIGH 
(Scheurich et al., 2005) YES YES U/C U/C U/C YES YES U/C 
(Schrijnemaekers et al., 2006) YES U/C U/C YES NO YES YES HIGH 
(Smith et al., 2007) YES U/C YES U/C U/C YES YES U/C 
(Takahashi et al., 2012) YES U/C YES YES U/C YES U/C U/C 
(Tsai et al., 2012) NO U/C YES U/C YES U/C YES HIGH 
(Woodard et al., 2005) YES U/C U/C U/C YES YES YES U/C 
(Yoshida et al., 2012) NO U/C U/C U/C U/C U/C YES HIGH 
(Zhao et al., 2011) NO U/C U/C YES YES YES YES HIGH 
(Zhao et al., 2012) NO U/C U/C U/C U/C YES YES HIGH 
Longitudinal Studies         
(Ahmed, Mitchell, Arnold, 
Nestor, et al., 2008) 
NO YES NO NO N/A YES NO HIGH 
(Sarazin et al., 2007) YES U/C YES U/C N/A YES NO HIGH 
KEY: 1 = Was a case-control design avoided?; 2 = Was a consecutive or random sample of patients enrolled?; 3 = Were the index test results interpreted without knowledge of the results of the 
reference standard?; 4 = Were the reference standard results interpreted without knowledge of the results of the index test?; 5 = Was there an appropriate interval between the index test and reference 
standard?; 6 = Did all patients receive the same reference standard?; 7 = Were all patients included in the analysis? ; RoB = Risk of Bias; U/C = unclear; N/A = not applicable  
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Appendix 3.1: Recruitment Flyer (v2) 
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Appendix 4.1: Memory Alteration Test (M@T) 
 
Encoding 
‘Try to remember these words. It is important to pay close attention’ 
Repeat please: cherry (R) axe (R) elephant (R) piano (R) green (R) 
1 I told you the name of a fruit, what was it?  0  1 
      
2 I told you the name of a tool, what was it?  0  1 
      
3 I told you the name of an animal, what was it?  0  1 
      
4 I told you the name of a musical instrument, what was it?  0  1 
      
5 I told you the name of a colour, what was it?  0  1 
 (for each question, if 0, repeat the correct answer) 
‘Later on I will ask you to recall these words’ 
 
‘Please pay attention to these sentences and try to remember them’ (max 2 trials): 
Please repeat: Thirty grey cats ate all the cheese (R) 
6 How many cats were there?  0  1 
      
7 What colour were they?  0  1 
      
8 What did they eat?  0  1 
(If 0 tell the subject the correct answer) 
 
Please repeat: A boy named Louis was playing with his bicycle (R) (max 2 trials): 
9 What was the boy’s name?  0  1 
      
10 What was he playing with?  0  1 
(If 0 tell the subject the correct answer) 
Encoding Score  
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Temporal orientation 
11 Day of the week  0  1 
      
12 Month  0  1 
      
13 Date  0  1 
      
14 Year  0  1 
      
15 Season  0  1 
 
Orientation Score  
 
Semantic memory 
(2 trials; if the subject is wrong, repeat the question) 
16 What is your date of birth?  0  1 
      
17 What do you call someone who repairs cars?  0  1 
      
18 What was the name of the last prime minister*?    0  1 
      
19 What is the last day of the calendar year*?    0  1 
      
20 How many days are there in a year?  0  1 
      
21 How many grams are there in one quarter of a kilo?  0  1 
      
22 What is the 8th month of the year?  0  1 
      
23 When is Christmas day?  0  1 
      
24 If the clock shows 11 o’clock, what number does the 
long hand point toward? 
 0  1 
    
      
25 Which season comes after summer?    0  1 
 Continued overleaf… 
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26 In the story of Adam and Eve, which animal deceived 
Eve with an apple*? 
 0  1 
    
      
27 Which fruit is necessary to make wine?  0  1 
      
28 Which plant is necessary to make chocolate?  0  1 
      
30 How many hours are there in two days?  0  1 
 
Semantic Memory Score  
 
Free recall 
 
31 Tell me all the words you can remember from the list I    
said to you at the start of the test  
(1 point per word: cherry-axe-elephant-piano-green) 
(Wait for the answer minimum 20 sec. You may repeat the question twice) 
 
32 Do you remember anything from the sentence about the cats?   
(1 point per idea:30–Gray–cheese) 
33 Do you remember anything from the sentence about a boy?   
(1 point per idea: Louis–cycle) 
 
Free Recall Score  
 
Cued-recall (if applicable) 
 
(Score 1 point for each word provided in the preceding question) 
34 I told you the name of a fruit, what was it?  0  1 
      
35 I told you the name of a tool, what was it?  0  1 
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36 I told you the name of an animal, what was it?  0  1 
      
37 I told you the name of a musical instrument, what was it?  0  1 
      
38 I told you the name of a colour, what was it?  0  1 
 
Try to remember the sentence about cats . . .  
39 How many cats were there?  0  1 
      
40 What colour were they?  0  1 
      
41 What did they eat?  0  1 
 
Try to remember the sentence about a boy . . . 
42 What was the boy’s name?  0  1 
      
43 What was he playing with?  0  1 
 
Cued Recall Score  
 
GLOBAL Score  
 
Time to complete  
 
* Non-validated English version 
© Rami L B-5483-04. The validated Spanish version of the M@T is available for 
clinical use, but licensed for research and commercial use. 
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Appendix 4.2: Changes to M@T questions 
 
Original Question Changed to 
What was the name of the last president? What was the name of the last prime 
minister? 
What is the last day of the year? What is the last day of the calendar year? 
In the Bible, which animal deceived Eve 
with an apple? 
In the story of Adam and Eve, which 
animal deceived Eve with an apple? 
What is the triple of one? What is three times one? 
How many words that I said at the 
beginning can you remember? 
Tell me all the words you can remember 
from the list I said to you at the start of the 
test 
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Appendix 4.3: Test Your Memory test (TYM) 
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Appendix 4.4: Demographic characteristics and M@T & TYM scores of matched aMCI and Control groups 
 
 aMCI (n=40) Control (n=112) U z p value 
 Mean  
(SD) 
Median  
(IQR) 
Mean  
Rank 
Mean  
(SD) 
Median  
(IQR) 
Mean  
Rank 
 
Age, years 78.0 (5.4) 78 (9) 80 77.4 (5.1) 77 (8) 75 2107.0 -0.6 0.58 
Education, years 11.4 (2.0) 11 (2) 74 11.5 (1.9) 11 (2) 77 2141.5 -0.4 0.67 
NART IQ 111.4 (9.9) 113 (17) 75 111.8 (9.8) 112.5 (15) 77 2175.5 -0.3 0.79 
M@T global score 33.9 (6.2)* 35 (9)* 30 43.4 (4.6)
† 
44 (6)
† 
91 397 -7.6 <0.001 
TYM global score 40.9 (4.7) 41 (6) 43 45.6 (3.2) 46 (4) 89 893 -5.7 <0.001 
 
KEY: IQR = interquartile range; SD = standard deviation; NART = National Adult Reading Test; M@T = Memory Alteration Test; TYM = Test Your Memory test 
p values reported are for aMCI vs. Control 
*n = 39; 
†
n = 110 
 
 
 
